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Pseudomonas aeruginosa is a ubiquitous environmental organism with the 
ability to cause opportunistic infections in humans. It is a key organism in cystic 
fibrosis (CF) patients, where colonization by P. aeruginosa in the CF lung is 
linked to a poorer prognosis. It is also a major causative agent of hospital-
acquired infections, particularly in ventilator associated pneumonia, burn wounds, 
urinary catheter infections, and immunocompromised individuals. 
The P. aeruginosa transcriptional regulator, AlgR, regulates several 
important and diverse virulence factors and has been shown to be essential for 
survival of P. aeruginosa in a mouse septicemia model. Microarray analyses 
have indicated broad effect of AlgR on the transcription profiles during log and 
stationary phase in broth and biofilm-growth. First identified as a regulator of 
algD and algC promoters for alginate production, it has since been discovered to 
regulate the fimU-pilVWXY1Y2E, hcnABC, rhlI, and rhlA genes.  
The AlgR response regulator activity is affected by phosphorylation of a 
conserved aspartate residue. In other response regulators, substitution of this 
aspartate to a glutamate structurally and functionally mimicked phosphorylation. 
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In order to lock AlgR in either an active or inactive state, the algRD54E allele was 
introduced into the wild type lab strain PAO1, and compared with PAO1 
expressing algRD54N that encodes a phospho-defective AlgR. Virulence factors 
that were previously found to be regulated by AlgR were tested with both 
transcriptional (reporter or RT-qPCR) and biological assays in PAO1 and its 
mutants, including type IV pili-mediated twitching motility and fimU promoter 
activity, rhlI promoter activity, and rhamnolipid and pyocyanin (phenazine) 
production. Pathogenicity was also explored using an acute mouse pneumonia 
model. 
 Strain PAO1 algRD54E had similar phenotypes with its parental PAO1 
strain in terms of twitching motility, rhamnolipid production, pyocyanin production, 
and mouse virulence. Strain PAO1 algRD54N was less virulent in an acute 
murine pneumonia model of infection, and was defective in twitching motility and 
rhamnolipid production, but had increased production of pyocyanin. The results 
strongly suggest that AlgR phosphorylation has a functional role in P. aeruginosa 
pathogenicity, and modulating AlgR phophorylation may provide another 
mechanism to control P. aeruginosa infection. 
 
 
The form and content of this abstract are approved. I recommend its 
publication. 
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Review of AlgR as it pertains to P. aeruginosa 
 
Significance of P. aeruginosa  
Pseudomonas aeruginosa is a ubiquitous, metabolically versatile, 
environmental organism with the ability to cause opportunistic infections in 
humans. Its 6.3 Mbp genome contains at least 5500 open reading frames, with 
hundreds of virulence determinants (1, 2). P. aeruginosa is a key organism in 
cystic fibrosis (CF) patients, where colonization by P. aeruginosa in the CF lung 
is linked to a worsening disease prognosis (3, 4). It is also a significant causative 
agent of hospital-acquired infections (5-9), particularly in burn-wounds (10, 11) 
and immuno-compromised individuals (12-14).  
P. aeruginosa carries a large number of virulence factors (15). They utilize 
various appendages such as type IV pili, a single polar flagellum, and adhesins 
to attach to surfaces (16, 17). Extracellular or secreted proteins such as exotoxin 
A, alkaline proteases, elastases, and phospholipases, have the capacity to 
disrupt cell membranes and sustain growth by utilizing degraded cellular lipids 
and proteins (18-21). P. aeruginosa is also able to translocate exotoxins into host 
epithelial cells using a needle-like appendage called the type 3 secretion system, 
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further causing apotosis or cell lysis (22). The organism has several iron-
scavenging mechanisms, including secretion of pyoverdine and pyochelin, heme-
scavenging proteins to sustain intracellular iron levels for metabolism, respiration, 
and growth (23-25). The production of the exopolysaccharide alginate helps the 
organism establish chronic respiratory infection (e.g. CF) (26). Not only is P. 
aeruginosa equipped with a large set of virulence factors - it is also able to 
establish biofilms, allowing them to colonize and persist on various surfaces, 
making eradication extremely challenging.  
  
The clinical significance of cystic fibrosis 
P. aeruginosa is the one of the most important etiological agents for Cystic 
Fibrosis (CF)-associated respiratory disease (27). Because AlgR was first 
characterized as an alginate production regulator in P. aeruginosa recovered 
from CF isolates, CF will be discussed in detail here. CF is the most common 
and deadly inherited autosomal recessive disease for Caucasians in the United 
States, affecting 1 in 2500 live births. This systemic disease results from 
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) 
gene, encoding a chloride ion channel that is localized to the apical membrane of 
epithelial cells. Mutations in the cftr gene affects ion transport in exocrine glands, 
leading to deleterious effects in pancreatic function (28), obstructive azoospermia 
and infertility (29, 30), and liver disease (31, 32) 
Over 1000 mutations within the cftr gene have been characterized that 
result in disease manifestation (33). These mutations are classified into 6 
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categories based on their effect on CFTR function or expression: premature 
truncation or nonsense alleles (class I), misfolding and degradation (class II, e.g. 
∆F508), properly processed full length protein lacking conductance activity (class 
III), partial ion-channel activity (class IV), reduced cftr transcripts (class V), and 
decreased CFTR stability at the membrane (class VI) (34-36). The class II, cftr 
phenylalanine 508 deletion (∆F508) is found in 70% of patients with CF (33). 
Although the cftr mutation causes systemic, multi-organ dysfunction, lungs 
of CF patients are the primary site of bacterial colonization and infection. The 
CFTR mutation leads to abrogated chloride ion secretion into the airway lumen, 
and increased uptake of water and sodium ions into the epithelial layers. This 
dehydration leads to the accumulation of dry, thick mucus that would normally be 
cleared by mucocilliary action (36). This environment is ideal for colonization by 
various bacteria, including Staphylococcus aureus, Haemophilus infuenzae, 
Stenotrophomonas maltophilia, Enterobacteriaceae, Burkholderia cepacia, and 
P. aeruginosa (37). Colonization by P. aeruginosa in the CF lung is associated 
with decreased lung function, poorer clinical status, and increased morbidity and 
early mortality (3, 4, 38).  
 
P. aeruginosa in the CF lung and the isolation of mucoid isolates 
Respiratory P. aeruginosa infection in CF patients occurs intermittently 
between 6 months and 13 years of life, usually from an environmental reservoir 
(Fig. 1.1 A) (39-43). Bacteria in the CF lung are constantly under stress due to 
bombardment by antibacterial compounds and oxidative stress related to 
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immune system assault (44). Over time, bacteria in the CF lung, including P. 
aeruginosa, adapt to these conditions and establish a chronic infection. The most 
significant, hallmark phenotype of a chronic P. aeruginosa infection is its 
overproduction of an exopolysaccharide capsule (45). The capsule is made of 
alginic acid (alginate), a thick, gelatinous polysaccharide consisting of a 
copolymer of (1-4) linked β-D-mannuronate and α-L-guluronate, and the 
phenotype of the organisms over-expressing it is termed mucoid (46-48). 
 
 
Figure 1.1. Model of progression of P. aeruginosa infection within a CF 
patient. (A), as infection proceeds to a chronic state, P. aeruginosa phenotypes 
associated with chronic infection (e.g. mucoidy) predominate, while acute 
virulence factors are selected against. (B), the inability of the host-immune 
respone to clear chronically established infection leads to a debilitating cycle of 
inflammation and tissue destruction.  
 
Colonization by mucoid P. aeruginosa is associated with a significant 
decline in pulmonary function and disease outcome (41, 49, 50). Reports vary on 
the time it takes for P. aeruginosa mucoid conversion, ranging from several 
months to a decade after initial detection in the CF lung (41, 51). As described by 
Govan and Deretic, treatment becomes extremely difficult after mucoid 
conversion (52). Briefly, alginate serves as a protective barrier for P. aeruginosa 
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that resists opsonization and phagocytosis (53-56), antibiotic permeation (57), as 
well as desiccation (58). Macrophages and neutrophils that are recruited through 
inflammatory chemotaxis are unable to clear the P. aeruginosa infection, and this 
“frustrated phagocytosis” leads to extensive auto-inflammatory lung damage (59) 
(Fig. 1.1 B). Currently, early intensive treatment against P. aeruginosa is 
recommended by physicians to delay the inevitable establishment of a chronic P. 
aeruginosa infection (60). Therefore, elucidating the molecular mechanisms of 
alginate overproduction has been an area of active study in the last forty years.  
 
Two mechanisms of alginate over-production 
The extracytoplasmic function (ECF) sigma/anti-sigma factor system 
encoded by the algUmucABCD operon (PA0762 - PA0766) is the major 
paradigm for alginate over-production and mucoid conversion in P. aeruginosa 
(Fig. 1.2 A). The algUmucABCD system is analogous to the well-characterized 
ECF sigma factor class (σE) envelope stress response system in Escherchia coli 
(61) that responds to environmental stressors, including reactive oxygen species, 
antimicrobial peptides, stationary phase, and carbon starvation, that contribute to 
cell wall perturbations (62-65). 
In non-mucoid P. aeruginosa, the MucA anti-sigma factor, encoded by the 
mucA gene, sequesters the stress-responsive AlgU (also known as AlgT, σ22) 
sigma factor to the inner-membrane (Fig. 1.2 A) (66-69). MucB (AlgN) and MucD 
(AlgY) are localized to the perpiplasm and are also negative regulators of AlgU 
function by stabilizing and protecting MucA (70-75). The role of MucC is not 
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known, but appears to be a negative regulator of alginate production in the 
mucoid background (76). Sequestration to the membrane prevents the 
transcriptionally competent AlgU- RNA polymerase (RNAP) complex from 
transcribing AlgU regulated genes, including the expression of alginate 
biosynthetic enzymes encoded on the PA3540 - PA3551 operon, and the algR 
(PA5261) gene (77).  
Oxidative stress (78), nutrient limitation (79, 80), iron limitation (80), and 
osmotic stress (81, 82) can all contribute to the mucoid phenotype in P. 
aeruginosa. Alginate over-production appears to be regulated at two general 
levels: at the post-translational level in which mucoidy is a response to 
environmental stress, and at the genetic level in which mucoidy arises from 
mutations in the chromosome.  
At the post-translational level, alginate biosynthesis is activated by the 
regulated proteolytic degradation of MucA. After exposure to the aforementioned 
stresses and the accumulation of mis-folded proteins, periplasmic proteases (e.g. 
MucD) cleave mis-folded proteins, which activate the periplasmic protease, AlgW 
(83, 84). AlgW is also activated by certain tripeptide motifs (including WVF, YVF, 
FTF, and variations thereof) that are found on outer-membrane proteins, such as 
MucE, OprP, OprO, and a certain truncation in PilA (75, 84, 85). Once AlgW is 
activated, AlgW cleaves MucA, releasing AlgU to the cytoplasm and activating 
alginate biosynthesis. MucA is also degraded by the periplasmic metalloprotease 
MucP, and by the cytoplasmic ATP-dependent serine protease complex ClpXP 
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(74, 86, 87). This post-translational mechanism of alginate over-production is 
reversible, and may represent earlier points in infections (Fig. 1.2 A) (88). 
At the genetic level, alginate overproduction occurs as a function of 
mutations in the chromosome. P. aeruginosa mismatch repair (MMR) system and 
the 7,8-dihydro-8-oxo-dGuanine repair (GO) system are two levels of genomic 
repair that are commonly impaired (and mutations in these systems are selected 
for) during chronic infection; highly mutable strains, containing mutations in the 
mutS gene, are commonly (36% frequency) isolated from CF patients (89-91). 
During chronic infections, mutations commonly arise in the mucA, mucB, and 
mucD genes that result in premature stop-codons, frameshifts, and mis-sense 
mutations. The most common mucA mutation found in P. aeruginosa isolates 
from CF patients is a deletion in a homopolymeric guanine tract at ∆G430, 
referred to as the mucA22 allele (92-96) (Fig. 1.2 B). This deletion introduces a 
premature stop codon and results in a C-terminus truncation of the MucA protein. 
The consequence of these mutations is that MucA, MucB, or MucD are non-
functional or have reduced function, resulting in the release of AlgU-RNAP to the 
cytoplasm. These mutations have been demonstrated to arise from P. 
aeruginosa exposure to environmental stressors. In in vitro experiments, addition 
of low levels of hydrogen peroxide (oxidative stress) to P. aeruginosa in a 3-8 
day biofilm model results in the isolation of mucoid mutants (97). Sequencing the 




Figure 1.2. Two mechanisms of alginate over-production. (A), post-
translational mechanisms of alginate production. The AlgU sigma factor (pink) is 
sequestered to the inner-membrane by the anti-sigma factor MucA (white). Upon 
membrane stress conditions, MucD cleaves misfolded periplasmic proteins, and 
certain cleavage sites activate the AlgW protease. MucA is cleaved by AlgW, 
MucP, or ClpXP proteases (illustrated with dotted lines) that release AlgU-RNAP 
complex to the cytoplasm and activate the AlgU regulon. Republished with 
permission from ASM Press. (98). (B), genetic mechanisms of alginate 
production.  The most common mutation in the mucA gene (mucA22 allele) is 
found in a homopolymeric guanine sequence. A deletion in guanine 430 (G430) 
results in a premature stop codon that truncates the MucA protein. Mutations 
also arise in the ORF of mucA, mucB, or mucD that results in non-functional 












































algU B C D
CAC
ǻ*
Q G A P Q V I T
CAG GGG GCG CCG CAG CTG ATC
AC
Q G R R S STOP







There is a selection for hypermutable P. aeruginosa during chronic 
respiratory infections (91), as it enables a multitude of phenotypic variants to 
arise from an isogenic progenitor (99). For instance, the lab strain PAO1 
develops mutations in the GO system after in vitro exposure to PMNs (100). In 
fact, deletion of mutS (or the overexpression of error-prone DNA polymerase IV, 
dinB) results in the increased incidence of mucoidy through mutations in mucA 
(101). Chronic infection is also associated with a decreased expression of acute 
P. aeruginosa virulence factors (102). Mutations are commonly found in genes 
related to iron acquisition, multidrug efflux pumps, as well as in the LasR quorum 
sensing regulator that is central to the expression of virulence factors (103, 104). 
There is also loss of the type III secretion system effector proteins (105), lack of 
swimming motility (106), and loss of the lipopolysaccharide (LPS) O-antigenic 
side chain, which renders the organisms less resistant to serum (107). 
Decreased virulence factor production gives a selective advantage for P. 
aeruginosa to evade immune system detection, and introduces a growth 
advantage for certain carbon sources, including amino acids (104). 
 
Regulation of the algD promoter 
As mentioned above, the release of AlgU to the cytoplasm activates the 
expression of the alginate biosynthetic enzymes encoded on the PA3540 - 
PA3551 (algD) operon (108-110). This activation occurs through AlgU’s direct 
activation of the algD promoter, as well as the activation of the algR gene (Fig. 
1.3). The alginate biosynthetic pathway was first discovered in the nitrogen-fixing 
 10 
diazotroph, Azotobacter vinelandii (111) and subsequently characterized in P. 
aeruginosa. In P. aeruginosa, the algD gene (PA3540) is the first open reading 
frame in an operon (PA3540 - PA3551) that encodes 12 genes (algD, alg8, 
alg44, algK, algE, algG, algX, algL, algI, algJ, algF, and algA) encoding for 
proteins involved in alginate biosynthesis, modification, and export (98, 112, 
113). Transcription of algD is increased significantly in mucoid P. aeruginosa, 
which leads to the over-production of alginate (114). Another gene, algC 
(PA5322), encoding a phosphomannomutase, is located at a different 
chromosomal locus and is part of the pathway (115). 
The regulation of the algD promoter/alginate biosynthetic genes (PA3540 - 
PA3551) is very complex (Fig. 1.4 A). In addition to AlgU, the following proteins 
bind and regulate algD transcription: a) AlgR (see below); b) KinB/AlgB, a two 
component system with the AlgB response regulator belonging to the NtrC family 
that positively regulates expression in an RpoN (σ54) dependent manner (116-
119); c) AmrZ (previously annotated as algZ in the literature), a positive regulator 
of the ribbon-helix-ribbon family of proteins (120-122); d) Integration Host Factor 
(IHF), a histone-like protein that binds to several regions on the promoter to 
induce DNA bending and activate transcription (123, 124); e) AlgP (AlgR3, Hp1), 
with a C-terminus histone-like element which also bends DNA and activates 
transcription (125, 126); and the activator CysB, a LysR-like transcriptional 
regulator that is also a central regulator of cysteine metabolism (127). This 




Figure 1.3. Alginate over-production is mediated by AlgU and AlgR. The 
release of AlgU to the cytoplasm by MucA cleavage or mucA, mucB, or mucD 
mutations activates algU, algR, and algD transcription. Transcription of algR by 
AlgU increases AlgR levels. AlgR and AlgU together activate the genes encoding 
the alginate biosynthesis, modification, and export enzymes encoded by the algD 




Significance of AlgR: Regulation of the algD promoter 
AlgR was the first regulator discovered to be required for alginate over-
production (128). A P. aeruginosa chromosomal cosmid library was placed in 
chemically mutagenized non-mucoid strains to screen for mucoid-rescue 
phenotypes (128). A cosmid that restored alginate production in the non-mucoid 
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alginate biosynthetic genes (PA3540 - PA3551). This 27.6 kDa gene was named 
algR (PA5261) for its ability to regulate alginate (129). The polypeptide encoded 
by algR contains an N-terminus with homology to CheY-like signaling 
transcriptional regulators (such as OmpR, NtrC) (130), and a C-terminus with 
homology to LytR/YehU/AgrA family of DNA-binding transcriptional regulators 
(131-133). 
Transcription of algD is dependent on AlgR (Fig. 1.3), as deletion of algR 
in phenotypically mucoid strains results in abrogated algD promoter activity and 
loss of alginate production (130, 134, 135). AlgR regulates the algD promoter 
through three distinct binding sites (Fig. 1.4 B C). Electrophoretic mobility shift 
assay (EMSA) and DNase I footprinting have demonstrated the presence of two 
AlgR binding sequences in a region -332 bp upstream of the transcriptional start 
site, named the far-upstream site (FUS). The binding sites, named algD-RB1 (for 
consistency, will be called ABS1 here for AlgR Binding Site 1) located at -470 bp, 
and algD-RB2 (for consistency, will be called ABS2 here) located at -394 bp 
upstream of the transcriptional start site, share a core 9 bp consensus sequence 
(5’-CCGTTCGTC-3’) (136, 137). Additionally, a third AlgR binding sequence, 
algD-RB3 (for consistency, called ABS3 here) (5’-CCGTTTGTC-3’) is located -45 
bp upstream of the transcriptional start site in the opposite orientation (136-138). 
The coordination of all three ABSs is required for maximal algD transcription.  
Promoter analyses show that the FUS is required for algD expression, as 
deletion of the FUS results in a 10-fold reduction in promoter activity (134, 135). 
A study using the algD transcriptional reporter showed that deletion of algD-
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ABS1 (RB1) results in a 70% reduction, and deletion of both algD-ABS1 (RB1) 
and algD-ABS2 (RB2) results in a 99% reduction in algD promoter activity (135). 
A mutation in algD-ABS3 (RB3) also reduces algD transcription by approximately 
30% of the wild type promoter (138). As these binding sites are located at 
relatively far distances, DNA looping is a proposed mechanism in which AlgR 
and the other transcriptional regulators affect the algD promoter in the mucoid 
background (26, 139) (Fig. 1.4 A). 
Additionally, binding affinity of AlgR to these AlgR binding sequences is 
also a contributing factor to algD regulation. Affinity of AlgR towards the two AlgR 
binding sequences in the FUS is higher (algD-ABS1 (RB1), Kd = 6.0 x 10-8; algD-
ABS2 (RB2), Kd = 7.2 x 10-8) than towards the algD-ABS3 (RB3) (Kd = 3.7 x 10-7) 
(138). The lower affinity is attributed to the single base difference within algD-
ABS3 (RB3) (5’-CCGTTTGTC-3’, different base is underlined) compared to its 
consensus sequence (138). Changing the sequence of algD-ABS3 (RB3) to a 
higher affinity sequence partially restores algD transcription, indicating that this 
third binding site is critical for modulating transcription (138). Furthermore, 
overexpressing AlgR represses algD transcription and alginate production, and 
indicates that tight regulation of intracellular AlgR amounts is required for 
maximal algD promoter activity (140). 
 14 
 
Figure 1.4. Complexity of the AlgR regulated promoters. (A), current model of 
the algD promoter activation. At least seven different transcriptional regulators, 
activate the algD promoter, causing a DNA looping of the promoter region. Not 
shown: AlgB and RpoN. (B), comparison of the best-characterized AlgR-
regulated genes and their promoters. Gene names are labeled within boxes, and 
pointed end of boxes indicate direction of the open reading frames. Promoters 
are aligned to the gene’s transcriptional start sites (+1). Identified AlgR-binding 
sites (ABS) are indicated by green arrows. Lux = LasR or RhlR binding box, anr 
= Anr binding box, bp= pase pairs. (C), comparison of identified AlgR binding 
sites from (B). Red letters indicated different nucleotides compared to consensus 
sequence 5’-CCGTTCGTC-3’ found on algD-RB1 and algD-RB2 (136). 
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AlgR regulation of the algC promoter  
AlgR regulates another enzyme in the alginate biosynthetic pathway, 
AlgC, encoded by the algC gene (PA5322) (Fig. 1.4 B C). AlgC is a 
phosphohexomutase enzyme that has dual phosphomannomutase / 
phosphoglucomutase activity (141). AlgC is a multifunctional enzyme, 
responsible for converting mannose 6-phosphate to mannose 1-phosphate (a 
key step in regulating alginate, psl, and pel polysccharide biosynthetic pathways) 
(142), and converting glucose 6-phosphate to glucose 1-phosphate, to provide a 
precursor for the core region of lipopolysaccharide (LPS) as well as the sugar 
moiety for rhamnolipids (143-145).  
The utilization of a cosmid library in conjunction with a chemically 
mutagenized strain library led to the discovery of algC (128) (115). The algC 
gene is transcriptionally un-linked to the algD operon. AlgR acts as an activator 
of algC transcription, as the activity of a algC::lacZ transcriptional reporter is 
decreased 4-fold in an algR deletion background (115). Like the algD promoter, 
the algC promoter contains three AlgR binding sequences (115, 146). However, 
their positions relative to the transcriptional start sites are different from those 
found in algD (Fig. 1.4 B). The algC-ABS1 is located at -94 bp upstream, and 
algC-ABS2 is located at +163 bp downstream of the algC transcriptional start 
site. The algC-ABS3 is located +391 bp downstream of the transcriptional start 
site, within the algC ORF. While algC-ABS1 (5’-CCGTTCGTC-3’) and algC-ABS3 
(5’-CCGTGCGTC-3’) are higher affinity ABSs, algC-ABS2 (5’-CCGTTGTTC-3’) 
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has two base pair changes as compared to the consensus sequence, thus algC-
ABS2 displays lower affinity to AlgR sequences (115, 146). 
There is evidence that algC-ABS1 acts like a Eukaryotic enhancer 
element (146). Translocating algC-ABS1 to +532bp downstream or to -432 bp 
upstream of the transcriptional start site does not affect algC transcriptional 
reporter activity (retaining 126% or 87% activity of wild type, respectively). 
Replacing algC-ABS1 with its reverse-complement also retains reporter activity 
(98% activity). Yet, there is a reduction to 0.5% activity when algC-ABS1 was 
deleted. Additionally, all three AlgR binding sites were required for maximal 
algC::lacZ expression (146). In summary, these data support the idea that the 
coordination of all three AlgR binding sequences is required for expression from 
the algD and algC promoters. 
 
Transcriptional regulation of algR 
Expression of the algR gene itself is significantly increased (up to 50-fold) 
in mucoid P. aeruginosa as compared to non-mucoid backgrounds (140, 147, 
148). In mucoid P. aeruginosa, algR expression is maximal at early stationary 
phase, coinciding with expression of several alginate biosynthesis genes 
including algA, algC, and algD (149). The region upstream of algR contains at 
least two transcriptional start sites (109, 150). AlgU regulates one of the proximal 
promoters (-73 bp upstream) of the algR ORF. This proximal promoter contains 
an AlgU binding sequence (5’-GCACTT-N17-TCTGA) (109, 150). AlgU is a 
functional ortholog of Escherichia coli σE (63), and is responsive to heat shock 
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(65) and superoxide radical-generating paraquat (65, 109). Therefore, as alluded 
to earlier, AlgR is part of the AlgU regulon and AlgR expression is responsive to 
membrane perturbation that cleaves MucA, or through mutations in the mucA, 
mucB, or mucD genes (Fig. 1.3).  
Another transcriptional start site, located approximately 160 bp upstream 
of the algR ORF appears to be expressed constitutively (Fig. 1.3) (109, 135, 
151). The expression from this algR promoter is unaffected by AlgU or the 
mucoid status of the bacteria (135). This algR promoter is also believed to be 
independent of the nitrogen-responsive sigma factor RpoN (σ54) (135, 147), 
though RpoN dependence was demonstrated in one study using a deletion of the 
rpoN gene in a particular strain (Pa strain PAK-SN) (148). In the mucoid 
background, the activity of this algR promoter is also responsive to high 
osmolarity (147, 148, 151) and nitrate (147). However, the responsiveness is 
contingent on different muc alleles within different P. aeruginosa strains that 
exhibit the mucoid phenotype (147). Incidentally, algR transcription is not 
responsive to osmolarity or nitrate levels in the strain PAO758 containing the 
mucA-22 allele (which is most commonly isolated from CF patients). However, 
PAO758 was generated by exposure to carbenicillin and may contain other 
mutations that influence the responses to osmolarity and nitrate. (147).  
 
AlgR protein 
AlgR is proposed to belong to the AlgZ/FimS-AlgR two-component 
regulatory system (130, 132). Two-component systems (TCS) are bacterial 
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sensing systems that couple environmental stimuli to adaptive responses (152, 
153). TCSs typically consist of a histidine kinase (HK, sensor component) and a 
response regulator (RR, response component). To date, 58 response regulators, 
59 sensor histidine kinases, and 7 sensor/regulator hybrids have been annotated 
in the P. aeruginosa PAO1 genome (154). The large number of two-component 
systems in P. aeriginosa has been attributed to its capacity to detect and adapt to 
various environments (155).  
At the core of the sensor-response system is a phosphotransfer between 
these two components. Phosphotransfer in two-component systems typically 
occurs in three main steps (156). First, the stimulus induces structural changes in 
the cytoplasmic portion of the HK, leading to the C-terminus catalytic domain that 
binds ATP and phosphorylates the Histidine residue (CA domain) accepting a 
phosphate from adenosine triphosphate (ATP). Second, there is an enzymatic 
cis- or trans-phosphorylation from the CA domain to the conserved L-histidine 
residue in the domain that hosts the Histidine residue that is phosphorylated 
(DHp region) of the histidine kinase. Third, the HK transfers the phosphate from 
its DHp domain to the RR at a conserved aspartate residue in the CheY-like 
receiver (REC) domain. The kinase or phosphatase activity of the HKs controls 
the level of RR phosphorylation, and thus its response (156). 
According to protein structure predictions, AlgR has two major structural 
domains (Fig. 1.5 A) (130, 157, 158). The N-terminus of AlgR contains a CheY-
like receiver (REC) domain. CheY is a well-studied signaling protein involved with 
the flagellar motor switch complex (159). Phosphorylation of a conserved 
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aspartate (Asp57) residue in CheY by the CheA histidine kinase leads to a 
clockwise rotation of the flagella. CheY and CheY-like domains contain a set of 5 
alternating β-pleated sheets and α-helices (Figure 1.5 B) (160).  
The AlgR-REC domain contains the residues required for aspartyl-
phosphorylation. While a crystal structure for AlgR has not been determined, 
various inferences could be made from its conserved residues. For instance, 
Asp7, Asp8, and Asp54 could form an acidic pocket that coordinates a divalent 
cation (Mg+2) (160, 161), which is required for catalyzing the phosphorylation of 
Asp54 (Fig. 1.5 C) (157). It is proposed that upon interaction with and 
phosphorylation by its cognate HK, AlgR Asp54 may covalently bind to 
phosphate and introduce a negative charge within the acid pocket, displacing the 
Mg+2 ion (Fig. 1.5 D). As demonstrated with other response regulators, the 
oxygen groups on the negatively charged phosphate are speculated to interact 
with Thr82 (hydrogen bonding) and Lys102 (salt bridge) (Fig. 1.5 D) (162, 163), 
which would alter the conformation and stabilize the AlgR REC domain. In 
addition, the Tyr99 residue is also conserved. The rotation of this residue in other 
reponse regulators is correlated with activation of the protein (162, 164).  
Like many CheY-like domain containing RRs (165), AlgR is able to 
catalyze its own auto-phosphorylation in the presence of high-energy phospho-
donors such as carbamyl phosphate and acetyl phosphate (166). A conservative 
substitution of AlgR Asp54 residue to an asparagine (D54N) eliminated in vitro 
phosphorylation by an E. coli derived CheA HK, indicating that, like other RRs, 
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Figure 1.5. Structural predictions of AlgR. (A), diagram depicting two major 
domains of the 249 amino acid AlgR polypeptide. (B), a ClustalW sequence 
alignment of the amino acid sequence of the N-terminus CheY-like receiver 
(REC) domain of AlgR and its homologs. “*” = identical amino acids, “:” = 
conserved substitutions, “.” =  semi-conserved substitutions. Red color denotes 
select highly conserved amino acids, most with functional importance for 
phosphorylation, italics indicate alpha helices, bold indicates beta sheets. The 
predicted secondary structure of AlgR according to Phyre2 is located above the 
sequence alignment. α = alpha helix, β = beta sheet. (C), an illustrated model 
depicting the location of conserved amino acids on the secondary structures of 
the REC domain of AlgR. Aspartate 7, 8, and 54 of CheY-like domains 
coordinate a magnesium ion, and required for aspartyl-phosphate transfer from 
histidine kinase. (D), once phosphorylated, residues threonine 82 and lysine 102 
interact with phosphate ion, changing the conformation of the REC domain. (E), a 
ClustalW sequence alignment of AlgR and AgrA, with same annotation as (B). 
Red color denotes select conserved amino acids that are required for DNA 
interction in AgrA, and may be required for AlgR interaction with DNA. (F), an 
illustrated model depicting the location of conserved amino acids on the 
secondary structures of the LytR/AgrA DNA-binding domain of AlgR.
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  The C-terminus of AlgR contains DNA-binding domain in the LytR/YehU/AgrA 
family of transcriptional regulators (131-133). This family is unique, as it 
represents 3% of all sequenced response regulators in Bacteria. In contrast, 
30.1% and 16.9% of response regulators contain winged-helix and helix-turn-
helix domains, respectively (167). Helix-turn-helix (HTH) (e.g. NtrC) (168) or 
winged-helix (e.g. OmpR) (169) motifs (167) contain alpha-helices that embed in 
the major grooves of the DNA to make specific hydrogen bond contacts with the 
recognition sequence. On the other hand, the LytR/YehU/AgrA/AlgR family of 
transcriptional regulators utilizes unstructured loop regions to recognize DNA 
sequences (133). 
Though the crystal structure of AlgR has not been solved, secondary 
structure prediction based on the Phyre2 protein fold recognition server using the 
last 139 a.a. of AlgR (DNA-binding region) predicts that AlgR carboxyl terminus 
may contain at least 9 beta-pleated sheets, and demonstrates a 100% precision 
(E-value 2.4e-11) with the AgrA C-terminus domain (Figure 1.5 E, F) (133, 158). 
AgrA is a S. aureus RR that (together with AgrC HK) regulates the agr 
(accessory gene regulator) locus in S. aureus. The agr locus encodes a set of 
regulatory RNAs (RNAIII) that control S. aureus virulence factors in a temporal, 
cell-density (quorum) dependent manner (170). In AgrA, flexible loops 
(unstructured regions) between pairs of beta-pleated sheets make 2 or 3 specific 
contacts in successive major grooves (133). The residues that make these 
interactions in AgrA are His169, Asn201, and Arg233. AlgR also has a conserved 
Asn200 and a pair of arginines (Arg235 and Arg236) that may correspond to 
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those found in AgrA (Figure 1.5 E). It is also tempting to speculate that AlgR-
Tyr167 may be a functional replacement of AgrA-His169 to interact with DNA, 
though whether these residues will interact with DNA will need to be 
experimentally validated. In addition to AgrA, another LytR-type response 
regulator from Bacillus cereus has been submitted to the RCSB Protein Data 
Bank (PDB id: 3d6w) (171) and may give additional insight into the structure of 
this family of regulators.    
LytR/YehU/AgrA/AlgR transcriptional regulators commonly affect the 
expression of virulence factors (131). Some of the regulators in this family 
include YehU of E. coli (172), AgrA of S. aureus (133, 173), FsrA of 
Enterococcus faecalis (174), VirR of Clostridium perfringens (175, 176), and 
PlnC and PlnD of Lactobacilus plantarum (177-179). A common characteristic of 
these proteins is the mode of binding to DNA (133). These regulators bind 
sequences that are between 8 and 13 bp long, arranged as two imperfect direct 
repeats that are approximately 12 bp apart (173-175, 177, 180). The exact 
spacing between the direct repeats is crucial for gene transcription, though the 
molecular basis for this exact spacing is unknown (133). According to the crystal 
structure of AgrA, large bends in the DNA are created to accommodate protein 
binding at direct repeats (133). Interestingly, AlgR binding sites are not 
necessarily arranged as direct repeats separated by 12 bp, as seen in the algD, 
algC, and other AlgR-regulated promoters (Fig. 1.4 B). The reason for this is 
unclear at the moment, and further studies on AlgR DNA binding are required.  
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The histidine kinase for AlgR is encoded by algZ/fimS 
One of the key paradigms in TCS regulation is mediated through the 
activity of the histidine kinase. AlgR’s putative cognate histidine kinase is located 
upstream of the algR gene, and is called algZ (also called fimS for fimbrae 
sensor, PA5262) (181, 182). The algZ/fimS gene was first discovered through a 
transposon mutagenesis screen of non-mucoid P. aeruginosa in search of alleles 
that abrogate twitching motility (182). The ORF of algZ/fimS is 1077 nucleotides, 
encoding a 40.1 kDa polypeptide AlgZ. The nucleotide sequence of algZ/fimS 
does not show similarity to most histidine kinases, and global homology searches 
initially did not detect it as a histidine kinase. However, algZ/fimS does show 
similarity to a subset of non-canonical histidine kinases, including LytS (183), 
YehU (172), the proposed AlgZ in the AlgZR system in Acinetobacter baumanii 
(ABAYE 3510) (184), as well as un-annotated genes found in Vibrio cholerae 
(VC0694 and VC0851) and the plant pathogens Xylella fastidiosa (XF1625) and 
Xanthomonas campestris (xccb100_0683). 
Because AlgR was first identified as a two-component regulator of alginate 
production, it was expected that its putative histidine kinase would play a 
regulatory role in alginate production (140). However, as it turns out, AlgR 
phosphorylation may not be required for alginate production. Expression of the 
algRD54N allele (expressing the phospho-defective AlgR protein) in the mucoid 
strain FRD1 does not affect alginate production (185). In fact, deletion of 
algZ/fimS in PAO1 or its mucoid isogenic derivative PAO568 resulted in a two-
fold increase in alginate production (181), suggesting that AlgR phosphorylation 
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may not effect, or even inhibit alginate production in the mucoid background. 
Neither direct binding nor phospho-transfer between AlgZ and AlgR have been 
demonstrated to date. Therefore, the proposed role of AlgZ as the cognate HK 
for AlgR has been inferred from genetic evidence on its regulation of the fimU 
and hcnA promoters (180, 186). As described below, twitching motility requires 
AlgR and its HK, AlgZ (182). 
 
Type IVa pili overview 
Type IVa pili are polar fiber-like organelles that allow surface attachment 
and motility for P. aeruginosa. These appendages enable attachment on abiotic 
surfaces (187), integrin (188), DNA (189), N-glycans (190) and possibly 
glycosphingolipids (191), though glycosphingolipid interaction is controversial 
(192, 193). Type IV pili are also required for several types of P. aeruginosa 
motility including twitching (194), walking (195), slingshot (196), and in some 
cases, swarming motility (197, 198). It is also an important component for biofilm 
formation (192, 199, 200). 
The major components of type IVa pili can be represented as five steps of 
pili assembly (with the important pilus components in parentheses) (201): 1) the 
building blocks of the pili filament are shuttled through the inner membrane via 
the general secretary pathway (PilA, FimU, PilV, PilW, PilX, PilE, PilY1); 2) a 
peptidase (PilD) cleaves the leader sequence off the prepillins and methylates 
the pilins (202-205); 3) ATPases assemble (PilB) or disassemble (PilT, PilU) the 
pilus fiber, coordinated by the inner-membrane bound PilC protein (206); 4) a 
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multi-protein complex (PilMNOPQ) scaffolds the PilA filament (207); and 5) the 
assembled pilus filament is extruded through a secretin gated-channel located on 
the outer membrane (PilQ) (208-210), which is localized to the outer membrane 
by FimV and PilF (211-213). Additionally, type IVa pili is transcriptionally 
regulated by a number of factors, including the PilSR two component regulatory 
system (214), RpoN (215), Vfr (216), and the global carbon metabolism regulator 
Crc (217). Post-translational regulation of pili assembly and retraction, and 
transcription of pilA require the chemosensory signal transduction system, 
encoded by the pilGHIJKchpABCDE genes (218, 219). 
 
The fimUpilVWXY1Y2E genes are required for twitching motility 
The fimUpilVWXY1Y2E genes encode prepillins (FimU, PilV, PilW, PilX, 
PilE) and a calcium-dependent retraction protein (PilY1) (the pilY2 ORF is 
located in this operon but is proposed to be a pseudogene). All of the genes 
encoded in the operon contain a hydrophobic N-terminus leader sequence 
required for translocation to the periplasm for type IVa pili assembly (220-223). 
FimU, PilV, PilW, PilX, and PilE incorporate and create a complex with the pilus 
fiber (224). The PilY1 protein, encoded by pilY1 gene, is a homolog of the 
Neisseria gonorrhoeae PilC adhesin protein (225). PilY1 appears to be a multi-
functional protein: pilY1 encodes a surface and outer-membrane associated 
integrin-binding protein (188, 226) that can inhibit PilT-mediated pilus retraction 
(227). It also regulates c-di-GMP levels and swarming motility either directly or 
indirectly through the diguanylate cyclase, SadC (197, 228). PilY1 also plays a 
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role in secretion of secondary metabolites such as pyocyanin and 4-hydroxy-2- 
alkylquinolines (HAQs) in certain strains (P.a. TBCF10839) (229). Surface 
expression of type IVa pili requires a proper stoichiometric expression of the 
prepillins; the interaction/compatibility of the FimU, PilV, PilW, PilX, PilY1, and 
PilE with other pilus assembly components dictates the efficiency of pilus 
assembly and disassembly (224, 230). 
 
AlgR regulates twitching motility through the fimUpilVWXY1Y2E genes 
A microarray comparing non-mucoid PAO1 with its isogenic algR deletion 
(PAO1 ∆algR strain termed PSL317), showed a clear decrease in the expression 
of the fimU, pilV, pilW, pilX, and pilY1 genes (231). Loss of algR also abrogated 
twitching motility, and trans-complementation of the fimU operon in PSL317 
restored twitching motility, indicating AlgR regulates twitching motility by 
regulating the levels of the prepillins (224, 231). 
AlgR phosphorylation is also required for fimUpilVWXY1Y2E operon 
activation. A strain lacking algZ (182) or expressing a phospho-defective AlgR 
D54N has abrogated twitching motility (157) and expresses these genes at a 
lower level (180). As demonstrated by DNaseI footprinting and EMSA, AlgR 
binds to an intergenic region between fimU and the upstream gene fimT at fimU-
ABS1 (5’-CCGTTTGGC-3’), as well as fimU-ABS2 (5’-CCCTCGGGC-3’) (Fig. 1.4 
B) (180). Together, these data indicate that AlgR phosphorylation by AlgZ 
increases AlgR affinity for the fimU promoter to activate its transcription. Though 
the signal for the AlgZ sensor kinase has not been determined, we anticipate that 
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discovering the signal will help in understanding the reason AlgZ/AlgR regulates 
these prepillins. 
 
Biofilms and quorum sensing 
Microbial biofilms are highly complex, multicellular communities, where 
organisms are embedded in a matrix that consists of proteins, polysaccharides, 
and extracellular DNA (eDNA). There are multiple steps in biofilm maturation: (1) 
initial attachment, (2) microcolony formation, (3) early biofilm development, (4) 
maturation, and (5) dispersion (232, 233). There is substantial evidence that 
quorum sensing is required for biofilm formation and virulence, both in vitro and 
in vivo (234-237). Quorum sensing is an autoinduction system that monitors cell-
density through the export of small molecules (238, 239). Biofilm formation is 
intimately tied to the capacity of the organism to quorum sense. P. aeruginosa 
has three main quorum sensing systems- the Las, Rhl, and PQS systems.  
The LasI-LasR (240), and RhlI-RhlR (241, 242) quorum sensing pairs are 
luxI-luxR type regulators. The LuxI component (LasI or RhlI) synthesize their 
respective N-acyl homoserine lactone (AHL) molecules, and the LuxR-type HTH-
containing DNA-binding regulator (LasR and RhlR) senses the signals (243, 
244). LasI synthesizes N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-C12-
HSL), and RhlI synthesizes N-butanoyl-L-homoserine lactone (C4-HSL) from S-
adenosylmethionine (SAM) and acyl-acyl carrier protein (ACP) from fatty acid 
biosynthesis (245, 246). The LasR and RhlR regulators bind their respective 
signaling molecules, dimerize, and bind to lux-box sequences of their promoters 
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to activate DNA transcription (241, 247). The PQS system produces 2-heptyl-3-
hydroxy-4-quinolone (PQS) (248) through a biosynthetic pathway encoded by the 
genes pqsABCD and pqsH (249-251). These genes are also responsible for the 
production of up to 55 types of 4-hydroxyl-2-alkylquinolines (HAQs) (252) that are 
similar to PQS and have antimicrobial properties (253-255). PQS induces the 
DNA-binding capacity of the LysR-type transcriptional regulator, PqsR/MvfR, to 
activate both the expression of the pqsABCDE (256) genes for auto-regulation, 
as well as genes responsible (phnAB) for the production of other HAQs (251). 
Together, these systems regulate a number of virulence factors. For instance, 
alkaline protease (apr), exotoxin A (exoA), elastase A (lasA), and elastase B 
(lasB) are under the control of the Las system (257-259). Rhamnolipids (rhlAB, 
rhlC), hydrogen cyanide (hcnABC), and pyocyanin are under the control of the 
Rhl system (241, 242, 260, 261).  
The interaction among the three QS circuits is complex. Initial studies 
reported the Las system was at the top of the regulatory cascade, where LasR 
directly regulates rhlI transcription (262). Later studies revealed a large amount 
of cross-talk among the three circuits (263).  LasR activates the pqsR/mvfR gene 
(264) while RhlR represses pqsABCDE transcription (264, 265). PQS and 
PqsR/MvfR can activate the Rhl quorum sensing system independently of the 
Las system (266, 267) as well as virulence factors under RhlI/RhlR control (268, 
269). Adding to the complexity is an orphan regulator, QscR, which responds to 
3-oxo-C12 HSL and represses quorum-sensing regulated factors, including 
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phenazine, hydrogen cyanide production and rhlI/rhlR and lasI expression (270-
272).  
 
AlgR regulates the Rhl quorum sensing system 
A deletion in algR (strain PSL317) caused a defect in a 6-day biofilm, 
which is restored by algR complementation on a plasmid (273). Additionally, 765 
genes were regulated at least two-fold in a 6-day biofilm comparing PAO1 with 
PSL317 (273). Genes in the Rhl quorum sensing system were the major genes 
regulated by comparing PAO1 with its isogenic ∆algR strain. (273). Microarray 
analysis showed that rhlABC, hcnAB, lecB, and genes in the biosynthetic 
pathway for pyocyanin production (phzC2-G2) were repressed by AlgR in the 
context of 6-day flow-cell biofilms. As these genes are under the control of the 
Rhl quorum-sensing system, it was surmised that this regulation was through the 
rhlI gene, encoding the C4-homoserine lactone (HSL) autoinducer synthase. 
Evidence indicated that AlgR repressed rhlI transcription, by binding the rhlI 
promoter directly at the rhlI-ABS (5’-CCGTTCATC-3’), located -28 bp upstream 
of the transcriptional start site. Site-directed mutagenesis of the rhlI AlgR binding 
site placed on the PAO1 chromsome and that did not allow AlgR to binding in 
vitro on the rhlI promoter showed a similar biofilm growth defect as in the algR 
deletion strain, and provided evidence that AlgR regulated the quorum sensing 
system at the level of rhlI transcription (273). 
Another set of genes under the exclusive control of the Rhl QS system 
(241, 274) and highly regulated by AlgR (273), are the rhlAB and rhlC genes. 
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These genes, encode key enzymes that are important for the production of the 
surface-active amphipathic glycolipids called rhamnolipids. Rhamnolipids are 
important wetting agents for group-coordinated swarming motility (275), normal 
biofilm formation (276, 277), and are a virulence factor (278, 279). In a biofilm, 
rhamnolipids are required for microcolony formation (280), fluid channel 
formation (276), and bacterial dispersion from a mature biofillm (281). The ∆algR 
mutant was unable to form structured biofilms, and instead, developed into a flat 
mat of cells over the course of 6-days (273). AlgR repressed the rhlA promoter in 
a 6-day biofilm, as both rhlA promoter activity and rhamnolipid production 
increased in an algR deletion strain. AlgR bound to the rhlA promoter at rhlA-
ABS1 (5’-CCGTTCGTC-3), located -702 bp upstream of the rhlA transcriptional 
start site (Figure 1.4 B). Therefore, the biofilm defect in the ∆algR strain was 
attributed to this increase in rhamnolipid production that disrupted the biofilm 
structure (273). 
 
AlgR represses genes involved with anaerobic metabolism 
Defining the AlgR regulon is of great interest; in addition to regulating 
alginate production in mucoid P. aeruginosa, type IVa pili mediated twitching 
motility, and the Rhl quorum sensing and rhamnolipid production in non-mucoid 
cells, AlgR may have a larger role in the organism’s physiology. Comparison of 
an algR deletion strain (PSL317) to its parental wild type PAO1 strain by 
microarray demonstrated that AlgR is involved with regulating hundreds of genes 
in logarithmic, stationary, and biofilm modes of growth (273, 282), and regulated 
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at least 47 polypeptides during logarithmic growth (282). In all, 95 genes during 
mid-log phase and 59 genes during stationary phase were differentially regulated 
two-fold or greater between PAO1 and PSL317, and 885 genes were 
dysregulated when algR was overexpressed (231). While the majority of genes 
regulated by AlgR in mid-log and stationary phase encode hypothetical proteins, 
there are indications that AlgR may control anaerobic metabolism genes. 
During anaerobic metabolism, P. aeruginosa is able to utilize nitrate as a 
terminal electron acceptor in lieu of molecular oxygen. This process, called 
denitrification, converts nitrate to nitrogen gas, and the reactions for this 
conversion are performed by a series of enzymes encoded by the following 
genes: 1) narGHI or napABC, encoding membrane-bound or periplasmic nitrate 
reductases, respectively, that convert NO3- to NO2-; 2) nirS, encoding nitrite 
reductase that converts NO2- to NO; 3) norCB, encoding nitric oxide reductase 
that converts/detoxifies NO to N2O, and 4) nosZ, that encodes nitrous oxide 
reductase that converts N2O to N2 (Fig. 1.6) (283). The various reductases are 
regulated by a number of transcriptional regulators that respond to oxygen, 
nitrate, or nitric oxide (NO).   
The transcriptional regulator, Anr (anaerobic regulation of arginine 
catabolism and nitrate reduction), is a homologue of E. coli FNR, and regulates 
the anaerobic denitrification system (284-287). Anr is a homodimeric, [4Fe-4S]+2 
cluster containing transcriptional regulator of the Fnr-Crp family. ANR is activated 
at low oxygen concentrations; increased oxygen can dissociate the homodimer 
and inactivate Anr (288). Dnr (dissimilatory nitrate reduction regulator) is a  
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Figure 1.6. Denitrification in P. aeruginosa.  At lowered oxygen 
concentrations, Anr activates transcription of narXL and dnr. In the presence of 
nitrate, NarX histidine kinase phosphorylates NarL response regulator and 
activates transcription of dnr and narGHI nitrate reductase. In the presence of 
nitric oxide, Dnr up-regulates transcription of the nitrate (nar), nitrite (nir), nitric 
oxide (nor), and nitrous oxide (nos) reductases to reduce nitrate to dinitrogen. 
Straight closed arrows and blunt-ended arrows indicate post-translational 
activation and repression, respectively. Straight open arrows indicate 
transcriptional activation.   
 
 
homodimeric, heme-binding, nitric oxide-sensing transcriptional regulator of the 
Fnr-Crp family, where the presence of NO activates the protein (289, 290). Anr 
activates the transcription of narK1K2GHJI (nitrate transporter and reductase) 
and dnr, as well as the genes required for anaerobic arginine and pyruvate 
fermentation. NarXL is a two component regulatory system that, when the NarX 
histidine kinase binds NO2-, phosphorylates the transcriptional regulator NarL, 
and activates the narK1K2GHJI and dnr genes. While the Anr and Dnr binding 
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sites are similar, Dnr specifically regulates the transcription of nir, nor, and nos 
genes required for denitrification (291-294). 
According to the PAO1 vs PSL317 logarithmic-growth microarray, there 
was overlap between Anr-regulated genes and AlgR-repressed genes (231). 
Some of the overlapping genes include: arcA (PA5171), part of the arcDABC 
operon encoding anaerobic arginine deiminase enzymes, which catabolizes 
arginine to create ATP under anaerobic conditions (295, 296); hemN (PA1546), 
which encodes an oxygen-independent copropophyrinogen III oxidase important 
for heme biosynthesis under anaerobiosis (297) and essential for anaerobic 
growth (298); ccoP2 (PA1555), ccoO2 (PA1556), and ccoN2 (PA1557), which 
are ccb3-2 type cytochrome oxidase components expressed at low oxygen 
concentrations (299); oprG (PA4067), which is an outer-membrane diffusion-
driven specific transporter of hydrophobic molecules that is upregulated under 
anaerobic conditions in the presence of iron (300, 301), and hcnB (PA2194), a 
gene encoding hydrogen cyanide synthase responsible for the production of 
HCN, and a possible mediator of anaerobic growth (186, 284, 302). Identification 
of AlgR binding sequences in the promoters of ccoN2 (PA1557) and hcnA 
(PA2193, part of the hcnABC operon) are suggestive of direct involvement of 
AlgR repression of these genes (186, 231, 303). When chronic “mutator” (late-CF 
infection) isolates were compared with their isogenic “non-mutator” (early-CF 
infection) isolates from the same patients, gene expression and/or protein 
production of anr, arcDABC, oprG, and hemN were upregulated in chronic 
isolates as compared to the early isolates (304). Based on these results and the 
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microarray data, AlgR appears to repress genes that are favorable for anaerobic 
growth, as demonstrated with ccoN2 and hcnA, although this contention requires 
experimental verification for these other genes. 
 
AlgR is a possible virulence factor 
AlgR has a global effect on transcription on a broad range of acute 
virulence factors, including twitching motility, the Rhl quorum sensing system, 
rhamnolipid production, hydrogen cyanide production, and anaerobic 
metabolism. Therefore, it was ascertained whether algR is required for P. 
aeruginosa virulence. Interestingly, a ∆algR allele gives the organism a selective 
advantage for growth in vitro under oxidative stress. AlgR represses genes 
required for survival against oxidative stress (282). While strain PAO700 
(algR::Gm) was more susceptible to hypochlorite treatment, it was more resistant 
to both hydrogen peroxide and myeloperoxidase as compared to its isogenic 
PAO1 parental strain. PAO700 is more resistant to killing by murine 
macrophages and primary human neutrophils, indicating that AlgR may normally 
repress the genes that are necessary to survive exposure to primary host 
response cells (282).  
Strain PAO700 (algR::Gm) was tested on acute septicemia and acute 
pneumonia models of infection in C57BL/6j mice. Mice injected interperitoneally 
with PAO700 show increased survival compared to injection with its isogenic wild 
type PAO1 strain (282). Co-infection model with PAO700 and PAO1 show 
decreased recovery of PAO700 as compared to wild type from the mice, 
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suggesting algR requirement for maximal virulence in these models. 
Interestingly, constitutive expression of algR decreased virulence as well, 
suggesting that AlgR protein levels in P. aeruginosa need to be balanced for 
normal pathogenicity of the organism (282). 
In all, algR appears to be an important acute virulence factor, though it 
affects the organism’s fitness in a broad manner. AlgR is also required for 
alginate production in a mucoid background, suggesting its importance in a 
chronic infection setting. We speculate that AlgR may have a more significant 
role in vivo, and may be required for both acute and chronic infections. 
Additionally, as with other two component sensor-regulator pairs, 
phosphorylation is believed to be an important mechanism for AlgZ/AlgR 
transcriptional control. Therefore, it is interesting to determine how AlgR 
phosphorylation also contributes to global gene transcription, thus, revealing the 
mechanism of AlgR’s role in virulence.  
 
 
Purpose of this study 
 
The purpose of this study was to explore the role of AlgR phosphorylation 
on P. aeruginosa virulence factor expression and overall fitness. While much is 
known about AlgR on activating alginate production as it pertains to a chronic CF 
infection, little is known on how AlgR phosphorylation is relevant for the 
regulation of acute virulence factors. Previous studies have shown that there are 
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thirty-six mutations that activate eleven response regulators (305). In particular, 
NtrC and OmpR response regulators in E. coli and S. enterica with a Asp to Glu 
mutation at the key phosphorylation residue have been shown to cause the 
protein to mimic the phosphorylated form of the protein (306-309). It was 
speculated that an Asp to Glu mutation at residue 54 in AlgR would also create a 
constitutively active mutant in AlgR. Using knowledge of substitution mutations 
created in other response regulators, a phospho-mimetic isoform of AlgR was 
created to further dissect the phospho-AlgR regulon in subsequent studies. In 
order to lock AlgR in either an active or inactive state, the algRD54E allele was 
introduced into PAO1 wild type lab strain and compared with WFPA8 (PAO1 
expressing algRD54N).  
As with other two component sensor-regulator pairs, phosphorylation is 
believed to be an important mechanism for AlgZ/AlgR regulation of its target 
genes. AlgR has a global effect on transcription. However, the mechanism in 
which phosphorylation of AlgR regulates genes is not completely understood. 
Particularly, phosphorylation of AlgR by AlgZ is important for certain genes, but 
not others. Virulence factors that were previously found to be regulated by AlgR 
were tested with both transcriptional (reporter or RT-qPCR) and biological assays 
in PAO1 and its mutants, including type IV pili-mediated twitching motility and 
fimU promoter activity, rhlI promoter activity, rhamnolipid and pyocyanin 
(phenazine) production, and biofilm formation.  
Previous data showed that strains with either an algR deletion or over-
expresssion were attenuated in an acute mouse septicemia model (282). Based 
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on evidence that AlgR phosphorylation controls a broad range of acute virulence 
factors, including twitching motility, the Rhl quorum sensing system, rhamnolipid 
production, and pyocyanin production, it was of great interest to determine if and 
how phosphorylation of AlgR may affect virulence. We therefore utilized the 
various algR mutants to determine their pathogenicity by measuring survival of 
Balb/c mice after intransal instillation, and explored why attenuation occurred 
with the algRD54N strain. 
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CHAPTER II   
 
 
MATERIALS AND METHODS 1 
 
 
Bacterial strains, plasmids, media, and culture conditions 
 
A list of all strains and plasmids used in this study is found in Table 1. 
Pseudomonas strains were maintained on Pseudomonas isolation agar (PIA), 
and E. coli strains were maintained on Miller lysogeny broth (LB) agar (Difco). 
For antibiotic selection, 150 µg/mL gentamycin, 200 µg/mL tetracycline, or 300 
µg/µL carbenicillin was added to PIA, and 100 µg/mL ampicillin, 15 µg/mL 
gentamycin, 10 µg/mL tetracycline, 50 µg/mL kanamycin, or 30 µg/mL 
chloramphenicol was added to LB agar, where appropriate. Overnight broth 
cultures were grown in LB, using the antibiotic concentrations listed above unless 
otherwise indicated. For allelic exchange mutagenesis, Pseudomonas cultures 
were selected on VBMM (310), supplemented with 50 µg/mL gentamycin for 
positive selection or 7.5% sucrose for counter-selection when needed. For 
rhamnolipid, hemolysis assays, and transcriptional studies with rhlA expression,  
  
                                                
1 Republished with permission from American Society for Microbiology Journal of 
Bacteriology. Sections were taken from: Okkotsu, Y, Tieku, P, Fitzsimmons, LF, 
Churchill, ME, Schurr, MJ. 2013. Pseudomonas aeruginosa AlgR 
phosphorylation modulates rhamnolipid production and motility. J. Bacteriol. 
JB.00726-13.   
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Table 1. List of strains and plasmids used in this study. 
Strains/Plasmids Description Reference or source 
Strains   
PAO1  Wild-type lab stock (311) 
PSL317 ∆algR (231) 
PAO1 algRD54E algR12 (or algRD54E, encoding AlgR 
D54E) 
this study 
WFPA8 algR7 (or algRD54N, encoding AlgR 
D54N) 
(157) 
PAZ-1 ∆algZ  (186) 
PAZ algRD54E ∆algZ  algR12  this study 
PAO1A pilA::Tc Dr. Daniel Hassett 
PAO1C fliC::aacC1 Dr. Daniel Hassett 
PAO1 ∆rhlA ∆rhlA Dr. Michael Vasil 
PDO111 rhlR::Tn501 (242) 
PAO1 rhlA::lacZ rhlA::lacZ (in attB site) this study 
PSL317 rhlA::lacZ ∆algR, rhlA::lacZ (in attB site) this study 
PAO1 algRD54E 
rhlA::lacZ 
algR12, rhlA::lacZ (in attB site) this study 
WFPA8 rhlA::lacZ algR7, rhlA::lacZ (in attB site) this study 
PAZ rhlA::lacZ ∆algZ, rhlA::lacZ (in attB site) this study 
PDO111 rhlA::lacZ rhlR::Tn501, rhlA::lacZ (in attB site) this study 
PAO200 rhlI::lacZ (in attB site) (273) 
PAO200 ∆algR ∆algR, rhlI::lacZ (in attB site) (273) 
PAO200 algRD54E  algR12, rhlI::lacZ (in attB site) this study 
PAO200 algRD54N algR7, rhlI::lacZ (in attB site) this study 
PAO1 lux luxABCDE (in glmS) this study 
PSL317 lux ∆algR, luxABCDE (in glmS) this study 
WFPA8 lux algR7, luxABCDE (in glmS) this study 
PAO1 algRD54E lux algR12, luxABCDE (in glmS) this study 
PAO1 ∆kinB kinB::aacC1 (312) 
PAO1 ∆kinBΔalgU kinB::aacC1, in-frame deletion of algU (312) 
PAO1 ∆kinBΔrpoN PAO1kinB::aacC1, in-frame deletion of 
rpoN 
(312) 
E. coli DH5a F-, φ80dlacZ M15, (lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, 
mk+), phoA, supE44, λ-, thi-1, gyrA96, 
relA1 
Lab strain 
E. coli Sm10 thi-1 thr leu tonA lacY supE recA::RP4-2-
Tc::Mu 
Lab strain 
E. coli BL21 Rosetta F- ompT hsdSB(rB-mB-) gal dcm pRARE2 
(Cmr) 
Novagen 
   
Plasmids   
pGEM-T Easy PCR product cloning vector Promega 
pEX18Gm Suicide cloning vector, Gmr (313) 
pEX18Gm algRKO algR deletion vector, Gmr this study 
pEX18Gm algRD54E algR12 allelic replacement vector, Gmr this study 
pEX18Gm algRD54N algR7 allelic replacement vector, Gmr this study 
pHERD30T  pBAD-based Pseudomonas  expression 
vector, Gmr 
(314) 
pHERD30T algR algR in pHERD30T, Gmr this study 
pHERD30T algRD54N algRD54N in pHERD30T, Gmr this study 
pHERD30T  algRD54E algRD54E in pHERD30T, Gmr this study 
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Strains/Plasmids Description Reference or source 
pHERD30T algRD7N algRD54D7N in pHERD30T, Gmr this study 
pHERD30T algRD8N algRD54D8N in pHERD30T, Gmr this study 
pHERD30T algRD49N algRD54D49N in pHERD30T, Gmr this study 
pHERD30T algRT82A algRD54T82A in pHERD30T, Gmr this study 
pHERD30T algRY99F algRD54Y99F in pHERD30T, Gmr this study 
pHERD30T  rhlAB rhlAB in pHERD30T, Gmr this study 
pGEX4T-3  GST fusion expression vector, Amr GE Healthcare Life 
Sciences 
pGEX4T-3 algR algR in pGEX4T-3, Ampr this study 
pGEX4T-3 algRD54N algR7 in pGEX4T-3, Ampr this study 
pGEX4T-3 algRD54E algR12- in pGEX4T-3, Ampr this study 
Mini-CTX-1 attB site chromosomal integration vector  (315) 
mini CTX-1 lacZ attB site chromosomal integration vector 
with promoterless lacZ 
this study 
CTX-1 fimU::lacZ  fimU promoter cloned into mini-CTX-1 
lacZ 
this study 
CTX-1 rhlA::lacZ rhlA promoter cloned into mini-CTX-1 lacZ this study 
pFLP2 Source of FLP recombinase, Ampr (313) 
pRK2013 Tra+ Mob+, ColE1 replicon; Kmr (316) 
 
 
cultures were grown in tryptic soy broth (TSB) (Difco) supplemented with 1% 
glycerol. For growth at various oxygen concentrations, cultures were grown in a 
trigas incubator (Heracell 150, Thermo Scientific) at 37°C at the oxygen 
concentrations indicated. For anaerobic growth conditions, LB agar was 
supplemented with 10 mM sodium nitrate or sodium nitrite. 
 
 
Genetic manipulations  
 
A list of oligonucleotides used in this study is found in Table 2. All cloning 
techniques were performed using E. coli DH5α to propagate and maintain 
plasmids, unless otherwise indicated. To make the algR complementation vector, 
the algR coding region was PCR amplified from PAO1 genome using the primers 
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algR-CdgRgn-KpnI-F and algR-CdgRgn-HindIII-R. This PCR product was 
digested with KpnI and HindIII and ligated into pHERD30T (314) to generate 
pHERD30T-algR. The pHERD30T-algRD54N vector was generated in a similar 
manner using chromosomal DNA extracted from WFPA8 (157). To create 
pHERD30T-algRD54E, the codon encoding asp 54 (GAT) in pHERD30T-algR 
was mutated to glu (GAA) using primers algR-D54E-XbaI-F and algR-D54E-
XbaI-R with Phusion site-directed mutagenesis kit (New England Biolabs). The 
mutagenesis was confirmed via restriction digest analysis and sequencing. 
Plasmids harboring the other algR residue mutants were created by site-directed 
mutagenesis in the same manner, with the following oligonucleotides (in 
parentheses) pHERD30T-algRD7N (algR-D7N-F and algR-D7N-R), 
pHERD30T-algRD8N (algR-D8N-F and algR-D8N-F), pHERD30T-algRD49N 
(algR-D49N-F and algR-D49N-R), pHERD30T-algRT82A (algR-T82A-F and 
algR-T82A-R), and pHERD30T-algRY99F (algR-Y99F-F and algR-Y99F-R). 
To construct the pHERD30T rhlAB vector, the rhlAB genes were amplified with 
the primers rhlAB EcoR1 F and rhlAB HindIII R from the PAO1 chromosome, and 
subcloned into pHERD30T vector using the restriction sites EcoRI and HindIII. 
The algR12 (algRD54E) allele was introduced into PAO1 or PAO1 ∆algZ 
with the following method. The algR open reading frame was amplified from 
pHERD30T-algRD54E using primers algRSalIF and algR-CdgRgn-HindIII-R, and 
subcloned into the suicide vector pEX18Gm (313), creating pEX18Gm 
algRD54E. The allele exchange vector pEX18Gm algRD54N was constructed by 
transferring the algR7 allele (algRD54N) from strain WFPA8 into pEX18Gm, as 
 43 
above. Allelic exchange was performed as previously described (313). The 
mutation was verified by PCR amplifying a region spanning algZ, algR, and part 
of hemC followed by XbaI digestion, as well as by DNA sequencing.  
The fimU::lacZ transcriptional fusion was created by ligating a 609 bp PCR 
product amplified from the PAO1 chromosome with the primer pair fimU TF Xba1 
and fimU TFR HindIII into mini-CTX-lacZ, to generate CTX-1 fimU::lacZ. The 
rhlA::lacZ transcriptional fusion was created by PCR amplifying 980 bp of the 
promoter region using the primer pair rhlA TF BamH1 F and rhlA TF Pst1 R to 
generate CTX-1 rhlATF::lacZ. The CTX-1 fimU::lacZ or CTX-1 rhlATF2::lacZ 
plasmids were transferred to a plasmid mobilization strain Sm10, and bi-
parentally conjugated into P. aeruginosa strains. The vector backbone was 
resolved by introducing pFLP2 vector into the strains containing CTX-1 
fimU::lacZ or CTX-1 rhlATF2::lacZ, and verified by PCR. For the rhlI::lacZ 
transcriptional fusions, the algR allele in strain PAO200 was replaced with algR7, 
or algR12 allele using pEX18Gm algRKO, pEX18Gm algRD54N, or pEX18Gm 
algRD54E, respectively.  
To construct the AlgR protein expression plasmids, the algR, algR12 
(algRD54E), or algR7 (algRD54N) alleles were PCR amplified using primers 
algRSalIF and algRNotIR, and directionally subcloned into pGEX4T-3 vector (GE 
Healthcare Life Sciences), generating the plasmids pGEX4T-3algR, pGEX4T-
3algRD54E, or pGEX4T-3algRD54N.  
To generate bioluminescent P. aeruginosa strains, the plasmids pUC18-
mini-Tn7T-Tp-lux and pTNS3 (EU215432) were co-electroporated into P. 
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aeruginosa strains and selected on LB with 1500 µg/ml trimethoprim. pUC18-
mini-Tn7T-based vectors integrate into the glmS site on the P. aeruginosa 
chromonosme (317). Light producing colonies were isolated and the FRT-flanked 
dhfRII cassette was removed by conjugation with pFLP2 (AF048702) encoding 
Flp recombinase. The loss of the dhfRII was confirmed by antibiotic resistance, 
and the pFLP2 plasmid was cured. 
 
Table 2. List of oligonucleotides used in this study. 
Primer name 5’→3’ sequence Gene 
algR-CdgRgn-Kpn1-F  TATCCGGTACCGTGACTCATGCAGGAAGCC algR 
algR-CdgRgn-HindIII-R  CCGCCGAAAGCTTTCAGAGCTGATGCATCA algR 
algRSalIF CCTGTCGACATGAATGTCCTGATTGTCGATGAC  algR 
algRNotIR AGCCGCGGCCGCTCAGAGCTGATGCATCAGACG algR 
algR-D54E-XbaI-F CTTCTAGAAATCCGCATGCCCGG algR 
algR-D54E-XbaI-R CGGATTTCTAGAAGGACGATATC algR 
fimU TF XbaI CATGGTCTAGAGGTCGCAGAGAGC fimU 
fimU TFR HindIII  CTCCAAGCTTTCTACGCCTGG fimU 
fimU gs frag F GGGGTCTACGCCTGGAAAGC fimU 
fimU gs frag R GTTGTCCTGCCCCTCGGGCCG fimU 
pscF GS ContF AAGGCGGTCTCGGCATTCTTTC pscEF 
pscF GS Cont R93 CCACGGTATCGAGGGTATTC pscEF 
rhlA TF BamH1 F GGACGGATCCCATGACCATCAAATCG rhlA 
rhlA TF Pst1 R CGAACCTGCAGACAGCTATCGCT rhlA 
rhlA qRT F TTTCACATCGACCAGGTGC rhlA 
rhlA qRT R CGAGACCGTCGGCAAATAC rhlA 
rhlA qRT probe 56-FAM/ 
ATGTGCTGA/ZEN/TGGTTGCTGGCTTTC/3IABKFQ 
rhlA 
rpoD qRT F GGGCGAAGAAGGAAATGGTC rpoD 
rpoD qRT R CAGGTGGCGTAGGTGGAGAA rpoD 
rpoD qRT probe 56-FAM/ 
TGAAGGCGG/ZEN/TGGACAAGTTCGAAT/3IABKFQ 
rpoD 
rhlA gs frag 1F GATTCGCGATCATTTTTCGCAGCT rhlA 
rhlA gs frag 1R CACGTCGTAGCCGTAGCTGGACAC rhlA 
rhlA gs frag 2F GTGTCCAGCTACGGCTACGACG rhlA 
rhlA gs frag 2R GTTCGGCGGGATGATGCAGACGTCG rhlA 
rhlA gs frag 3F CGACGTCTGCATCATCCCGCCGAAC rhlA 
rhlA gs frag 3R CGTAGATCTTCGCCGGCAGGTTG rhlA 
rhlA gs frag 4F CCAACCTGCCGGCGAAGATCTACG rhlA 
rhlA gs frag 4R GTTTCCGGTGTCGAAACGCTCTG rhlA 
rhlA gs frag 5F CAGAGCGTTTCGACACCGGAAAC rhlA 
rhlA gs frag 5R CAAACGATTGGCGTCCGTGTTCACG rhlA 
rhlA gs frag 6F CGTGAACACGGACGCCAATCGTTTG rhlA 
rhlA gs frag 6R CGCGCCGCATTTCACACCTCCC rhlA 
rhlA SDM WT RB1 F GCATGATCGAGCCGTTCGTCGAGCGCCAG rhlA 
rhlA SDM delta RB1 F GCATGATCGAGCCATTTGTAGAGCGCCAG rhlA 
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Primer name 5’→3’ sequence Gene 
rhlA SDM WT RB2 R CTCGATCATGCCGTGCTCCTGAGCCATGC rhlA 
rhlA SDM delta RB2 R CTCGATCATTCCATGTTCTTGAGCCATGC rhlA 
rhlAB EcoR1 F GAGGAATTCGATGCGGCGCGAAAGTC rhlAB 
rhlAB HindIII R CAAGCTTTCAGGACGCAGCCTTCAGC rhlAB 
dnr gs frag F GACTGGCCACTGTAGCGGGCCCGG dnr 
dnr gs frag R GGAGAAAGCAGCCAAAACCACC dnr 
rhlI gs frag 1F GCTGGGTCTCATCTGAAGCGCAGG rhlI 
rhlI gs frag 1R ATGACCAAGTCCCCGTGTCGTGCC rhlI 
rhlI gs frag 2F GACTTGGTCATGATCGAATTGCTC rhlI 
rhlI gs frag 2R GGCTCATGGCGACGATGTAGC rhlI 
rhlI gs frag 3F CCCGGTCTGCCTGACCATC rhlI 
rhlI gs frag 3R CTGCGCTTCAGATGAGACCCAG rhlI 
rhlI gs frag 4F CCGCGCGCCGAACAATTTG rhlI 
rhlI gs frag 4R GTCGGCGGTCCATTGCAGG rhlI 
rhlI gs frag 1.1 F AGGTTGCCTGCCGTTCATCCTCCTTTAG rhlI 
rhlI gs frag 1.2 F GTGTGCTGGTATGTCCTCCGACTGAGAG rhlI 
algR-D7N-F AATGTCCTGAATGTCAATGACGAACC algR 
algR-D7N-R CAGAGGTTCGTCATTGACAATCAGG algR 
algR-D8N-F GTCCTGATTGTCGATAACGAACCTCT algR 
algR-D8N-F CCAGAGGTTCGTTATCGACAATCA algR 
algR-D49N-F CCTCAAGCCCAATATCGTCCTG algR 
algR-D49N-R AGGACGATATTGGGCTTGAGGC algR 
algR-T82A-F GTGATCTTCTGCGCGGCCCAT algR 
algR-T82A-R GAATTCGTCATGGGCCGCGCAGAAGAT algR 
algR-Y99F-F CAGCGCCGTGGGCTTCCTGGTCAA algR 





Transcriptional reporter assays 
 
Transcriptional expression of the fimU, rhlA, and rhlI promoters were 
measured by β-galactosidase assay as previously described (273, 318), with 
modifications. Cells were lysed using a sonic dismembrator (15 Watts) in 
breaking buffer (200 mM Tris HCl, 200 mM NaCl, 2% glycerol, 1 mM 
dithiothreitol, pH 7.6). An 800 µL volume of Z-buffer (60 mM Na2HPO4, 40 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4•7H2O, 50 mM 2-mercaptoethanol, pH 7.0) 
was mixed with a volume containing 10 µg of total protein, and 200 µL of ONPG 
solution (4 mg/mL) was added to initiate the reaction. Kinetic readings were 
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measured at OD420nm. The activity was expressed as microUnits/mg, where 1 
Unit was defined as the enzymatic activity of β-galactosidase to convert 1 µmol 
ONPG to o-nitrophenol per minute (319).  Each fusion was assayed with at least 
three biological replicates. 
 
 
Quantitative PCR and microarray 
 
For relative real-time quantitative PCR analysis (qPCR), total RNA was 
extracted from cultures using RNeasy spin columns (Qiagen) and treated with 
DNase I (New England Biolabs). cDNA was generated using Superscript II 
Reverse Transcriptase and random primers (Invitrogen Life Science 
Technologies) according to the manufacturer’s instructions under the following 
conditions: 25°C for 10 min, 37°C for 60 min, 42°C for 60 min, and 70°C for 10 
min.. Real-time PCR reactions were conducted in a LightCycler 480 Instrument 
with LightCycler 480 Probes Master mix (Roche Applied Science) and rhlA and 
rpoD transcripts were analyzed using appropriate primer pairs (Table 1). Data 
were analyzed using LightCycler 480 Software Release 1.5.0 (Roche Applied 
Science). Relative expression was normalized to rpoD cDNA levels in each 
sample. 
For microarrays PAO1, algRD54N, or algRD54E microarrays, 3 to 6 x108 
CFU of bacteria were inoculated in 100 mL LB cultures, and grown for 16 hrs 
with aeration (250 rpm) at 37°C. RNA was extracted from 600 uL of cells and 
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cDNA was generated as performed for qPCR. RNA quality and the presence of 
residual DNA were checked on an Agilent Bioanalyzer 2100 electrophoretic 
system. The cDNA was fragmented by DNase I (0.6 U/g-1 of cDNA; Amersham) 
at 37°C for 10 min and then end labeled with biotin-ddUTP with use of an Enzo 
BioArray Terminal Labeling kit (Affymetrix) at 37°C for 60 min. Microarray data 
were generated using Affymetrix protocols as previously described (231, 273). 
Absolute ex- pression transcript levels were normalized for each chip by globally 
scaling all probe sets to a target signal intensity of 500. Three statistical 
algorithms (detection, change call, and signal log ratio) were then used to identify 
differential gene expression in experimental and control samples. The detection 
metric (presence, absence, or marginal) for a particular gene was determined 
using default parameters in MAS software (version 5.0; Affymetrix). Batch 
analysis was performed in MAS to make pairwise comparisons between 
individual experimental and control GeneChips in order to generate change calls 
and a signal log ratio for each transcript. These data were imported into Partek 
Genomic Suite software ver5.0 (Partek). Transcripts that were absent under both 
control and experimental conditions were eliminated from further consideration. 
Statistical significance of signals between the control and experimental 
conditions (P < 0.05) for individual transcripts was determined using the t test. 






For AlgR protein expression, 100 mL flasks containing LB were inoculated 
with 5.7 x 106 to 7.5 x 106 colony forming units (CFU) and grown for various 
periods of time. Collected cells were sonicated in PBS and centrifuged (5 min, 
16000 ×g) to pellet cell debris. Denatured samples were separated by SDS-
PAGE.  Separated proteins were transferred to a polyvinylidene fluoride 
membrane (PVDF) (BioRad). Western blot was performed as previously 
described (126) with modifications. Duplicate blots were probed with either α-
AlgR rabbit serum (Open Biosystems) pre-absorbed with cell-free extract from an 
overnight culture of PAO1 ∆algR, or with α-OmlA antibody (generous gift from Dr. 
Michael Vasil). Goat -rabbit HRP conjugate and the ECL kit (GE Healthcare) 
were subsequently used to detect AlgR or OmlA proteins using 
chemiluminescent-based immuno-detection. Blots were imaged with the 
ChemiDoc XRS system, and band intensity quantification was performed using 




Purification of AlgR, AlgRD54N, AlgRD54E 
 
Vectors pGEX4T-3algR, pGEX4T-3algRD54N, or pGEX4T-3algRD54E 
were transformed into BL21 Rosetta cells (Novagen) and grown in LB 
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supplemented with antibiotics. Cell were grown at 37°C until cultures reached an 
OD600nm of 0.48, and protein expression was induced with 0.5 mM of IPTG for 4 
hrs at 15°C. Cells were centrifuged (30 minutes, 8000 ×g) and lysed in PBS 
containing 1 mM PMSF in a French-pressure cell press. Cell extracts were 
treated with 30 U/mL DNase, 1 mg/mL lysozyme, and HALT Protease Inhibitor 
(Thermo Scientific), centrifuged, passed through a 0.2 µm GD/X PVDF filter 
(Millipore), and supernatants containing soluble GST-AlgR fusion protein were 
bound to glutathione-sepharose beads (GE Healthcare Life Sciences). Beads 
were fitted into a gravity column and washed with PBS. The AlgR protein or its 
isoforms were cleaved from the GST tag with thrombin (10 units/mL column 
volume) for 18 hrs at 4°C (GE Healthcare Life Sciences) before elution with PBS. 
All fractions were tested for protein expression and contamination by resolving on 
an SDS-PAGE gel and coomassie blue staining. PBS was immediately replaced 
with storage buffer (20 mM Tris, 100 mM NaCl, 5 mM MgCl2, 10% glycerol, pH 
7.5) using a stirred ultrafiltration cell (Millipore), and protein aliquots were stored 
at -80°C.  
 
 
In vitro phosphorylation with radiolabeled acetyl phosphate 
 
Radioactive [32P] acetyl phosphate (AcP) was generated as previously 
described (320). Briefly, 1U of B. stearothermophilus acetate kinase (Sigma) was 
incubated with 50 µCi [γ-32P]ATP (6000 Ci/mM) in AKP buffer (25 mM Tris-HCl, 
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60 mM potassium acetate, 10 mM MgCl2, pH 7.6) for 3 hrs at 30°C. The [32P]AcP 
was then incubated with 5 µg AlgR, AlgRD54N or AlgRD54E for 30 min at 37°C. 
Lysozyme was also used as a negative control. The reactions were terminated 
with SDS-PAGE loading buffer without boiling, and separated on a 12% 
acrylamide SDS-PAGE. The protein gel was then exposed to x-ray film and 
imaged. Subsequently, proteins were stained with coommassie brilliant blue and 





Thermal denaturation of AlgR, AlgR D54N, or AlgR D54E proteins was 
performed to study their stability. 5x SYPRO orange was used as an indicator of 
protein unfolding (binding to hydrophobic regions and un-quenching of 
fluorescence). Experiments were conducted using 0.3 ng (10.9 pmol) of AlgR or 
its isoforms, or porcine citrate lyase (as a positive control) in the following buffer: 
140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 5 mM MgCl2, 
20% glycerol (storage buffer). Relative fluorescent intensity (RFU) was detected 
at 530 nm (after excitation with 490 nm) as the temperature was increased at 1°C 
increments from 4°C to 95°C. The first derivative of the values were plotted to 




Electrophoretic mobility shift assays (EMSAs) 
 
Electrophoretic Mobility Shift Assays (EMSAs) were performed using 
purified AlgR proteins, as previously described (321). DNA fragments were 
prepared by PCR amplification of PAO1 chromosomal DNA with Taq polymerase 
(New England Biolabs) and the oligonucleotides listed in Table 2 for fimU, rhlA, 
rhlI, and dnr. Oligonucleotides were 5’- end-labeled with [γ-32P]ATP (6000 
Ci/mmol) (Perkin Elmer) with polynucleotide kinase (New England Biolabs). 
Excess radio-nucleotide was removed with Illustra microspin G-25 columns (GE 
Healthcare). The fragments rhlA∆1 (rhlA SDM delta RB1 F and rhlA SDM WT 
RB2R), rhlA∆2 (rhlA SDM WT RB1 F and rhlA SDM delta RB2R), and rhlA∆1∆2 
(rhlA SDM delta RB1 F and rhlA SDM delta RB2R) were created using site-
directed mutagenesis of the vector pGEMT-rhlAprom (primers used are in 
parentheses). The Purified AlgR protein was pre-incubated with non-radioactive 
acetyl phosphate (acetylphosphate lithium potassium salt) (Sigma) for 30 min at 
37°C at the various acetyl phosphate concentrations indicated, prior to DNA 
binding studies.  
Binding assays were performed as described by Jones et. al. (321). 
Binding reactions were performed for 30 minutes at 25°C in the following buffer 
(25 mM Tris (pH 8.0), 25 mM KCl, 5% glycerol, 0.5 mM EDTA, 0.5 mM 
dithiothreitol, 2.5 ng/µL poly dI•dC, 0.1 µg/uL BSA), using the protein and DNA 
concentrations indicated. Samples were loaded in a native 6.5% polyacrylamide 
gel (10 mM Tris (pH 8.0), 0.38 mM glycine, 1 mM EDTA, 6.5% (2.67% bis-
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acrylamide) acrylamide) and electrophoresed in a tris-glycine-EDTA running 
buffer (10 mM Tris (pH 8.0), 0.38 mM glycine, 1 mM EDTA) at 4°C. Following 
electrophoresis, the gels were dried under a vacuum and were applied to either 
phosphor screen or Kodak film, and imaged using Molecular Imager FX and 





Subsurface twitching motility assays were performed as previously 
described (221). Briefly, overnight cultures were inoculated in the interstitial 
space between the plastic Petri dish and basal surface of LB 1.0% bacto agar, 
and incubated for 48 hrs at 37°C. Cultures were stained with 0.5% crystal violet, 
and the diameter of the twitching zone was measured. Surface twitching motility 
assays were performed as previously described (322, 323). Cultures were grown 
in brain heart infusion (BHI) medium (Difco) to OD600 1.2, and concentrated to 9 x 
109 cells/ml in morpholinepropanesulfonic acid (MOPS) buffer (10mM MOPS, 8 
mM MgSO4, pH 7.6). A 2.5 µL volume of the suspension was spotted on buffered 
twitching motility plates (10 mM Tris, 8 mM MgSO4, 1 mM NaPO4, 0.5% glucose, 
pH 7.6, solidified with 1.5% bacto agar) and incubated at 37°C for 24 hrs at 5% 
O2 (HeraCell 150, Thermo-scientific). The twitching zone was imaged using a 
digital camera and an Axiovert 25 inverted light microscope at 100x magnification 
(10x phase contrast objective lens and 10x optical eyepiece) (Carl Zeiss).  
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Swarming motility was measured as previously described (324). Briefly, 
stationary phase cultures were concentrated by centrifugation, and adjusted to 
OD600 3.0 in phosphate buffered saline (PBS). Five µL were spotted onto the 
center of modified M9 medium agar (20 mM NH4Cl, 12 mM Na2HPO4, 22 mM 
KH2PO4, 8.6 mM NaCl, 1 mM MgSO4, 1 mM CaCl2 2H2O, 11 mM dextrose, 0.5% 
casamino acids, solidified with 0.5% bacto agar), and was grown for 10 hrs at 
30°C followed by 20 hrs at room temperature. For arabinose induction, volumes 
from a 20% stock solution of L-arabinose were added to swarming plates prior to 
solidifying. Swimming motility assays were performed using 0.3% agar as the 
solidifying agent. Swarming and swimming plates were imaged with the 
ChemiDoc XRS system (BioRad) and image contrast was adjusted using 





Determination of rhamnolipids was performed using four different assays: 
1) orcinol assay; 2) thin-layer chromatography (TLC); 3) a hemolysis assay; and 
4) a semi-quantitative colormetric assay, as previously described (273, 325-330). 
To quantify the amount of rhamnolipid produced by each strain, the orcinol 
rhamnolipid assay was used (273, 327, 331). 100 mL of bacterial cultures were 
grown at 37ºC shaking at 250 rpm in beveled flasks (for assays in Figure 5.4, 5 
mL of bacterial cultures in 14 ml culture tubes were used). Briefly, a 1 mL volume 
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of samples was then collected and centrifuged. Rhamnolipds were extracted 
from cell supernatants three times with 0.5 mL ethylacetate. After ethylacetate 
extraction, 1 mL of orcinol reagent (53% sulfuric acid, 0.2% orcinol) was added. 
Samples were incubated at 80ºC for 30 minutes then cooled at room temperature 
for 15 minutes. 200 µL of each sample was then added to a 96-well plate and the 
Absorbance at 522 nm was recorded by a synergy 2 plate reader, and compared 
with a standard curve of rhamnose monohydrate. Total rhamnolipid values were 
normalized to total protein of cell pellets measured by Bradford assay.   
TLC was performed as previously described (328). Briefly, samples were 
extracted as described for the orcinol assay. Ethylacetate extracts were 
completely dried and re-suspended in 20 µL of 90% chloroform, 10% methanol. 
A 5 µL volume was added to a silica gel 60A thin layer chromatography plate 
(Whatman) and mobilized in a solvent system containing 65 chloroform:15 
methanol:2 acetic acid (v/v). The plate was incubated in a bath of 15% sulfuric 
acid in ethanol, and developed with a heat gun. 
Hemolysis assay was performed as previously described with modification 
for 96-well plates (332). Horse blood in Alsevers (Colorado Serum Company) 
was washed three times with PBS prior to use. Bacterial supernatants were 
obtained from 1 mL of 24 hr cultures grown at 37°C, which was centrifuged for 5 
minutes at 16000 × g to pellet cells and separate supernatants. The supernatants 
were heat-treated at 95°C for 10 minutes, cooled, and serially diluted. Diluted 
supernatants were applied to a final blood concentration of 1% v/v. PBS and 
water was used as negative and positive controls, respectively. Hemolysis 
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reactions were incubated for 1 hr at 37°C, and solubilized hemoglobin was 
separated from cell debris by centrifugation (10 minutes, 750 × g). Supernatants 
were transferred to new 96-well plates, and the absorbance of free hemoglobin 
was read at OD 542 nm. Percent hemolysis was calculated with the following 
formula: %hemolysis = (Abssample - Absblank) / Abspositive control × 100.  
Semi-quantitative measurements of rhamnolipid production was 
performed using minimal medium containing cetyl trimethylammonium bromide 
(CTAB, Acros, NJ) and methylene blue (MB, Sigma Aldrich, St. Louis MO) 
(CTAB/MB). Agar plates were made as previously described (329, 330) using 
1.6% (v/v) glycerol as the sole carbon sources. Wells were prepared by pressing 
a heated 4 mm diameter glass rod into the agar. Overnight cultures were 
adjusted by diluting to an OD600 of 0.2, and 10 uL of cultures were inoculated in 
the wells. Plates were grown at 37°C for 48 hrs, and subsequently stored at 4°C 
for 24 hrs to increase the contrast of the blue halo indicative of surfactant 
diffusion. Diameters were measured and compared with a standard of known 
rhamnolipid amounts (generous gift from Dr. Michael Vasil). 
 
 
Quantification of C4-HSL 
 
For quantification of C4-HSL, the procedure was adapted from a previous 
study with modifications (333). Cultures (strains without rhlI::lacZ) were grown for 
16 hrs at 37°C in LB, shaking at 250 rpm, and the final CFU/mL of the cultures 
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were between 5.0 × 108 to 8.5 × 108. Bacterial supernatants were retained after 
centrifugation at 8000 × g for 30 min. A 5 mL volume of supernatants was 
transferred to new tubes, and 2 nmol of C4-HSL-d5 was added (Caymen 
Scientific) and vortexed to homogeneity. A 2.5 mL volume of this mixture was 
passed through a 0.2 µm GD/X PVDF filter (Millipore) to cold-sterilize and 
remove any cell debris from the supernatant. The culture supernatants were 
extracted twice with 5 mL each of acidified ethyl acetate (with 0.01% glacial 
acetic acid), pooled, and dried down using a vacuum centrifuge. Dried down 
AHL-extracts were resuspended in 100 µL methanol and applied to pre-activated 
Sep Pak Plus Silica Cartridges (Waters) fitted to glass 6 mL reaction vials to 
purify AHLs. Cartridges were pre-activated using 1:1 isooctane:ethyl ether and 
0.01% acidified ethyl acetate, as described previously. The AHLs were allowed to 
bind to the column, washed with 1:1 isooctane:ethyl ether, and eluted with 0.01% 
acidified ethyl acetate and collected. The purified AHLs were dried down by 
vacuum centrifuge, and used right away, or re-suspended in 100 µL methanol for 
short-term storage.  
Liquid chromatography was performed as previously described (333). 
Briefly, Purified AHLs for LC-MS/MS analysis were re-suspended in 200 µL of 
mobile phase solvent which was in a 98:2 ratio of solvent A (0.1% glacial acetic 
acid in water) and solvent B (65% acetonitrile, 35% methanol, 0.1% glacial acetic 
acid). A 10 µL volume of re-suspended sample was injected onto a 3.0-mm × 
50.0-mm, 2.6 U columbus C18 reverse-phase column (Phenomenex), which was 
operated at a flow rate of 250 µL/min with the effluent flowing directly into the 
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mass spectrometer with solvent A and B. The gradient elution method started at 
2% solvent B for 5 min, went to 65% solvent B over 4 min, stayed isocratic at 
65% for a minute, then went to 95% in 5 min and remained isocratic at 95% 
solvent B for 7 min. The column was re-equilibrated for 6 mins, and a blank run 
was performed between each analysis.  
Mass spectrometric analyses were performed on a PE Sciex API-2000 
triple-quadrupole tandem mass spectrometer (Perkin-Elmer Life Sciences). The 
instrument parameters were as follows: ion spray voltage of 4,400 V, 
declustering potential of 30 V, focusing potential of 200 V, and collision energy of 
15 V. Nitrogen was used as the collision gas. Multiple reaction monitoring (MRM) 
experiments were conducted using the same HPLC conditions and MS 
parameters as previously described. Q1 was set to monitor m/z of 171.2 for the 
C4 acyl moiety, and 177.2 for the C4-d5 acyl moiety, and Q3 was set to monitor 
m/z of 102.1 for the lactone ring. These ions correspond to the transition from the 
parent ion of each AHL to both the acyl moiety [M+H-102.1]+, as well as the 
lactone moiety. Precursor ion-scanning experiments were also conducted as 
confirmation for the MRM.  
Standard curves were prepared by making 1-mg/ml reference stock 
solution of C4-HSL (Caymen Scientific). The stock solution was serially diluted to 
yield concentrations of 125, 25, 5, 1, 0.2, 0.04, and 0.008 nmol. To each of those 
dilutions, 1 nmol of the C4-HSL-d5 internal standard was added. The AHLs were 
dried down and replaced with 200 µL of mobile phase solvent. The standard 
curve samples were analyzed by MRM using the same HPLC conditions and 
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instrument parameters as above. The reference and analyte peak areas were 
integrated using a quantitation software package (Analyst 1.2; Perkin-Elmer). 
The standard curves generated of the ratio of the areas of the reference and 
internal standard peaks to the ratio of the area ratio of the analyte and internal 
standard peak area in each sample. Each integrated peak was inspected 
manually, and the data were plotted to obtain a standard curve. Experimental 





Pyocyanin production was measured by a colorimetric assay (334, 335). 
Five mL broth cultures were pelleted, and supernatants were transferred to fresh 
tubes. Pyocyanin was chloroform-extracted from supernatants using 5 mL of 
choloroform. The organic and aqueous layers were separated by centrifigation, 
and the aqueous layer was discarded. One mL of 0.2 N HCl was added to the 
chloroform to reduce pyocyanin and solubilize it into the aqueous acidic solution. 
The change in color of pyocyanin induced by acid was measured by reading its 
absorbance of the aqueous layer at a wavelength of 520 nm. Measurements 
were standardized to total protein by lysing cell pellets and measuring protein 






Biofilm assays were conducted using a 96 well microtiter plate. Cells were 
grown at 30°C in LB in the wells of polystyrene microtiter plates. Spent medium 
was replaced with fresh medium every 24 hours to prevent dispersion over the 
course of growth. At indicated time points, biofilm formation was enumerated. 
Wells were washed with distilled water and stained with 0.5% crystal violet. 
Excess crystal violet was washed, resuspended in ethanol, and the absorbance 
was measured at 595 nm using a Synergy HT automated plate reader (Biotek).  
 
 
Murine acute pneumonia model and bioluminescence detection 
!
P. aeruginosa strains were grown on Pseudomonas Isolation Agar (PIA, 
Becton Dickinson) plates for 24 hrs at 37° C and suspended in 1X PBS.  Optical 
density of 2-fold serial dilutions was measured in a Perkin Elmer Victor 3 
Absorbance and Luminescence reader. Absorbance at 595 nm and 
luminescence (Counts Per Second; CPS) were measured. The slopes of the 
serial dilution curves were used to find the linear range and calculate the desired 
challenge dose in 20 µl of 4x107 CFU. Nine-week-old female BALB/c mice 
(Harlan Laboratories) were anesthetized by intraperitoneal injection of 0.25 ml of 
ketamine (6.7 mg/ml) and xylazine (1.3 mg/ml) in 0.9 % w/v saline.  Anesthetized 
animals were placed on their backs and 10 µl inoculums were pipetted directly 
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into each nostril (20 µl total).  Bacterial doses were verified immediately after 
infection by serial dilution in 1x PBS + 1% BSA and plating on PIA.  All animals 
were carefully observed for the duration of the trials according to University of 
Virginia Animal Care and Use Committee approved protocols. For statistical 
analysis of the survival curves, the Logrank test ran on GraphPad Prism v4.0 
was used. Analysis of bacterial luminescence in lung homogenates at time of 
death and mean time of death were performed using a one-way ANOVA with 
Bonferroni multiple comparison test ran on GraphPad Prism v4.0. To determine 
CFU and/or CPS, animals were dissected and lungs were homogenized in 1ml 
PBS, plated at appropriated dilutions on PIA and 100 µl of homogenate were 
used in triplicate for measurement of luminescence.  Mice that survived to 48 or 






To measure growth rate of bacteria in anaerobic conditions, overnight 
cultures were adjusted to 104 CFU/mL. 103 CFU were spread on LB agar 
medium supplemented with either 10 mM of sodium nitrate or sodium nitrite. Petri 
dishes were placed in anaerobic jars containing BBL anaerobic gas packs 
(Becton Dickinson). At indicated time points, bacteria were resuspended in 5 mL 
of saline, and CFU/mL was enumerated from 1 mL of the 5 mL sample.  
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CHAPTER III   
 
 
VIRULENCE FACTOR PRODUCTION BY SENSOR KINASE KINB AND 





Besides AlgR, AlgB is another transcriptional response regulator that 
activates alginate production. The σ54 family of sigma factors are unique in 
comparison with others (e.g. σ70, σE), as they require a cognate NtrC-type 
regulator to activate the protein prior to transcriptional initiation (336). The algB 
gene (PA5483) encodes an NtrC subfamily of response regulators that is 
required for regulating σ54 (RpoN)-dependent promoters (116, 118, 312). The 
AlgB protein contains three domains. The N-terminus has a CheY-like receiver 
domain. The central domain has structural homology to the ATP-binding motif of 
NtrC subfamily of transcriptional activators (116), required for the ATP hydrolysis 
of σ54 holoenzyme from closed complex to open complex (337). The C-terminus 
has a helix turn helix (HTH) DNA binding domain required for transcriptional 
regulation. 
                                                
2 Republished with permission from American Society for Microbiology Journal of 
Bacteriology. Sections were taken from: Damron FH, Owings JP, Okkotsu, Y, 
Varga JJ, Schurr JR, Goldberg JB, Schurr MJ, Yu HD. 2012. Analysis of the 
Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and 
sigma factor RpoN. J. Bacteriol. 84(4):595-607.   
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AlgB regulates the algD promoter, as an algB::Tn501 insertional 
inactivation or algB deletion mutants in a mucoid clinical isolate (strain FRD), 
displays a nonmucoid phenotype (117), and has at least a 20-fold decrease in 
algD::cat transcriptional reporter activity (116, 118). The AlgB C-terminal domain 
contains a helix turn helix (HTH) DNA binding domain (185), and in vitro binding 
of AlgB to the algD promoter has been demonstrated (338). Even though these 
data suggest AlgB binds and directly regulates algD transcription, the role of 
AlgB’s cognate sigma factor, RpoN, on the algD promoter is indirect and strain 
dependent. RpoN is not required for algD transcription, as deletion in rpoN did 
not affect algD::xylE activity (135). 
The cognate histidine kinase for AlgB is encoded by kinB (PA5484), 
located directly downstream of algB on the PAO1 chromosome. KinB is a 66.1 
kDa inner-membrane localized histidine kinase (339). The kinB gene encodes 
the AlgB cognate histidine kinase; evidence shows that purified KinB can auto-
phosphorylate [γ-32P]ATP in vitro, transfer the phosphate group to purified AlgB, 
and loses phosphotransfer activity when key amino acids within the catalytic 
domain are mutated (339). Similar to AlgZ/AlgR, AlgB phosphorylation by KinB is 
not required to activate alginate production (185). Expressing a phospho-
defective mutant (algBD59N, encoding an asparagine substitution at the 
conserved aspartate residue, D59), or a REC domain deletion mutant (AlgBD1-
145, encoding AlgB with an intact central and C-terminus domains), did not 
decrease alginate production in a mucoid background strain (FRD) (185). A kinB 
deletion also did not abrogate alginate production in this mucoid background, 
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indicating that AlgB phosphorylation does not regulate alginate production in 
mucoid backgrounds (containing a mucA mutation).  
Interestingly, a kinB deletion in non-mucoid PAO1, PA14, and PAK 
background strains results in mucoidy (185, 312, 339, 340). AlgW protease 
responds to mis-folded proteins (e.g. tripeptide motifs caused by membrane 
stress) and degrades MucA, which releases AlgU-RNAP complex to the 
cytoplasm to activate alginate biosynthetic genes (Fig 1.2 A) (83, 84, 341). A 
∆kinB∆algW double mutant was phenotypically non-mucoid, indicating that KinB 
represses AlgW degradation of MucA (312). The mucoid phenotype in a ∆kinB 
background is also mediated through AlgB or RpoN, as ∆kinB∆algB or 
∆kinB∆rpoN double mutants were also non-mucoid and had decreased alginate 
production (312). These results strongly suggest that KinB, AlgB, and RpoN 
repress genes that induce alginate production through the AlgW-mediated 
mechanism.  
This current study was first initiated under the model that KinB and RpoN 
may repress genes that induce alginate production through an AlgW-mediated 
mechanism (Fig 3.1 A). In order to investigate the role of KinB and RpoN in P. 
aeruginosa, microarray analyses were performed on PAO1 ∆kinB and compared 
with PAO1 ∆kinB∆rpoN strains. Alginate-related genes were found to be 
dependent on both kinB and rpoN. Additionally, previous work demonstrated that 
KinB plays a role in P. aeruginosa virulence (340). Virulence factors including 
rhamnolipid production and twitching motility were regulated by KinB and RpoN. 
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Figure 3.1. Model of KinB and microarray result overview. (A), P. aeruginosa 
sensor kinase KinB regulation of alginate overproduction. KinB is a sensor kinase 
that localizes to the inner membrane. KinB is also a negative regulator of alginate 
overproduction. In the absence of kinB, AlgB and RpoN activate expression of 
unknown genes (step 1). These unknown factors cause AlgW-mediated 
proteolysis of MucA, resulting in activated AlgU (step 2). AlgU then drives 
expression of the alginate biosynthetic operon as well as other AlgU regulon 
genes (step 3). (B), genes that were dysregulated were grouped based on their 
primary PseudoCAP classifications (154). Major classes that were dysregulated 






P. aeruginosa PAO1 ∆kinB or PAO1 ∆kinB∆algB were grown on 
Pseudomonas isolation agar (PIA) (as PIA has been shown to induce mucoidy). 
Condensed microarray results are shown in Table 3 (119). Transcriptome 
analysis showed that 926 genes were differentially regulated, of which 427 were 
up-regulated and 499 were down-regulated by the PAO1 ∆kinB∆rpoN vs PAO1 
∆kinB (Fig. 3.1 B).  
 
Table 3. Select KinB genes regulated by ∆kinB∆rpoN vs ∆kinB. † 
Gene Group and 
PA locus 




   
PA0762 algU Sigma factor AlgU NS 
PA0763 mucA Anti-sigma factor MucA NS 
PA0764 mucB Negative regulator for alginate 
biosynthesis MucB  
-2.8 
PA0765 mucC Positive regulator for alginate 
biosynthesis MucC 
-2.3 
PA0766 mucD Serine protease MucD precursor -2.8 
PA3540 algD GDP-mannose 6-dehydrogenase AlgD -71.6 
PA3541 alg8 Alginate biosynthesis protein Alg8 -13.9 
PA3542 alg44 Alginate biosynthesis protein Alg44 -13.0 
PA3543 algK Alginate biosynthetic protein AlgK  -16.5 
PA3544 algE precursor Alginate production outer 
membrane protein AlgE  
-13.8 
PA3545 algG Alginate-c5-mannuronan-epimerase 
AlgG 
-12.6 
PA3546 algX Alginate biosynthesis protein AlgX  -12.9 
PA3547 algL Poly(beta-D-mannuronate) lyase 
precursor AlgL  
-20.2 
PA3548 algI Alginate O-acetyltransferase AlgI -13.7 
PA3549 algJ Alginate O-acetyltransferase AlgJ -15.0 
PA3550 algF Alginate O-acetyltransferase AlgF  -25.0 




PA4446 algW  Regulated protease AlgW  -11.1 
PA5322 algC Phosphomannomutase AlgC -4.5 
PA5483 algB Two-component response regulator AlgB  -3.0 
PA3692 lptF Lipotoxin F, LptF -5.9 
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Gene Group and 
PA locus 




PA3622 rpoS Sigma factor RpoS NS 
PA1430 lasR Transcriptional regulator LasR NS 
PA1432 lasI Autoinducer synthesis protein LasI NS 
PA1871 lasA LasA protease precursor  12.0 
PA3724 lasB Elastase LasB 3.2 
PA3476 rhlI Autoinducer synthesis protein RhlI 3.3 
PA3477 rhlR Transcriptional regulator RhlR NS 
PA3478 rhlB Rhamnosyltransferase chain B 10.0 
PA3479 rhlA Rhamnosyltransferase chain A 10.7 
PA1245  Hypothetical protein 2.8 
PA1246 aprD Alkaline protease secretion protein AprD 3.5 
PA1247 aprE Alkaline protease secretion protein AprE 3.6 
PA1248 aprF Alkaline protease secretion protein AprF 2.6 
PA1249 aprA Alkaline protease secretion protein AprA NS 
† Edited from Tables 1 and 2 from Damron FH, Owings JP, Okkotsu, Y, Varga JJ, Schurr JR, 
Goldberg JB, Schurr MJ, Yu HD. 2012. Analysis of the Pseudomonas aeruginosa regulon 
controlled by the sensor kinase KinB and sigma factor RpoN. J. Bacteriol. 84(4):595-607. Data 
generated by Damron FH, Schurr JR and Schurr MJ. 
 
In agreement with the loss of mucoidy observed by introducing the ∆rpoN 
in a ∆kinB background (312), alginate regulation and biosynthesis genes were 
down-regulated in the PAO1 ∆kinB∆rpoN vs PAO1 ∆kinB (Table 3). These genes 
included those in the algD operon (PA3540-3551), algC, algB, and algW. While 
algU or mucA transcript levels were unchanged in the microarray, transcription of 
algU, mucA and algW were in fact down-regulated in PAO1 ∆kinB∆rpoN when 
verified by RT-qPCR (data not shown) (119). The data support the idea that the 
mucoid phenotype observed in a ∆kinB background is mediated through RpoN 
(119). 
The transcriptome analysis also revealed a large number of QS-regulated 



























Figure 3.2 Rhamnolipid production of P. aeruginosa PAO1, kinB, and 
kinB rpoN strains. (A) rhamnolipid content was measured using the 
CTAB/MB colormetric rhamnolipid assay, and amounts are shown for the strains 
indicated, with PAO1 rhlA as a negative control. N=3. ND, statistical analysis 
was not determined due to the values of 0. ***, significant P value compared to 
PAO1. (B), a representative visualization of rhamnolipid production of the strains 
on a CTAB/MB assay plate. 
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3). The expression level of rhlI was increased in ∆kinB∆rpoN (Table 3), 
suggesting that the increased expression of QS genes may be due an increased 
production of C4-HSL by the acyl-homoserine lactone synthase encoded by rhlI. 
QS-controlled lasB, which encodes the LasB protease, was increased 3-fold in 
the transcriptome analysis (Table 3) and 2-fold by RT-qPCR (data not shown) 
(119). Furthermore, the rhamnolipid genes rhlA and rhlB were 10-fold up-
regulated in PAO1 ∆kinB∆rpoN in the transcriptome analysis (Table 3) and 7.7 
and 27.8-fold increased, respectively, analyzed by RT-qPCR (data not shown). 
To verify this transcriptional analysis, rhamnolipid production in PAO1, PAO1 
∆kinB, or PAO1 ∆kinB∆rpoN strains was measured. PAO1 or PAO1 ∆kinB∆rpoN  
produced three times more rhamnolipids than PAO1 ∆kinB, indicating that the 
decreased activity of the Rhl quorum-sensing system in the ∆kinB background is 
mediated by RpoN (Fig. 3.2). 
RpoN was previously shown to be required for formation of the type IVa 
pilus and flagellum assembly (342-344). Therefore, motility was also measured in 
PAO1, PAO1∆kinB, PAO1 ∆kinB∆rpoN or PAO1 ∆algU strains. The kinB 
mutation resulted in a decrease in all three forms of motility (Fig. 3.3 A and B). 
Not surprisingly, rpoN deletion completely abrogated swimming and twitching 
motility. However, a small amount of swarming was observed in the kinB ∆rpoN 
strain (Fig. 3.3 A and B). Swarming motility requires rhamnolipid production and 
flagellum motility (345), and restoration of rhamnolipid production (Fig. 3.2) could 
explain this phenotype. AlgU was previously shown to repress flagellum 




Figure 3.3. Motility of P. aeruginosa kinB mutant strains. (A) Swimming, 
swarming, and twitching motility are shown for the strain indicated, with standard 
deviations. Data generated by Damron FH. (B) Representative surface twitching 
motility. Cultures adjusted to an A590 of 1.2 were centrifuged and resuspended 
in MOPS buffer, and 2.5 ul was spotted onto the surface of a predried buffered 
agar plate. Organisms were allowed to twitch outwards for 48 hrs at 37°C. The 
arrow shows the leading edge of PAO1 twitching (n=3). Bar, 500 µm. 
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background (Table 3). A ∆kinB∆algU background displayed elevated levels of 
swimming motility as compared to ∆kinB (Fig. 3.3 A), suggesting that the 





This work demonstrated that the alginate biosynthesis genes are activated 
in a ∆kinB background. It also demonstrated that alginate production in the ∆kinB 
background is through the activity of σ54 family of sigma factors, RpoN. Notably, 
there was an increased expression of the algW gene encoding the protease that 
cleaves MucA and activates the AlgU regulon. RpoN has been inactivated from 
mucA mucoid mutants (342), and no change in the mucoid phenotype was 
observed. However, the kinB mutant (312) and the muc-23 mutant found in strain 
PAO579 require rpoN for alginate production (348). Recently, it was discovered 
that PAO579 contains a mutation in the pilA gene that introduces a premature 
stop codon. The resulting truncated PilA polypeptide contains a tripeptide motif 
that is capable of activating the AlgW protease (85), thereby inducing alginate 
production (Fig. 1.2 A). Because RpoN regulates the pilSR genes encoding the 
PilSR two component system that activates pilA expression (214), strain 
PAO579's mucoid status is dependent on RpoN through a different mechanism. 
Recently, Chand et. al. suggested that KinB’s phosphatase activity acts as 
a switch to mediate acute and chronic virulence factors through AlgU (349). AlgU 
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has been shown to repress acute virulence factors, as a mucA22 allele (where 
AlgU is active) represses type 3 secretion system expression and elastase 
production (321). According to the model proposed by Chand et. al., in wild type 
non-mucoid P. aeruginosa, KinB phosphatase activity reduces intracellular 
phosphorylated AlgB, which decreases transcription of algU and up-regulates 
acute virulence factors (349). Conversely, when KinB phosphatase activity is 
inactivated (e.g. a ∆kinB strain), AlgB would be phosphorylated (by an unknown 
mechanism) and de-repress algU, that then activates chronic virulence factors 
(such as alginate production) (349). In support of this model, both a ∆kinB or 
algBD59N allele decreased (repressed) the virulence factors pyocyanin and 
elastase, while a ∆algB or ∆kinB∆algB allele did not (349).  
Our study further established that acute virulence factors (motility and 
rhamnolipids) are regulated by KinB and RpoN (Fig. 3.2, Fig. 3.3), and adds to 
the model that quorum-sensing related virulence factors are also regulated by 
KinB phosphatase activity. Our study demonstrated that in a ∆kinB background, 
virulence factors under the control of the Rhl quorum sensing system are 
repressed by RpoN. (Table 3, Fig. 3.2) (119). RpoN appears to either activate or 
repress rhlI transcription, depending on medium conditions. RpoN activates the 
Rhl quorum sensing system using rich medium (350), while it represses rhlI and 
rhlR transcription, and C4-HSL production in minimal medium (351). In this work, 
under our experimental conditions with Pseudomonas isolation agar, RpoN, 
together with KinB and perhaps AlgB, appear to repress the Rhl quorum sensing 
system. Additionally, although RpoN binding sites have been identified in the rhlA 
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promoter (350), RpoN regulation of rhlAB transcription appears to be indirect 
(352). Taken together, RpoN appears to repress the Rhl quorum sensing system 
at the level of rhlI transcription. 
Twitching motility was also decreased in the ∆kinB or ∆kinB∆rpoN 
backgrounds. The reason for this decrease is currently unknown. Several type 
IVb pili genes were up-regulated in the ∆kinB∆rpoN vs ∆kinB microarray (data 
not shown) (119). Unlike the type IVa pili, however, type IVb pili is not required 
for motility (353). Chand et. al., observed that a ∆kinB in a PA14 background did 
not affect twitching motility (349). Therefore, it is possible that the twitching 
motility phenotype observed in this study is due to strain differences.  
Inactivation of kinB resulted in attenuation in both a murine acute 
pneumonia (data not shown) (119) and zebrafish embryo models of infection 
(340, 349). The virulence defect in the ∆kinB strain is most likely due to the 
repression of a number of acute virulence factors including those in the Rhl 
quorum sensing system. Future studies involving manipulation of the KinB 
phosphatase activity could be of great interest for managing P. aeruginosa 





CHAPTER IV   
 
 
CHARACTERIZATION OF ALGR MUTANTS AND EFFECT ON THE 
FIMUPILVWXY1Y2E OPERON 3 
 
 
The AlgR D8N and AlgR T82A affected twitching motility and fimU promoter 
activity 
 
Based on secondary structure alignment of AlgR with other CheY-like 
receiver domains, there are conserved residues involved in phosphorylation, 
consistent with other CheY-like proteins (Fig. 1.5). In order to evaluate how these 
residues are involved with the function of AlgR, site-directed mutagenesis was 
performed on several conserved residues of the algR gene to create proteins 
with alanine, asparagine, or phenylalanine substitutions. These alleles were 
transformed into a ∆algR background and tested for an AlgR-dependent 
phenotype, twitching motility.  
As shown in Figure 4.1 A, most of the site-directed mutants were 
comparable to the wild type algR. The algRT82A allele resulted in a two fold-  
                                                
3 Republished with permission from American Society for Microbiology Journal of 
Bacteriology. Sections were taken from: Okkotsu, Y, Tieku, P, Fitzsimmons, LF, 
Churchill, ME, Schurr, MJ. 2013. Pseudomonas aeruginosa AlgR 
phosphorylation modulates rhamnolipid production and motility. J. Bacteriol. 
JB.00726-13.   
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Figure 4.1. Site-directed mutants of algR and its expression on twitching 
motility and fimU activity. (A), the ∆algR strain harboring site-directed mutants 
of algR (D7N, D8N, D49N, T82A, and Y99F) were measured for twitching 
motility. Twitching assays were performed for 48 hrs in 1.0% agar LB plates at 
37°C. (B), the plasmids used in (A) were placed in the strain PSL317 fimU::lacZ. 
Beta-galactosidase activity from the fimU promoter were measured in broth 
cultures after growth in LB, 37°C for 17 hrs. One Way ANOVA with Bonferroni 
post-test comparisons with wild type are indicated. P-values: * 0.05 to 0.01, ** 
0.01 to 0.001, n=3. 
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reduction in the twitching zone. In order to investigate whether this decrease was 
due to a decrease in fimU promoter activity, the plasmids were expressed in 
PSL317 containing a fimU::lacZ reporter (Fig. 4.1 B). The algRT82A allele 
displayed decreased fimU activity, indicating that the twitching defect (Fig. 4.1 A) 
was probably due to decreased fimU operon expression. Interestingly, for the 
algRD8N allele, there was an increase in fimU promoter activity. This result was 
in agreement with previous work on the RcsB response regulator (306) and 
CheY (161) from E. coli, where the comparable RcsB D11N mutation resulted in 
the activation of the cps genes involved with capsule formation, and a CheY 
D13N mutation that locked flageller motility in a counter-clockwise rotation. The 
CheY D13N mutation was shown to stabilize its phosphorylation (161), and thus 
may explain the increased fimU activity in the strains expressing algRD8N (Fig. 
4.1 B). As we were interested in AlgR constitutive activity to dissect the role of its 
phosphorylation, we explored other potential mutants, as described below.  
 
 
P. aeruginosa fimU expression increased in PAO1 algRD54E  
 
In order to elucidate the role of AlgR phosphorylation in P. aeruginosa, a 
constitutively active, phospho-mimetic form of AlgR was constructed to compare 
it with an inactive, phospho-defective form of the protein in the PAO1 
background. In previous studies with NtrC from Salmonella enterica, OmpR and 
RcsB from E. coli, and HupR from Rhodobacter capsulatus, a glutamate 
substitution in the phospho-accepting aspartate residue, resulted in constitutive 
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activation of the response regulators by mimicking the structure of the phospho-
aspartyl form of the proteins (306-309, 354) According to crystal structures of 
“phospho-locked” HupR, replacing the phospho-accepting aspartate to a 
glutamate exposed its carboxyl group within the acid pocket to interact with a 
threonine on the same REC face, locking the REC domain in the active 
conformation and overriding the need for the phosphorylation for its activation 
(354). We surmised that AlgR would behave similarly based on structural 
evidence from other phospho-mimetic response regulators. 
Transcription of the fimU operon was previously found to be dependent on 
the AlgR protein, and a strain expressing a phospho-defective AlgR (algRD54N) 
was incapable of expressing the genes in the operon and had abrogated 
twitching motility (157, 180, 231).  These results indicate that the phospho-
accepting Asp of AlgR is located at residue 54 (157). As summarized and 
suggested by Smith et. al. (305), we substituted the phospho-accepting aspartate 
(Asp 54) in the REC domain in AlgR with a glutamate (D→ E) to create a 
phospho-mimetic AlgR isoform. Because AlgR phosphorylation is required for 
fimU expression (157, 180, 231), a chromosomal fimU::lacZ reporter was 
constructed to determine if the algRD54E mutation expressed the phospho-
mimetic form of AlgR. It was hypothesized that AlgR D54E would activate 
transcription while AlgRD54N would not.  
The pHERD30T vectors encoding wild type algR, algRD54N, or algRD54E 
genes were placed in the PAO1 ∆algR (strain PSL317) background containing 
the fimU::lacZ transcriptional fusion, and β-galactosidase activity was quantified 
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(Fig. 4.2). As expected, the ∆algR strain carrying an empty vector had little β-
galactosidase activity, and this phenotype was complemented with a wild type 
copy of algR in the vector. The activity of the fimU promoter with algRD54N was 
also reduced, but not to the levels of ∆algR background. This result was 
unexpected as fimU activity with algRD54N expressed from the chromosome 
was reported at 25-fold less than PAO1 as determined by RT-qPCR (180). These 
results indicate that the increased copy number of the plasmid-born phospho-
defective algRD54N allele affected fimU expression. Importantly, expressing 
algRD54E from the plasmid increased fimU promoter activity 18-fold as 
compared to the wild type strain, suggesting that the AlgR D54E isoform is a 
phospho-mimetic and activates the fimU promoter. 
 
 
Figure 4.2. The algRD54E allele expressed from a plasmid activates the 
fimU promoter. Beta galactosidase activity of strain PSL317 fimU::lacZ 
harboring plasmid containing algR, algRD54N, or algRD54E, or PAO1 fimu::lacZ 
were measured at 21 hrs, growth. Student t-tests compared to PAO1 fimu::lacZ 
are indicated. P-values: *** <0.001. n=3. 
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Because the pHERD vector introduces multiple copies of the algR gene 
into the organism (314), we sought to express algR or its isoforms under the 
regulation of its native promoter and from a single copy on the chromosome. 
Using site-specific recombination via allelic exchange, the algR12 allele 
(encoding AlgR D54E, referred to as the algRD54E allele) was introduced into 
the PAO1 chromosome to create the strain, PAO1 algRD54E (Fig. 4.3 A). To 
study the effect of strains expressing different forms of AlgR, the fimU::lacZ 
transcriptional reporter was introduced into the backgrounds containing the 
following alleles: algR+ (PAO1), ΔalgR (PSL317), algR7 (encoding AlgR D54N, 
referred to as algRD54N) (WFPA8), or algRD54E (PAO1 algRD54E). The fimU 
transcriptional activity in the PAO1 ΔalgR and PAO1 algRD54N strains was 
greatly decreased, whereas activity from the same promoter in the PAO1 
algRD54E strain showed a 15-fold increase as compared to PAO1 (Fig. 4.3 B). 
These data again supported the hypothesis that AlgR D54E activated the 
transcription of the fimU promoter. It was also hypothesized that AlgR D54E 
should be a phospho-mimetic in the absence of its putative cognate histidine 
kinase, AlgZ (FimS). In order to test this hypothesis, the algRD54E allele was 
introduced into the ∆algZ background to create the strain PAZ algRD54E (∆algZ 
algRD54E). As shown in Figure 4.3 B, fimU::lacZ reporter activity was 
significantly increased (36-fold) in the ∆algZ algRD54E background.  
In order to eliminate the possibility that the fimU promoter activity in PAO1 
algRD54E and PAZ algRD54E was due to elevated protein expression, western 
blot analysis was performed using anti-AlgR polyclonal antibody to measure AlgR  
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Figure 4.3. AlgR D54E increased fimU transcription. (A), a diagram showing 
the genotypes of the following strains: PAO1 (algR+), PSL317 (ΔalgR), WFPA8 
(algRD54N), PAO1 algRD54E (algRD54E), PAZ (ΔalgZ), or PAZ algRD54E 
(ΔalgZ algRD54E). The dashed regions represent the deletion of that particular 
gene. (B), the strains corresponding to the diagram in (A) were tested for fimU 
transcriptional activity. Strains contained a fimU::lacZ transcriptional reporter in 
the chromosomal attB locus. β-galactosidase activities were assayed from 21 hr 
LB broth cultures grown at 37°C. Student t-tests compared to wild type are 
indicated. P-values: n.s. = not significant, *** < 0.001, n=3. (C), western blots 
were performed using AlgR and OmlA specific antibodies. Sixteen hour cultures 
of strains without fusion reporters were grown in LB at 37°C, normalized to 
CFU/mL, cells were sonicated, and proteins were separated on SDS-PAGE. (D), 
relative AlgR protein levels of strains compared to wild type were quantified by 
measuring the intensity of the western blot bands, normalized to OmlA, as 
described in the Materials and Methods. One Way ANOVA with Bonferroni post-
test comparisons with wild type are indicated. P-values: n.s. = not significant, * 
0.05 to 0.01, ** 0.01 to 0.001, n=3. 
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expression levels. AlgR protein levels for algR+, algRD54E, or ∆algZ 
backgrounds were comparable, and a slightly lower amount was expressed in 
algRD54N as compared to wild type. Unexpectedly, PAZ algRD54E strain did 
have a significant increase in AlgR protein expression as compared to wild type 
PAO1 (Fig. 4.3 C) and suggests possible auto-regulation when AlgR is 
phosphorylated. This increased protein expression may explain the large 
increase in fimU::lacZ transcriptional activity in this mutant. Overall, these results 
indicated that the AlgR D54E was most likely locked in the phospho-mimetic 




Acetyl phosphate phosphorylated AlgR but not AlgR D54E or AlgR D54N 
 
It was hypothesized that the increased fimU transcriptional activity 
observed in the AlgR D54E expressing strain was due to the recombinant protein 
folded in the active conformation. In order to examine the autokinase properties 
of AlgR or its isoforms for the proceeding in vitro studies, all three proteins were 
overexpressed and purified in E. coli, using a GST-tagged expression system 
(Fig. 4.4 A). We further characterized the melting temperature of the AlgR D54E 
or AlgR D54N isoforms to determine if the Asp mutation had an effect on protein 
stability. Though both isoforms displayed a 10°C decrease in melting 
temperature compared to the wild type AlgR (Fig. 4.4 B), only the PAO1  
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Figure 4.4. Protein purification and melting temperature analysis. AlgR, 
AlgR D54N, and AlgR D54E proteins were purified as described in the Materials 
and Methods. (A), coomassie stain of eluted fractions. Proteins were bound to 
glutathione-sepharose column, and the column was washed with PBS, and 
proteins eluted with PBS. Fractions were pooled and concentrated for further 
biochemical studies. (B), thermal denaturation curves of AlgR, AlgR D54N, and 
AlgR D54E. The fluorescence intensity due to SYPRO orange binding to 
exposed hydrophobic regions of denatured proteins was measured as a function 
of temperature, and the slope (first derivative) of the values were plotted. The 
minimum of each curve represented the thermal denaturation temperature of the 
proteins and are labeled. Isocitrate lyase was also run (not shown) as a positive 
control.  
 
algRD54E strain transcriptionally activated the fimU promoter (Fig. 4.3) and AlgR 
D54E bound the fimU promoter by EMSA (Fig. 4.6 D).  
To eliminate the possibility that there was non-specific phosphorylation on 
the AlgR D54N and AlgR D54E proteins, an in vitro phosphorylation reaction was 
conducted. Previously, AlgR auto-phosphorylated in the presence of acetyl 
phosphate (AcP) and carbamyl phosphate (166). Additionally, previous studies 
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showed that phosphorylation is specific to the aspartate residue (D54), where E. 
coli CheA acted as a histidine kinase to phosphorylate AlgR, but not AlgR D54N, 
with [γ-32P]ATP as the phosphate donor (157). However, the phospho-mimetic 
AlgR D54E has not been tested to date, and its phospho-accepting capacity was 
examined using Acetyl phosphate (AcP).  
Radio-labeled [32P]AcP was generated by incubating B. 
stearothermophilus acetate kinase (AckA) in the presence of the substrates [γ-
32P]ATP and acetate (Fig. 3), as previously described (320).  As shown in Fig. 
4.5 A, lane 4, wild type AlgR auto-phosphorylated in the presence of [32P]AcP, 
while AlgR D54N and AlgR D54E remained unlabeled with [32P]AcP (Fig. 4.5 A, 
lanes 5 and 6, respectively). None of the proteins was phosphorylated by [γ-
32P]ATP (Fig. 2A, lanes 1-3), indicating that ATP was not able to act as an AlgR 
phosphodonor. Lysozyme was also tested as a control to eliminate the possibility 
of non-specific phosphorylation (Fig. 4.5 A, lane 7). The Coomassie stained gel 
showed that equivalent amounts of purified AlgR, AlgRD54N and AlgRD54E 
were used in the assay (Fig. 4.5 B). These data indicated that only wild type AlgR 
was phosphorylatable in vitro by the phosphodonor AcP, and Asp 54 was 
required for the phospho-labeling. Additionally, in order to observe differences in 
AlgR protein conformation with and without its phosphate group, AlgR was 
treated with acetyl phosphate and run on a native PAGE. Addition of acetyl 
phosphate appeared to affect how the protein migrated in the native PAGE as 
determined by western blot, suggesting a conformational change in the AlgR 





Figure 4.5 Wild type AlgR, but not AlgR D54N or AlgR D54E displayed auto-
kinase activity with radio-labeled acetyl phosphate (AcP). [γ32P]ATP (lanes 1-
3) or [32P]-AcP (lanes 4-8) were incubated with 15 µM AlgR (lanes 1 and 4), AlgR 
D54N (lanes 2 and 5), AlgR D54E (lanes 3 and 6), or lysozyme (lane 7) for 30 
min at 37°C. (A), autoradiogram of proteins separated by SDS-PAGE, and (B), 
coomassie stain of corresponding gel. Closed arrows, purified AlgR or AlgR 
isoforms. Open arrow, acetate kinase (AcK). Shown is a representative blot of 
four replicates. (C), western blot using α-AlgR serum after separation on a native 





Phosphorylated AlgR and AlgRD54E bound specifically to the fimU 
promoter 
 
The fimU::lacZ transcriptional activity increased in the presence of AlgR 
D54E as compared to wild type AlgR (Fig.4.2, Fig 4.3). Therefore, it was 
hypothesized that AlgR-P (in vitro phosphorylated AlgR) or AlgR D54E would 
have different DNA binding characteristics as compared to AlgR. In order to test 
this hypothesis, electrophoretic mobility shift assays (EMSA) were performed. 
Previous studies on AlgR binding to the fimU promoter showed the presence of 
two AlgR Binding Sites (ABS) within the intergenic region of fimT and fimU (180). 
Therefore, an 82 bp fimU promoter fragment containing both of the identified 
AlgR binding sites was tested for the effect of increasing amounts of AcP on 
AlgR binding to this fimU promoter fragment (Fig. 4.6). Elevating the molar ratio 
of AcP to AlgR increased AlgR binding (Fig. 4.6 B, lanes 3-8), where a 20:1 
molar ratio was the minimum ratio required for binding (Fig. 4.6 B, lane 6).  AlgR-
P interaction with fimU DNA was specific, as addition of unlabeled fimU DNA 
significantly decreased this interaction (Fig. 4.6 B, lanes 9-12) and did not bind to 
the pscE-F promoter (Fig. 4.6 C, lanes 11-13). These results indicated that AlgR-
P might have a higher affinity towards fimU DNA.  
Next, AlgR or AlgR-P binding to fimU DNA was compared. Based on 
empirical evidence that an excess of 20x AcP was required for binding (Fig. 4.6 
B), we performed binding assays with 500x molar excess of AcP. As shown in 
Figure 4.6 C, lanes 6-9, AlgR pretreated AcP (AlgR-P) showed enhanced binding
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Figure 4.6. Phosphorylated AlgR and AlgRD54E bound to the fimU 
promoter
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Figure 4.6. Phosphorylated AlgR and AlgRD54E bound to the fimU 
promoter. The effect of in vitro phosphorylation of AlgR on binding to an 82 bp 
fimU DNA fragment was compared with purified AlgR D54N or AlgR D54E using 
EMSA. (A), diagram of 82 bp fragment used in EMSA assays and location within 
the fimT-fimU intergenic region. (B), increasing amounts of the phosphate donor, 
acetyl phosphate (AcP) was added to the AlgR protein to determine the effect of 
phosphorylation on DNA binding. Wild type AlgR protein was pre-treated with 
AcP for 30 minutes, prior to binding reactions: fimU DNA alone (lane 1), fimU 
DNA in the presence of AlgR without (lane 2) or with increased concentrations of 
AcP (lanes 3-8). AlgR-P - DNA complex was competed with addition of non-
radiolabeled fimU DNA (lanes 9-12). (C), phosphorylated AlgR protein was 
compared with untreated AlgR for DNA binding. Purified AlgR protein was 
pretreated with either water only or AcP (AcP:AlgR ratio of 500:1) prior to binding 
reactions. Lanes 1-10, fimU DNA incubated with no protein control (lane 1), 
increasing concentrations of AlgR (lanes 2-5) or AlgR-P (lanes 6-9), and 5 mM 
AcP only (lane 10). Lanes 11-13, 5 nM pscEF DNA incubated with no protein 
control (lane 11), 2.5 µM AlgR (lane 12), and 2.5 µM AlgR-P (lane 13). (D), 
purified AlgR D54N or AlgR D54E proteins were tested for binding to fimU DNA. 
No protein control (lane 1), increasing concentrations of AlgR D54N (lanes 2-5), 
and increased concentrations of AlgR D54E (lanes 6-9). Open arrows, unbound 
DNA, closed arrow, AlgR-DNA complexes. All concentrations listed in the figure 





as compared to AlgR by itself (Fig.4.6 C, lanes 2-5). This result supported the 
hypothesis that phosphorylation directly affected AlgR affinity to the fimU 
promoter DNA. At higher protein:DNA ratios, an additional band was detected 
above the prominent main band. (Fig. 4.6 C, lane 9). The concentrations of AlgR 
or AlgR-P that bound to fimU DNA did not bind to the non-specific pscEF control 
DNA (Fig. 4.6 C, lanes 11-13) indicating that AlgR interaction with fimU DNA was 
specific.  
In order to verify that the AlgR isoforms, AlgR D54E and AlgR D54N, 
mimicked phosphorylated and unphosphorylated AlgR, respectively, these 
purified proteins were tested on the same fimU promoter fragment. As shown in 
Figure 4.6 D, AlgR D54E had higher affinity towards DNA as compared to AlgR 
D54N. Interestingly, the AlgRD54E protein did not form a higher order shift (Fig. 
4.6 D, lane 9) observed for AlgR-P (Fig. 4.6 C, lane 9). In summary, AlgR binding 
to the fimU promoter was dependent on AlgR phosphorylation, and the strains 
expressing the phospho-defective and phospho-mimetic AlgR isoforms have 
potential usage to characterize the role of AlgR phosphorylation in P. aeruginosa. 
 
 
The twitching motility phenotypes of PAO1 algRD54E and PAO1 were 
identical  
 
The fimU promoter is upstream of six open reading frames (ORFs) (fimU, 
pilVWXY1E), which encode prepilins and a calcium-dependent retraction protein 
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required for the normal assembly and function of the type IVa pili apparatus (188, 
221, 224, 227, 228). Because the expression of the fimU operon directly affects 
type IVa pili function, the twitching motility phenotype in the context of the algR 
and algZ mutants was tested. Wild type PAO1, or strains with the ΔalgR, 
algRD54N, algRD54E, ΔalgZ, or ΔalgZ algRD54E alleles were examined for sub-
surface (Fig. 4.7 A) and surface associated twitching motility (Fig. 4.7 B). In both 
assays, the twitching zone size for PAO1 algRD54E was comparable to wild type  
PAO1, indicating that despite increased fimU expression in algRD54E strain, 
there was no net effect on normal twitching motility. As expected, ΔalgR and 
algRD54N strains were defective in twitching motility due to decreased fimU 
operon transcription, which corroborated previous studies (157, 180, 231). 
Motility was also decreased in the ∆algZ background as predicted (182), as 
deletion of the cognate histidine kinase would render intracellular AlgR mostly 
unphosphorylated.  
It was also considered possible that introduction of the algRD54E allele 
into the ∆algZ background would restore twitching motility.  Yet, twitching motility 
was mostly, but not completely, restored in strain PAZ algRD54E as compared to 
the wild type, using the subsurface and surface assays (Fig. 4.7 A, B). Western 
blots showed a significant increase in AlgR protein expression (Fig. 4.3 C, D), 
accompanied by a significant increase in fimU::lacZ activity (Fig. 4.3 B). 
Previously, it was shown that the expression of the genes in the fimU operon 
were tightly regulated, and overproduction of any of those genes could contribute 
to the loss of type IV pili function (224). Consequently, our observations are 
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consistent with the view that over-expression of the genes encoded in the fimU 
operon, and the twitching motility defect observed in strain PAZ algRD54E may 
be explained by the 12-fold increase in AlgR protein production (Fig. 4.3 D), and 




Figure 4.7. The effect of different algR alleles on twitching motility. (A), 
subsurface twitching motilities were analyzed at 48 hrs after inoculation in LB 1% 
agar, and the average diameters of twitching zones were measured. PAO1 
(algR+), PSL317 (ΔalgR), WFPA8 (algRD54N), PAO1 algRD54E (algRD54E), 
PAZ (ΔalgZ), PAZ algRD54E (ΔalgZ algRD54E), or PAO1A (pilA::Tc) was used 
as a negative control. Statistical analysis was performed with one-way ANOVA. 
P-values: n.s. = not significant, *** < 0.001. (B), surface associated twitching 
motilities of the same strains found in (A) were tested in a 5% O2 incubator. 
Bacteria were inoculated on the surface of M9 minimal medium. Cells were 
imaged at 24 hrs post inoculation. Arrows mark the extent of twitching front. Solid 
bar represents 1 mm. 
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CHAPTER V   
 
 
ALGR AND ITS ROLE IN THE RHL QUORUM SENSING SYSTEM 4 
 
 
AlgR phosphorylation was required for swarming motility 
 
Motility plays a significant role in the pathogenesis of P. aeruginosa (355, 
356) and facilitates colonization of the host, as well as in biofilm formation (357, 
358). P. aeruginosa exhibits three major forms of appendage-mediated motility: 
(i) flagellar based swimming motility in an aqueous environment, usually 
assessed on low agar concentrations in vitro (0.3% [wt/vol]), (ii) type IVa pili, 
twitching motility evaluated on solid surfaces (1% [wt/vol] agar) or at the 
interstitial surface between the agar and plastic or glass (359) and (iii) swarming 
motility, which requires both flagella and type IV pili and is observed on semisolid 
surfaces (0.5 to 0.7% [wt/vol] agar) (360, 361). Swarming motility also uses 
biosurfactants produced by the bacteria, such as rhamnolipids and 3-(3-
hydroxyalkanoyloxy) alkanoic acids (HAAs), as they decrease the surface 
tension between the bacterial cells and the surface (275, 345). In addition to 
                                                
4 Republished with permission from American Society for Microbiology Journal of 
Bacteriology. Sections were taken from: Okkotsu, Y, Tieku, P, Fitzsimmons, LF, 
Churchill, ME, Schurr, MJ. 2013. Pseudomonas aeruginosa AlgR 
phosphorylation modulates rhamnolipid production and motility. J. Bacteriol. 
JB.00726-13.   
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swimming, twitching, and swarming, P. aeruginosa exhibits sliding/spreading 
motility in the absence of both flagella and type IV pili, on semisolid surfaces 
(362). Murray and Kazmierczak showed that rhamnolipid production is required 
for sliding motility and this phenotype responded to some of the same 
environmental cues as swarming motility (362) 
Previously, a deletion of algR showed a 4-fold reduction in swarming 
motility (273, 361). Because twitching motility was affected, the effects of AlgR 
phosphorylation status were examined with swarming motility. Deletion of algR or 
algZ in PAO1 resulted in a swarming phenotype that lacked discernible dendrites 
(or tendrils) (Fig. 5.1 A) In fact, when the pilA::Tc background was tested, it 
displayed a similar phenotype to that of the ΔalgR or ΔalgZ backgrounds, 
possibly indicating that AlgR affected swarming motility through its impact on 
type IV pili function (Fig. 5.1 A). Swarming motility was also altered in the 
phospho-defective algRD54N expressing strain, where there was a decreased 
swarming zone as compared to either the wild type PAO1 or PAO1 algRD54E 
strains with non-discernible dendrites. Lastly, PAO1 algRD54E reproduced the 
swarming phenotype of the wild type strain, indicating that the phospho-mimetic/ 
phosphorylated form of AlgR is required for the swarming phenotype.  
Swarming motility is thought to also be coordinated and affected by 
flagellar-mediated motility and biosurfactant production (β-D-(β-D-
hydroxyalkanoyloxy) alkanoic acid (HAA), mono-rhamnolipids, and di-
rhamnolipids (198, 275, 345, 363). On the other hand, swimming motility is 
primarily mediated by a single polar flagellum, and does not require rhamnolipid  
 92 
 
Figure 5.1. The effect of different algR alleles on swarming and swimming 
motility. (A), PAO1 (algR+), PSL317 (ΔalgR), WFPA8 (algRD54N), PAO1 
algRD54E (algRD54E), PAZ (ΔalgZ), PAZ algRD54E (ΔalgZ algRD54E) PAO1 
∆rhlA (ΔrhlA), PAO1C (fliC::Gm), or PAO1A (pilA::Tc) were examined for 
swarming motility on 0.5% agar M9 minimal medium with 0.5% casamino acids, 
grown for 20 hrs at 30°C. (B), the same strains as in (A) were utilized for 
swimming motility, using 0.3% agar M9 minimal medium with 0.5% casamino 
acids. Solid bar represents 1 cm. 
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production (345). To eliminate the possibility that the defect in swarming motility 
was due to AlgR or AlgZ mediated regulation of flagella, swimming motility 
assays were performed. Deletion or mutation of algR did not affect swimming 
motility (Fig. 5.1 B), indicating that a flagellar defect was not responsible for the 
swarming motility phenotypes. Though there was a discernible decrease in 
swimming in the ΔalgZ or ΔalgZ algRD54E backgrounds, this phenotypic effect 
was small compared to the fliC::Gm negative control.  
 
 
Expression of the rhlA gene was decreased in the phospho-defective AlgR 
background 
 
The results from the swarming and swimming motility assays using the 
algR deletion, phospho-defective or phospho-mimetic mutants suggested there 
was a flagella-independent dysregulation of the swarming phenotype in the strain 
expressing phospho-defective AlgR (AlgR D54N). Both flagella and rhamnolipids, 
and a number of other factors (345, 363), are required for the swarming 
phenotype across many Pseudomonas strains (364). We previously observed 
that AlgR repressed rhamnolipid production in the context of a 6-day biofilm 
(273). Therefore, it is possible that AlgR phosphorylation affects swarming 
motility through the regulation of rhamnolipid production.  
In order to test whether the difference in swarming motility was due to 




Figure 5.2. Maximal rhlA gene expression required phosphorylated AlgR. 
(A) Strains contained a rhlA::lacZ transcriptional reporter in the chromosomal 
attB locus. β-galactosidase activities were assayed from 10 hrs TSB+1% glycerol 
broth cultures grown at 37°C. n=3. (B), qPCR of rhlA gene expression of cultures 
(without reporter fusion) grown for 10 hrs at 37°C in LB. Total RNA was isolated, 
reverse transcribed to cDNA, and the amount of rhlA transcripts were 
standardized to rpoD transcripts. Levels are represented by fold difference 
compared to wild type PAO1. n=4. Statistical analyses were performed with one-




transcriptional analyses were performed on the rhlA gene. Previously, AlgR was 
found to repress the rhlAB genes in a biofilm-specific manner, and exert its 
regulation specifically at the rhlA promoter (273). The rhlA promoter is also rhl 
quorum-sensing dependent, activated by the C4-HSL sensing RhlR regulator 
(241), and a strain containing a rhlR null allele was used as a negative control for 
rhlA expression. A transcriptional reporter of the rhlA promoter was constructed 
and placed in the wild type, ∆algR, algRD54N, algRD54E, ∆algZ, or rhlR::Tn501 
backgrounds (Fig. 5.2 A). In addition, RNA was isolated and rhlA transcript levels 
were measured by RT-qPCR (Fig. 5.2 B). In agreement with the rhamnolipid 
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production (see below), rhlA promoter activity was decreased in the algRD54N or 
∆algZ background strains. As expected, expression in the rhlR::Tn501 or ∆rhlA 
mutant was diminished. 
 
 
Rhamnolipid production was decreased in the phospho-defective AlgR 
background 
 
To test whether rhamnolipid production was affected by AlgR 
phosphorylation, rhamnolipid production was measured in the PAO1 wild type, 
PAO1 ΔalgR, and the mutant strains expressing the phospho-defective and 
phospho-mimetic AlgR. Measurements were conducted in three separate ways: 
1) thin-layer chromatography (TLC) (Fig. 5.3 A); 2) an orcinol-based colorimetric 
assay (Fig. 5.3 B); and 3) a hemolysis assay (Fig. 5.3 C). Both the TLC and 
orcinol assays of the corresponding cell secreted supernatants showed 
decreased total rhamnolipid production in the algRD54N or ∆algZ strains as 
compared to the wild type (Fig. 5.3 A, B). Rhamnolipids are heat-stable 
hemolysins, and can be measured indirectly by hemolysis assays. Hemolytic 
activity was abrogated by the heat-treated supernatants of algRD54N or ∆algZ 
strains (Fig. 5.3 C) (332). In contrast, the PAO1 algRD54E strain was 
comparable to wild type in all assays measured. The ∆algR background on the 
other hand, produced slightly decreased rhamnolipid levels in two of the three 
quantitative measurements. We were also able to replicate these results by  
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Figure 5.3. AlgR phosphorylation was required for maximal rhamnolipid 
production. (A), Thin-layer chromatography (TLC) of PAO1 (WT), PSL317 
(ΔalgR), WFPA8 (algRD54N), PAO1 algRD54E (algRD54E), PAZ (ΔalgZ), or 
PAO1 ΔrhlA (ΔrhlA) strains were grown for 16 hrs in TSB + 1% glycerol. Mono, 
mono-rhamnolipid band; Di, di-rhamnolipid band. (B), Strains in (A) were tested 
for rhamnolipid production using the orcinol colormetric assay in comparison with 
a standard curve (see Materials and Methods). Values were normalized to total 
protein. Data in (A) and (B) were generated by Liam F. Fitzsimmons. (C), 
Hemolysis due to rhamnolipid production was measured. Cultures were grown 
for 24 hrs in phosphate-limiting media (tryptic soy broth supplemented with 1% 
glucose), and cell-free supernatants were heat treated to denature polypeptide 
based hemolysins. Serial dilutions were applied to 1% horse red blood cells for 1 
hr at 37°C, and percent hemolysis was calculated based on total and no 
hemolysis. Statistical analysis was performed with one-way Anova. P-values: n.s. 
= not significant, * 0.05 to 0.01, ** 0.01 to 0.001, *** < 0.001. 
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measuring rhamnolipid production in a colormetric plate assay (CTAB/MB assay) 
(data not shown). These data support the hypothesis that AlgR phosphorylation 
is required for full production of rhamnolipids.   
Rhamnolipid production of PSL317 (∆algR) harboring plasmids with algR, 
algRD54N, or algRD54E was also determined to see the effect of 
complementation on rhamnolipid production. Interestingly, the expression of algR 




Figure 5.4. Amount of AlgR affected rhamnolipid production. Rhamnolipid 
production was measured using the orcinol method from PAO1, or PSL317 
(∆algR) harboring pHERD30T plasmid containing algR, algRD54N, or algRD54E. 
Strain rhlI∆ABS contains an AlgR-binding site mutation in the rhlI promoter. The 
∆rhlA containing strain was used as a background control (marked with a 
horizontal solid line). Cultures were grown in LB medium at 37°C for 16 hrs. 
Statistical analyses were performed with One Way ANOVA, and Bonferroni post-
test comparisons with wild type are indicated. P-values: * 0.05 to 0.01, ** 0.01 to 
0.001. 
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increased amounts of AlgR D54N activated rhamnolipid production. These 




Phosphorylated AlgR differentially bound to the rhlA promoter  
 
Because the phospho-mimetic and phospho-defective AlgR mutants 
showed different effects on rhamnolipid production, it was considered whether 
AlgR phosphorylation might alter its binding to the rhlA promoter. AlgR was 
previously shown to bind a DNA fragment spanning -804 to -622 relative to the 
transcriptional start site (Fig. 5.5 A, fragment 1 AlgR binding site 1) with specific 
binding to a 9 bp consensus sequence found 702 bp upstream of the 
transcriptional start site. A second binding site was also previously discovered by 
homology, but AlgR did not bind to this site (273). Due to the apparent distance 
between the rhlA transcriptional start site and the AlgR binding sites, EMSAs 
were performed to determine if additional AlgR binding sites exist within the rhlA 
promoter. Six rhlA promoter fragments, spanning 1.1 kb were PCR amplified and 
radiolabeled (Fig. 5.5 A). Both AlgR and phosphorylated AlgR (AlgR-P) displayed 
binding to frag 1 (Fig. 5.5 B, C), and phosphorylated AlgR (AlgR-P) displayed 
binding to frag 5 (Fig. 5.5 B, E). 
The rhlA frag 1 was further examined using a range of concentrations of 
AlgR or AlgR-P (Fig. 5.5 C). Phosphorylated AlgR displayed a third bound form 
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(top black arrow) not observed with the non-phosphorylated form of the protein 
(AlgR-P vs AlgR, Fig. 5.5 C). This result was also observed with EMSAs using 
AlgR D54N or AlgR D54E isoforms on rhlA frag 1 (data not shown). These 
results suggest cooperativity between multiple binding sites within the tested 
fragment. In order to dissect these binding characteristics further, either one or 
both of the AlgR binding sites were mutated (Fig. 5.5 D). The highly conserved 
AlgR binding Site 1 (5’-CCGTTCGTC) was mutated to (5’-CCATTTGTA) to 
generate rhlA frag 1 ∆1, and un-phosphorylated AlgR displayed decreased 
binding for this DNA fragment (Fig. 5.5 D, ∆1). The second proposed AlgR 
binding site (5’-CCGTGCTCC) was also mutated to (5’-CCATGTTCT), and rhlA 
frag 1 ∆1∆2 containing mutations in both binding sites was tested. Deletion of 
both binding sites (∆1∆2) resulted in loss of binding altogether, which was 
suggestive that the AlgR binding site 2 is a possible binding site only in the 
presence of AlgR-P. However, mutation of only AlgR binding site 2 (rhlA frag 1 
∆2) did not affect binding, corroborating previous results that this may not be a 
binding site (273).  
In addition, a fragment proximal to the transcriptional start site of rhlA (-
192 to -36 relative to the transcriptional start site) displayed evidence of protein 
binding (Fig. 5.5 B, rhlA frag 5). AlgR-P displayed higher affinity towards frag 5 
DNA than AlgR (Fig. 5.5 B, E). These results suggest that multiple binding sites 
may be involved with regulating the rhlA promoter, which depends on the 









Figure 5.5. Phosphorylated AlgR recognized three different binding sites 
within the rhlA promoter. 
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Figure 5.5. Phosphorylated AlgR recognized three different binding sites 
within the rhlA promoter. (A), Diagram of fragments used for EMSAs 
corresponding to their location on the rhlA promoter. The location of the 
previously identified AlgR binding site and sequence are indicated- the 
consensus AlgR binding site 1 (sense strand, 5’-CCGTTCGTC) and AlgR binding 
site 2 (antisense strand, 5’-CCGTGCTCC). (B), EMSAs using AlgR or acetyl-
phosphate treated AlgR on DNA fragments corresponding to those in (A). 
Purified AlgR protein was pretreated with either water only or AcP (AcP:AlgR 
ratio of 500:1) prior to binding reactions. Concentration of proteins in binding 
reactions are indicated. Controls containing rhlA fragments only (lanes 1, 5, 9, 
13, 17, or 21). (C), Further examination of rhlA frag 1, using AlgR, or AlgR-P. 
Control lanes (lanes 1, 8) contained rhlA frag 1 only. For AlgR-P, AlgR was pre-
incubated with 10x molar ratio of acetyl phosphate (AcP:AlgR ratio of 10:1) prior 
to binding reaction. AlgR or AlgR-P concentrations were increased (lanes 2 to 9, 
or 11 to 18, containing 1, 5, 10, 50, 125, 250, 500, and 1250 nM protein) in the 
presence of 5 nM radiolabeled DNA. Black arrows indicate location AlgR-bound 
DNA, open arrows indicate the unbound DNA. (D), Either AlgR binding site 1 
(∆1), site 2 (∆1) or both (∆1∆2) were mutated (see Materials and Methods), and 
tested for AlgR or AlgR-P binding. A 25:1 protein to DNA molar ratio was used. 
(E), Increased AlgR or AlgR-P protein were bound to frag 5. Control lanes (lanes 
1, 8) contained rhlA frag 5 only. AlgR or AlgR-P concentrations were increased 
(lanes 2 to 7, or 9 to 14, containing 1, 5, 10, 50, 125, and 250 nM protein) in the 
presence of 5 nM radiolabeled DNA. 
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Expression of rhlAB restored the swarming motility phenotype in the 
algRD54N background 
 
Based on the observations that the algRD54N expressing strain had a 
defective swarming motility phenotype and decreased rhamnolipid production 
under a range of conditions, we examined whether the swarming motility defect 
was due to its decreased rhamnolipid production. Therefore, a vector containing 
the rhlAB genes with an arabinose-inducible promoter was constructed. The 
vectors pHERD30T or p30TrhlAB were cloned into the ∆rhlA or algRD54N 
backgrounds. As shown in Figure 5.6 A, induction with increased arabinose 
corresponded to increased rhamnolipid production in the ∆rhlA background by 
TLC (Fig. 5.6 A, lanes 3-5). The addition of 0.5% arabinose to algRD54N 
background harboring p30TrhlAB increased the production of mono-rhamnolipids 
(Fig. 5.6 A, lane 7) as compared with 0% arabinose (Fig. 5.6 A, lane 6).  
Because rhamnolipid production was restored by the expression of the 
rhlAB genes, swarming motility was tested in the PAO1 ∆rhlA background 
containing the p30T rhlAB vector. Increased amounts of arabinose in the M9 
medium restored the dendrites and the swarming motility for the ∆rhlA harboring 
p30T rhlAB strain, but not ∆rhlA carrying the empty vector control (Fig. 5.6 B). 
Additionally, swarming motility was restored in the algRD54N background 
harboring p30T rhlAB, but not the same strain harboring the vector alone (Fig. 








Figure 5.6. Swarming phenotype was restored in algR D54N by in trans-
expression of rhlAB. (A), TLC of rhamnolipids from 16 hr cultures grown in 
TSB+1% glycerol, 37°C. PAO1 ΔrhlA containing empty vector (p30T) or rhlAB 
expression vector (p30T rhlAB), and WFPA8 (algRD54N) were tested. The rhlAB 
genes were induced with arabinose: 0% (lanes 1, 3, and 6), 0.01% (lane 4), 0.5% 
(lanes 2, 5, and 7). The datum in (A) was generated with the assistance of Liam 
F. Fitzsimmons (B), swarming motility assays of PAO1 ΔrhlA with p30T or p30T 
rhlAB, with various concentrations of arabinose in the swarming agar. (C), 
swarming motility assays of WFPA8 (algRD54N) containing p30T or p30TrhlAB 






arabinose, supporting the hypothesis that a defect in rhamnolipid production 




AlgR phosphorylation repressed C4-HSL production 
 
Previously, deletion of the AlgR binding site within the rhlI promoter on the 
PAO1 chromosome resulted in the same biofilm phenotype as the PAO1 ∆algR 
strain, indicating that the AlgR directly repressed rhlI expression (273). Because 
the Rhl quorum sensing system has been extensively shown to regulate rhlAB 
transcription (241, 274), the effect of AlgR-phosphorylation on the rhlI promoter 
was also studied. Using strains harboring rhlI::lacZ reporters, the activity of the 
rhlI promoter was measured (Fig. 5.7 A). Beta-galactosidase activity was 
increased in PAO1 ∆algR, in agreement with previous studies (273). This 
phenotype was restored to wild type levels with the presence of algR expressed 
from a plasmid. Furthermore, PAO1 algRD54N also showed elevated rhlI 
transcription. Therefore, it is possible that the algRD54N allele resulted in the de-
repression of rhlI.  
In order to verify the increase in rhlI transcription, C4-HSL production was 
quantified from cultures grown in LB (Fig 5.7 B). Using HPLC coupled to a triple-
quadrupole mass spectrometry, the amount of C4-HSL present in culture 
samples was quantified against a standard curve, using deuterated C4-HSL-d5 
as an internal standard (333). At 16 hrs, PAO1 ∆algR produced two-fold greater 
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C4-HSL than PAO1, which is similar to previous results (273). PAO1 algRD54N 
also produced twice as much C4-HSL as PAO1, indicating that the phospho-
defective AlgR resulted in increased C4-HSL production. On the other hand, the 
strain expressing the phospho-mimetic algRD54E was comparable to wild type 
(Fig. 5.7 B). These results suggested that phosphorylated AlgR repressed C4-
HSL production, while the absence of AlgR or the AlgR D54N protein de-
repressed its production.  
 
 
Figure 5.7. C4-HSL production was regulated by AlgR phosphorylation. (A), 
transcriptional activity of the rhlI promoter was measured from strains PAO200, 
PAO200 ∆algR, PAO200 ∆algR harboring pHERD30T-algR, PAO200 algRD54N, 
or PAO200 algRD54E, using β-galactosidase assay over a time course. 100 mL 
ultures were grown at 37*C and time points were taken where indicated. 
Statistical analyses were performed with one-way Anova at each time point. P-
values: * 0.05 to 0.01, ** 0.01 to 0.001. *** < 0.001. n=3. (B), C4-HSL production 
by PAO1 (WT), PSL317 (ΔalgR), WFPA8 (algRD54N), PAO1 algRD54E 
(algRD54E), or PDO111 (∆rhlR) was quantified from 16 hr cultures grown in LB, 
37°C, using HPLC coupled to tandem mass spectrometry. Mass spectrometry 
and generation of this data was performed by Prince Tieku. Statistical analysis 
was performed with One-way Anova with Bonferroni post-test. P-values as 




Phosphorylated AlgR bound to the rhlI promoter 
 
Previously, AlgR was found to bind to a 198 bp fragment within the 
promoter of rhlI (273). A consensus AlgR binding site (5’-CCGTTCATC) is 
located -28 to -20 upstream relative to the transcriptional start site. This AlgR 
binding site is located between a possible -35 and -10 region of RpoS binding 
regions (based on sequence similarity) (365, 366) and downstream of an 
identified RpoN binding region (350), suggesting AlgR repression of rhlI 
transcription. In the context of a 6-day biofilm, both the transcription of the rhlI 
gene and the production of the quorum-sensing molecule, N-butyryl-L-
Homoserine lactone (C4-HSL) were increased upon deletion of algR (PSL317) 
(273).  Because phosphorylation had been found to increase fimU transcription 
and both AlgR-P and AlgR D54E protein had higher affinity towards fimU DNA, 
we tested the effect of AlgR phosphorylation on rhlI binding. 
Both algD and algC promoters have three AlgR binding sites (ABS), and 
the affinities to each binding site vary. PalgD contains two AlgR binding sites 
located -394 and -470 bp from the transcriptional start site (Far-upstream site, 
FUS), while PalgC contains one AlgR binding site within the coding region of 
algC. In order to determine if other unidentified AlgR bindings sites may be 
located within the promoter, three other fragments were designed to cover 600 
bp upstream of the start codon and 200 bp within the coding region of rhlI (Fig 
5.8 A). Binding assays using all four fragments and AlgR, AlgR-P, AlgR D54N, or 
AlgR D54E protein showed that only fragment 1 bound to protein (Fig 5.8 B), 
indicating AlgR’s regulation is limited to rhlI frag 1.  
 107 
 
Figure 5.8. AlgR and phosphorylated AlgR bind to the rhlI promoter. (A), 
Diagram of the promoter region of rhlI and the DNA fragments used for EMSAs. 
Previously identified AlgR binding site is boxed with solid line. RpoD/RpoS 
binding sites are underlined, and are located -35 and -10 bp upstream of the 
transcriptional start site (bent arrow). Lux box is marked with dotted box. (B) rhlI 
frag 1 (5 nM), located adjacent to the rhlI transcriptional start site displayed 
binding to purified AlgR protein, AlgR treated with acetyl phosphate, AlgR D54N, 
or AlgR D54E proteins (1.25 µM). Purified AlgR protein was pretreated with either 
water only or AcP (AcP:AlgR ratio of 500:1) prior to binding reactions. (C), rhlI 
frag 1 was further studied for AlgR, AlgR-P, AlgR D54N, or AlgR D54E binding. 
Increased protein concentrations (0.05, 0.25, 1.25, and 2.5 µM for lanes 2-5, 7-
10, 13-16, 18-21) of above proteins were added to 5 nM of rhlI frag 1. Binding 
competition was also observed using un-labeled rhlI frag 1 (50 nM) added to 
lanes 6, 11, 17, and 22. Open triangle = unbound DNA, closed triangle = shift in 
DNA due to protein binding.  
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In order to test the hypothesis that AlgR-P or AlgR D54E had increased 
affinity towards the rhlI promoter, rhlI frag 1 was further tested using acetyl-
phosphate treated AlgR, AlgR D54N and AlgR D54E (Fig 5.8 C). Interestingly, 
phosphorylated AlgR appeared to bind the fragment differently than non-
phosphorylated AlgR at lower concentrations (lanes 4, 5, and 9, 10). Higher order 
shifts, marked by the top black arrow in Figure 5.8C (lanes 9 and 10) were 
observed for phosphorylated AlgR, yet were not observed with the other proteins. 
Furthermore, AlgR D54N showed decreased binding to the rhlI fragment 
compared with AlgR D54E, as seen with the qualitative intensity of the free 
radiolabeled rhlI frag 1 DNA (marked by the open arrow in Fig. 5.8 C lanes 15 
and 16 versus lanes 20 and 21). Contrary to our predictions, AlgR D54E did not 
recapitulate the AlgR-P binding characteristics towards rhlI frag 1. These data 
are suggestive that (AlgR-P) may bind to multiple sites or bind cooperatively on 
the rhlI fragment, and that AlgR D54E, while hypothesized to be phospho-
mimetic, could have differences in DNA binding characteristics as compared to 
AlgR-P. 
We speculated that another unidentified AlgR-binding site was located 
within the rhlI promoter. Alignment with fimU and rhlA promoters show another 
consensus sequence (5’- GCCSSNNGG) approximately 30 bp upstream of the 
currently identified ABS (Fig 5.9 A, italics). The presence of a second AlgR 
binding site fits with current models of CheY-like receiver domain-containing 
transcriptional regulators (particularly LytR-type RR’s such as AgrA) that predict 
interaction with DNA as a dimer and recognition of a palindromic sequence.  
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We further dissected rhlI frag 1 by using various fragments of the rhlI frag 
1 region for EMSAs. Using the primer located at the 3’ end of rhlI frag 1 as an 
anchor, a 141 bp (rhlI frag 1.1) and 100 bp (rhlI frag 1.2) fragments were 
constructed (Fig 5.9 A). Using rhlI frag 1.1, which removes the speculated AlgR 
consensus sequence, binding did not change for AlgR or AlgR-P as compared to 
the whole rhlI frag 1 (Fig 5.9 B). Interestingly, using rhlI frag 1.2, which removed 
the consensus AlgR binding site, retained AlgR-P binding but eliminated  
 
Figure 5.9.  Dissection of AlgR and AlgR-P binding to the rhlI promoter. (A), 
diagram showing the nucleotide sequence of rhlI frag 1, annotated with truncated 
fragments, to test for other AlgR binding regions. The whole rhlI frag 1 sequence 
spans the two diamonds (♢), a 141 bp truncated rhlI frag 1.1 spans between the 
triangles (△), and the 100 bp truncated rhlI frag 1.2 spans between the stars (☆). 
Fragments were amplified using the same 3’end oligonucleotide (Table 2.2, rhlI 
frag 1R). Solid box marks the consensus AlgR binding site, and the bent arrow is 
the transcriptional start site. (B), EMSAs of the three DNA fragments labeled with 
their corresponding symbols from (A): rhlI frag 1 (lanes 1-7), rhlI frag 1.1 (lanes 
8-16), rhlI frag 1.2 (lanes 9-21). DNA only controls (lanes 1, 8, or 17) were run 
alongside binding reactions with DNA containing various concentrations of AlgR 
(lanes 2-4, 9-12, 18-19) or AlgR-P (lanes 5-7, 13-16, 20-21). AlgR was 
phosphorylated as in Fig 5.8. Specific concentrations are shown.  
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unphosphorylated AlgR binding. This result is highly suggestive that another 
AlgR binding sequence is located within the 100 bp downstream of rhlI 
translational start site. In attempts to identify a consensus sequence, the rhlI frag 
1.2 sequence was aligned with sequences from both rhlA frag 5 (Fig. 5.5) and 
fimU gs frag (Fig. 4.6) using nucleotide blast (blast.ncbi.nlm.nih.gov), but a 
definitive consensus sequence was not identified. Follow-up work with 
footprinting experiments on rhlI frag 1.2 would need to be performed to further 
characterize this second binding site. 
 
 
AlgR phosphorylation repressed pyocyanin production 
 
Microarray data showed AlgR repressed genes in the biosynthetic 
pathway for pyocyanin production (phzC2-G2) by 13 to 26-fold in 6-day flow-cell 
biofilms (273). Therefore, the role of AlgR phosphorylation on this phenotype was 
determined. PAO1, PSL317 (∆algR), WFPA8 (algRD54N), and PAO1 algRD54E 
(algRD54E) were grown for 24 hrs and assayed for pyocyanin (Fig. 5.10 A, B). 
An algR deletion resulted in a slightly increased amount of pyocyanin production, 
corroborating with AlgR’s role as a repressor of the phzC2-G2 genes. PAO1 
algRD54E produced similar levels of pyocyanin as compared to PAO1. 
Interestingly, WFPA8, expressing the algRD54N allele, had displayed three-fold 




Figure 5.10. Pyocyanin production is repressed by AlgR and AlgR-P. (A), 
Representative image of strains PAO1, PSL317 (∆algR), WFPA8 (algRD54N), 
PAO1 algRD54E, and PAZ (∆algZ) (alleles in parentheses) grown on 
Pseudomonas Isolation Agar (PIA). (B), Relative pyocyanin production was 
measured by colormetric assay. Cultures were grown in LB medium for 24 hrs at 
37°C in a shaking incubator. Strain containing the phzM::Tn allele, defective in 
pyocyanin production, was used as a negative control. (C), PAO1, and PSL317 
harboring plasmid with algR, algRD54N, or algRD54E alleles were tested for 
pyocyanin production. Cultures were grown in LB medium for 17 hrs at 37°C in a 
shaking incubator. Strain PDO300 with the ∆rhlR allele was utilized as a negative 
control. Statistical analysis was performed with One-way Anova with Bonferroni 





corroborating with the coloration of this strain when grown in flasks (data not 
shown) and on Pseudomonas isolation agar (Fig 5.10 A).  
Strain PSL317 (∆algR) harboring plasmids containing algR, algRD54N, or 
algRD54E were also measured for pyocyanin production. Interestingly, algR and 
algRD54E repressed pyocyanin production, while algRD54N did not (Fig. 5.10 
C). This result indicates that amounts of active AlgR protein affects pyocyanin 
production, and increased AlgR phosphorylation level leads to its repression. 
 
 
algRD54N confers increased biofilm formation/attachment 
 
Because we observed AlgR phosphorylation affects Rhl quorum sensing 
system, and we have previously observed a biofilm defect by the strain harboring 
∆algR, we also explored biofilm formation by several of these strains. Biofilm 
formation was enumerated using PAO1, PSL317 (∆algR), PAZ (∆algZ), WFPA8 
(algRD54N), and PAO1 algRD54E using a 96-well assay at 24 hrs (Fig. 5.11 A). 
As compared to wild type, the algR mutants displayed a decreased biofilm 
phenotype at this time point. Interestingly, PAO1 algRD54E did not phenocopy 
PAO1 like it did for other assays. Figure 5.11 B shows the progression of biofilm 
formation of PAO1, PSL317 (∆algR), PAZ (∆algZ), and WFPA8 (algRD54N), over 
the course of 72 hrs. WFPA8 (algRD54N) displayed slightly increased levels of 
biofilm formation compared to wildtype cells, indicating that the presence of 




Figure 5.11. Strain containing algRD54N displayed delayed biofilm 
formation and attachment. (A), PAO1, PSL317 (∆algR), WFPA8 (algRD54N), 
PAO1 algRD54E, and PAZ (∆algZ) were grown in 96-well microtiter plates 
without shaking for 24 hrs at 30°C in LB medium. Non-adherent cells were 
removed, and biofilm formation was measured as the amount of crystal violet 
staining to the adherent cells. Statistical analysis was performed with One-way 
Anova with Bonferroni post-test. P-values as compared to wild type are shown: 
*** < 0.001. n=3. (B), PAO1, PSL317 (∆algR), WFPA8 (algRD54N), and PAZ 
(∆algZ) were grown as in (A). Biofilm measurements were taken at 11, 18, 24, 





other hand, the ∆algR biofilm was abrogated, recapitulating previous results 
(273). PAZ (∆algZ), interestingly was defective in biofilm formation throughout the 
time course. We were able to complement the PAZ biofilm defect by introducing 
a plasmid with algZ (data not shown), suggesting that AlgZ may play a crucial 
role in biofilm development. 
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CHAPTER VI   
 
 
ROLE OF ALGR IN VIRULENCE AND POSSIBLE MECHANISM OF ACTION 
 
 
AlgR phosphorylation was required for virulence in a mouse pneumonia 
model 
 
In order to determine whether AlgR phosphorylation affects virulence, 
PAO1, PSL317 (∆algR), WFPA8 (algRD54N), and PAO1 algRD54E (algRD54E) 
were used for mouse virulence studies. All four strains were modified to include a 
luxABCDE cassette within the attTn7 site in the glmS gene (317) using the 
pUCP18-mini-TN7-P1-lux-Tp plasmid (contains site-specific sequences and 
luxABCDE gene) and pTNS3 plasmid (encodes transposase). Utilizing 
chemiluminescent bacteria ensured sufficient inoculation of the mice by detection 
of luminescence using an IVIS detector, and measurement of infection by 
correlating bacterial CFU with luminescence.  
A total load of 4x107 CFU was used to intranasally infect nine-week old 
BALB/c mice. Two replicate experiments were performed (4 mice per strain, 8 
mice total per strain), where mouse survival was measured over a 48 or 70 hr 
time period (Fig 6.1 A). Mice infected with strain PSL317 (∆algR) displayed a  
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Figure 6.1. Murine acute pneumonia model. (A) Mouse survival curve after 
challenge with PAO1 lux, PSL317 lux, WFPA8 lux, or PAO1 algRD54E lux 
strains expressing luciferase (luxABCDE cassette). Eight nine-week-old female 
BALB/c mice (Harlan Laboratories) were used per strain. Mice were anesthetized 
by intraperitoneal injection of 0.25 ml of ketamine (6.7 mg/ml) and xylazine (1.3 
mg/ml) in 0.9 % w/v saline, and further intranasally injected with 10 uL of culture 
into each nostril (20 uL total, 4x10
7
 CFU). For statistical analysis of the survival 
curves, the Logrank test was used. P-values are compared with PAO1 wildtype. 
ns = not significant. (B), representative images of disseminating bioluminescent 
bacteria were captured using a ChemiDoc XRS system (BioRad) at the time of 
death indicated. False-color was applied to signal intensity using Image Lab 
ver2.0.1 (BioRad). Animal studies were performed in corroboration with F. Heath 



































longer mean time to death as compared to PAO1 (p value = 0.0289). This result 
corroborated with previous data showing decreased virulence of PSL317 (∆algR) 
in a mouse-septicemia model (282). Mice infected with algRD54N strain had a 
mean time to death that was significantly different from PAO1 (p-value = 0.0067) 
Three mice (out of eight) infected by algRD54N succumbed to infection and 
death prior to the end points during the two experiments as opposed to all of the 
mice that succumbed to infection with PAO1. All but two of the mice succumbed 
to infection by PAO1 algRD54E. Using the chemiluminescent property of the 
strains, we also visualized the degree of cell spread in the organs. While PAO1 
disseminated into nearby organs, mice infected with the algRD54N had a 
localized infection in the lungs at the time of sacrifice (Fig. 6.1 B). Two mice were 
able to clear and survive infection by the algRD54E strain. However, this result 
was not statistically significant compared to PAO1 (p-value = 0.1679), indicating 
that the algRD54E strain was as virulent as wild type. In summary, the strain with 
algRD54N had decreased virulence compared to the other three strains, 




AlgR phosphorylation was required for anaerobic growth 
 
Because previous microarray data (with a ∆algR mutant vs wild type) 
showed AlgR-repressed genes that overlap with Anr-regulated genes (231), it  
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Figure 6.2. Decreased growth of algRD54N or ∆algZ in anaerobic 
conditions. (A) PAO1, PSL317 (∆algR), WFPA8 (algRD54N), PAO1 algRD54E, 
and PAZ (∆algZ) were grown on LB agar supplemented with 10 mM sodium 
nitrate (NaNO3) in anaerobic jars, at 37°C. Samples were taken at 0, 16, 24, 40, 
48, and 99 hrs. Bacteria were resuspended in 5 mL of saline, and CFU/mL was 
enumerated from 1 mL of the 5 mL sample. (B), strains from (A) were grown on 
LB agar supplemented with 10 mM sodium nitrite (NaNO2). Bactera were 
enumerated at 0, 22, 52, and 145 hrs. (C), EMSA using a 148 bp DNA fragment 
upstream of the dnr gene. Purified AlgR protein was pretreated with either water 
only or AcP (AcP:AlgR ratio of 500:1) prior to binding reactions. Binding reactions 
were performed with 5 nM of dnr fragment and the final concentration of AlgR 
protein indicated.  
 
was determined whether a phenotype associated with the algR mutants could be 
observed under lowered oxygen concentrations. Preliminary data show that there 
is a growth defect when either the algRD54N or algZ strains are grown 
anaerobically at 37°C, supplemented with nitrate (NO3-) (Fig. 6.2 A) or nitrite  
 119 
(NO2-) (Fig. 6.2 B). The growth of algRD54N halts once the cultures approach 
stationary phase. The ∆algZ mutant, on the other hand, displays overall 
decreased growth.Because there was a growth phenotype under anaerobic 
conditions, possible mechanisms were considered. During anaerobic growth, 
Anr, Dnr, and NarXL activate denitrification, arginine deamination, or pyruvate 
fermentation genes (Fig. 1.6) (284, 290). Anr regulates Dnr transcription, while 
Dnr directly regulates nirS, nirQ, norCB, and nosZ. Interestingly, a highly 
conserved AlgR binding site is located on the dnr promoter that overlaps the Anr 
binding site. Therefore, we preliminarily tested whether AlgR binds a fragment of 
the dnr promoter. Using EMSA, we observe AlgR-phosphorylation increases 
affinity for the dnr promoter (Fig. 6.2 C). This result is suggestive that AlgR may 
regulate the dnr gene. In light of the previous data (Fig. 6.2 A B), we suggest that 
AlgR phosphorylation may be required to activate the dnr gene, thus regulating 
denitrification.  
Because there appeared to be an AlgR phosphorylation-dependent growth 
under anaerobic conditions, it was investigated whether AlgR phosphorylation 
was affected under various oxygen concentrations. In order to measure AlgR 
phosphorylation activity, the fimU::lacZ reporter was utilized. PAO1 fimU::lacZ 
was grown under 0%, 2%, 5%, 10%, 12%, 15%, and 20% oxygen, regulated by a 
trigas incubator (Fig. 6.3). The activity of the fimU::lacZ reporter was maximal at 
10% oxygen, but decreased at higher or lower oxygen concentrations. As 
controls, PSL317 fimU::lacZ or PAO1 algRD54E fimU::lacZ were tested, and no  
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Figure 6.3. Transcriptional reporter activity of fimU::lacZ was maximal at 
10% O2. β-galactosidase activitiy of strain PAO1 fimU::lacZ was measured at 
different oxygen concentrations. Cultues were grown in LB medium at 37°C. 
Statistical analysis was performed with One-way Anova with Bonferroni post-test. 
P-value as compared to 10% O2 is shown *** < 0.001. n=3. Datum was 
generated by Alex Little and Michael J. Schurr. 
 
changes in fimU activity was observed among the oxygen gradient (data not 
shown). These results indicate that the fimU promoter was oxygen concentration-
dependent, and could suggest that the oxygen concentration may affect the 
phosphorylation status of AlgR.   
 
 
Microarray Analysis of algRD54N and algRD54E 
 
In order to dissect the AlgR-phoshorylation regulon and uncover possible 
reasons for the attenuation by algRD54N, microarrays were performed on PAO1, 
and their isogenic algRD54N, and algRD54E mutants grown in LB for 16 hrs. In 
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all, 235 genes were differentially regulated between algRD54E and algRD54N, 
where 115 genes were up-regulated two-fold or greater, and 120 genes were 
down-regulated two-fold or greater in algRD54E vs algRD54N (Appendix A).  
Results showing at least a 3-fold increase or decrease in transcription are 
shown in Table 4 and Table 5. A full list for all arrays is listed in Appendix A. The 
most up-regulated set of genes in algRD54E compared to algRD54N include the 
genes in the fimUpilVWXY1E operon (ranging from 6.8 to 23.7-fold) (Table 4), 
corroborating with previous results that AlgR D54E activates the transcription of 
these genes (Figs. 4.2, 4.3). Because type IVa pili are a well-established 
virulence factor in P. aeruginosa, the lack of functional pili in the algRD54N 
background would contribute to its attenuation (Fig. 6.1). In Chapter V, we also 
determined rhlA expression was affected by algRD54N (Fig. 5.2). In 
corroboration with those results, we also observed a 2.4-fold decrease in rhlB 
expression (PA3478, found directly downstream of rhlA) in the microarray 
comparing algRD54N vs wild type (Appendix A). 
Motility-related genes, including flgB (PA1077), flgC (PA1078), flgF 
(PA1081), and PA4844 were also up-regulated by algRD54E (down-regulated by 
algRD54N). The FlgBC and FlgF proteins make up structural elements of the 
flagellar motor complex within the periplasm (367). However, swimming motility 
was not affected by the algRD54N allele (Fig. 5.1 B), indicating that this 
difference in the microarray does not affect the flagellum function under the 
experimental condition tested. 
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Table 4. Genes up-regulated 3-fold or more in PAO1 algRD54E vs PAO1 
algRD54N. 
Gene Function Gene Symbol Fold Change p-value 
PA0534 FAD-dependent oxidoreductase pauB1 5.8 0.03 
PA0535 hypothetical - 3.8 0.02 
PA0730 3-oxoadipate enol-lactonase activity - 4.7 2E-03 
PA0734 hypothetical - 11.3 0.04 
PA0758 hypothetical - 22.2 0.02 
PA0921 hypothetical - 3.7 0.01 
PA1077 flagellar basal-body rod protein FlgB flgB 3.1 0.02 
PA1081 flagellar basal-body rod protein FlgF flgF 3 0.01 
PA1116 Predicted RNA-bindining protein - 4.8 0.01 
PA1363 sigma factor - 3.3 0.04 
PA2426 sigma factor PvdS pvdS 3.2 0.03 
PA2428 polyphosphate kinase - 5.3 0.01 
PA3397 ferredoxin--NADP+ reductase fpr 6.2 0.01 
PA3410 sigma factor - 6 0.01 
PA3537 ornithine carbamoyltransferase, 
anabolic 
argF 3.2 4E-07 
PA3722 hypothetical - 3 0.03 
PA3743 tRNA (guanine-N1)-
methyltransferase 
trmD 3.7 0.01 
PA3744 16S rRNA processing protein rimM 3.2 0.01 
PA3745 30S ribosomal protein S16 rpsP 3.2 0.01 
PA3904 hypothetical - 3.1 0.02 
PA4550 type 4 fimbrial biogenesis protein 
FimU 
fimU 23.7 0.02 
PA4551 type 4 fimbrial biogenesis protein 
PilV 
pilV 20.5 0.02 
PA4552 type 4 fimbrial biogenesis protein 
PilW 
pilW 22.9 0.02 
PA4553 type 4 fimbrial biogenesis protein 
PilX 
pilX 12.2 0.03 
PA4554 type 4 fimbrial biogenesis protein 
PilY1 
pilY1 13.8 0.03 
PA4555 type 4 fimbrial biogenesis protein 
PilY2 
pilY2 11.1 0.03 
PA4556 type 4 fimbrial biogenesis protein 
PilE 
pilE 6.8 0.04 
PA4563 30S ribosomal protein S20 rpsT 3 0.03 
PA4844 Methyl-accepting chemotaxis protein - 4.4 0.01 
PA4853 DNA-binding protein Fis fis 3 0.01 
PA4896 sigma factor - 5.3 0.01 
PA5360 two-component response regulator 
PhoB 
phoB 7.6 2E-03 
PA5368 membrane protein component of 
ABC phosphate transporter 
pstC 3.1 2E-03 
PA5369 pstS analog, phosphate binding 
protein 
pstS 8.3 0.01 




Some of the genes that make up an inorganic phosphate uptake 
(pstABCSphoU) and sensing system (phoRB) were up-regulated in algRD54E vs 
algRD54N (that included phoB (PA5361), pstC (PA5368), and pstS (PA5369)). 
Briefly, PstS is a Pi-binding protein that shuttles inorganic phosphate from the 
periplasm to the inner-membrane bound PstA and PstC transmembrane 
transporter proteins, where the PstB ATPase energizes the translocation of 
phosphate across the inner membrane. Transcription of the pstSCAB-phoU 
operon is regulated by PhoU and the two component system PhoRB. Phosphate 
limitation induces PhoR (HK) phosphorylation of PhoB (RR), and increases 
transcription of this phosphate uptake system (368). The reason for increased 
expression of the Pst genes in PAO1 algRD54E is not well understood, but does 
suggest that expressing algRD54E induces phosphate limitation under our 
experimental conditions. There is no evidence that this induction is direct, 
however, as canonical AlgR-binding sequences are not found within the coding 
or promoter regions of pstS, pstA, or phoR. Additionally, the up-regulation of 
these genes is most likely unique to the algRD54E allele; while there was an 
increase in pstS, pstC, and pstA (PA5367), and the two-component system 
phoRB (PA5360-PA5361) in the algRD54E vs wild type microarray (Table 6), no 
differences were observed between algRD54N vs wild type (Appendix A).  
The other most up-regulated genes in algRD54E, PA0734 (11.3-fold) and 
PA0758 (22.2-fold), encode hypothetical proteins, but their functions are not 
known at this time. Several iron/heme responsive ECF sigma factors that are 
repressed by ferric uptake regulator (Fur) were also up-regulated by algRD54E 
 124 
(or conversely, down-regulated by algRD54N) (Table 4, Appendix A). They 
included PA3410, PA4896, PA1300, and pvdS (PA2426) (369). Because iron-
regulated genes were differentially regulated, PAO1, ∆algR, algRD54N, and 
algRD54E strains were grown on low- and high-iron medium (DTSB + 0 μM or 
150 μM FeCl3). No differences were observed in their growth (data not shown), 
indicating that there may be other, more specific conditions in which an iron-
responsive phenotype could be observed. PvdS regulates a number of virulence 
factors, including exotoxin A, pyoverdine, and extracellular protease (PrpL) (23, 
370-373). However, none of the genes associated with these virulence factors 
appeared on our microarrays. The pvdS gene is also required for virulence in 
vivo (372, 374). More work would be required to determine whether a decrease 
in pvdS in the algRD54N strain contributes to its attenutation. 
Table 5 shows genes that were up-regulated/de-repressed at least three-
fold in algRD54N compared to algRD54E (or conversely, down-regulated by 
algRD54E). The most up-regulated genes by algRD54N were genes encoding 
hypothetical proteins (Table 5). These genes included PA1970 (-17.3-fold), 
PA2486 (ptrC) (-20.5-fold), PA2759 (-36.8-fold), PA3229 (-24.2-fold), PA4623 (-
18.4-fold), and PA4881 (-38.5-fold) that encode for small proteins (that are 
between 8.7 and 12.4 kDa). A couple of the predicted proteins encoed by these 
genes (PA1970 and PA2759) contain a type I (ABC transporter) secretion 
sequence, and several (PA3229, PA4623, and PA4881) contain a type II 
lipoprotein secretion sequence (375). Additionally, bacteriophage components  
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Table 5. Genes down-regulated 3-fold or more in PAO1 algRD54E vs PAO1 
algRD54N. 
Gene Function Gene Symbol Fold Change p-value 
PA0807  hypothetical - -3 0.04 
PA0911  hypothetical - -3.9 0.04 
PA1172 cytochrome c-type protein NapC napC -3.1 0.03 
PA1173 cytochrome c-type protein NapB 
precursor 
napB -4.4 0.02 
PA1174 periplasmic nitrate reductase protein 
NapA 
napA -3.7 0.02 
PA1216  hypothetical - -3.4 0.03 
PA1333 hypothetical - -3.6 1E-03 
PA1744  hypothetical - -3.7 3E-06 
PA1970  hypothetical - -17.3 7E-06 
PA2274  hypothetical - -3.8 2E-03 
PA2486  hypothetical - -20.5 2E-05 
PA2491  hypothetical mexS -9 8E-07 
PA2493 Resistance-Nodulation-Cell Division 
(RND) multidrug efflux membrane 
fusion protein MexE 
mexE -14.2 2E-03 
PA2494 Resistance-Nodulation-Cell Division 
(RND) multidrug efflux transporter 
MexF 
mexF -13.1 3E-03 
PA2495 Multidrug efflux outer membrane 
protein OprN precursor 
oprN -13 1E-03 
PA2507 catechol 1,2-dioxygenase catA -17.5 0.04 
PA2508  muconolactone delta-isomerase catC -11.8 0.03 
PA2519 transcriptional regulator XylS xylS -4.1 0.01 
PA2532 thiol peroxidase tpx -3.3 4E-05 
PA2759  hypothetical - -36.8 1E-06 
PA2762  hypothetical - -3.8 0.05 
PA2811  ntrC-type response regulator - -3.8 1E-03 
PA2812  hypothetical - -3.2 4E-04 
PA2813  Glutathione S-transferase - -4.3 5E-05 
PA3229  hypothetical - -24.2 4E-04 
PA3236  ABC-type proline/glycine betaine 
transport systems 
- -4.4 0.02 
PA3628  hypothetical - -3.1 0.02 
PA3629 alcohol dehydrogenase class III adhC -3 0.02 
PA4139  hypothetical - -6.4 0.02 
PA4623 hypothetical - -18.4 2E-06 
PA4811 nitrate-inducible formate 
dehydrogenase, beta subunit 
fdnH -3 0.02 
PA4881  hypothetical - -38.5 9E-07 
PA5378  choline ABC transporter, periplasmic 
binding proteinC-type proline/glycine 
betaine transport systems 
- -3.3 0.01 
PA5379 L-serine dehydratase sdaB -3.4 0.01 
PA5396  hypothetical - -5.8 0.01 
PA5397  hypothetical - -6.6 0.01 
PA5398  Hypothetical dgcA -5 0.01 
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Gene Function Gene Symbol Fold Change p-value 
PA5399  Hypothetical - -3.1 0.01 
PA5401  probable electron transfer flavoprotein 
beta subunit 
- -3.2 0.01 
PA5410  glycine betaine catabolic process gbcA -6 0.02 
PA5411  glycine betaine catabolic process gbcB -3.7 0.02 
PA5415 serine hydroxymethy ltransferase / 
serine hydroxymethyl transferase 
glyA1/ glyA2 -4.2 0.01 
PA5416 sarcosine oxidase beta subunit soxB -4.8 0.02 
PA5417 sarcosine oxidase delta subunit soxD -5.4 0.02 
PA5418 sarcosine oxidase alpha subunit soxA -4 0.02 
PA5419 sarcosine oxidase gamma subunit soxG -4.1 0.01 
PA5420 formyltetrahydrofolate deformylase purU2 -3.4 0.01 
PA5421 glutathione-independent 
formaldehyde dehydrogenase 




were up-regulated that included a set of genes spanning from PA0617 to PA0643 
(Appendix A). 
Another set of genes up-regulated/de-repressed in PAO1 algRD54N 
included PA2491 (mexS) (-9-fold), and PA2493-PA2495 (mexEFoprN) (-13 to -
14-fold). MexEFOprN form a drug-efflux pump that is involved with increased 
antibiotic resistance (chloramphenicol, norfloxicin, and trimethroprim). The mexS 
gene encodes an oxidoreductase and mexT (PA2492) encodes a LysR-type 
regulator. Together, they activate mexEFoprN genes. Interestingly, PA2486 
(ptrC, -20.5-fold) encodes a small peptide that may interact with MexT and 
repress the type III secretion system (T3SS) (376). The PAO1 laboratory strain 
usually expresses an inactive MexT, due to an 8 bp insertion in the mexT 
(PA2492) gene (377). Under certain laboratory conditions (e.g. passage on 
chloramphenicol), these strains may lose the 8 bp insertions in mexT, which 
restores MexT function (at this point, they are considered to have an nfxC 
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phenotype, including increased antibiotic resistance). As a result, these strains 
(with a functional MexT) have various effects on virulence factor expression, 
including those under the control of the Rhl quorum sensing system (378). Tian 
et. al. recapitulated the nfxC phenotype by introducing a plasmid expressing a 
functional mexT gene (379). Overexpression of mexT decreased the 
expression/production of Rhl-quorum sensing regulated virulence factors, 
including the hcnB and rhlA genes and pyocyanin production. Köhler et. al. also 
observed a decrease in rhlI expression and C4-HSL production in the nfxC 
mutant (378). Our results show that hydrogen cyanide production (186), 
pyocyanin production (Fig. 5.10 A B), rhlI expression (Fig. 5.7), and C4-HSL 
production (Fig. 5.7) are repressed by algRD54N. We expressed the algR 
mutants from a plasmid in the ∆algR background, and observed AlgR or AlgR 
D54E, but not AlgR D54N-specific repression of rhamnolipid (Fig. 5.4) and 
pyocyanin (Fig. 5.10 C) production. These results indicate that the phenotypes 
observed by the algRD54N allele are more direct through AlgR.  
Genes involved with respiration and metabolism were also up-regulated 
by algRD54N as compared to algRD54E (Table 5). These included the 
periplasmic nitrate-reductase genes, napABC (PA1174-PA1172) (-3.1 to -4.4-
fold), which are part of the napEFDABC operon, and utilize nitrate as an alternate 
electron acceptor. P. aeruginosa encodes two nitrate reductases (encoded within 
the operons narK1K2GHJI and napEFDABC) (380), utilized for anaerobic growth 
using nitrate as a terminal electron acceptor. The FNR- homologs, Anr and Dnr, 
as well as the two component regulatory system, NarXL, activate transcription of 
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the narK1K2GHJI operon (381, 382). The napEFDABC operon, on the other 
hand, is repressed by the NarL response regulator, and is able to compensate for 
the absence of narGHI (encoding the membrane-bound nitrate reductase 
complex) by 40 hrs of anaerobic growth (383). However, the napABC genes 
(encoding the periplasmic nitrate reductase complex) appear to be expendable 
as compared to narGHI for P. aeruginosa growth anaerobically and for the proper 
regulation of virulence factors (383, 384).  
While little is known about napABC in P. aeruginosa, the nap genes have 
been investigated more thoroughly in other organisms. Much research on 
NapABC has been done on the alpha proteobacteria Paracoccus pantorophus, 
where NapABC complex is utilized for aerobic nitrate reduction (385). As 
opposed to the membrane bound nitrate-reductases encoded by narGHI, which 
couples quinol oxidation to proton translocation and ATP synthesis, the napABC 
system is not coupled with proton translocation. Rather, napABC appears to be 
involved with redox balance by reducing nitrate (386, 387). Additionally, by 
biochemically analyzing the reduction potential of NapABC, it has been 
suggested that NapABC may be able to dissipate excess reducing equivalents by 
reducing the quinol pool (388).  
The perisplasmic nitrate reductase genes napABC were de-
repressed/activated in the algRD54N as compared to algRD54E (Table 5). There 
are two possible reasons for this de-repression. First, it is possible that the 
napABC genes are up-regulated to compensate for the algRD54N strain’s 
inability to respire properly using its membrane-bound NarGHI nitrate reductase. 
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In our study, we showed that AlgR binds to the dnr promoter directly (Fig. 6.2 C). 
While this binding is only suggestive of AlgR regulation of dnr, it leads to the 
hypothesis that AlgR phosphorylation may regulate anaerobic metabolism. This 
proposition is supported by the observation that the algRD54N mutant was 
unable to grow properly anaerobically on nitrate (Fig. 6.3 A). More transcriptional 
analyses would be required to confirm whether AlgR phosphorylation regulates 
these genes under anaerobic conditions, and if it could explain the virulence 
defect caused by algRD54N.  
Second, it is possible that the up-regulation of the napABC genes is a 
physiological response to overall reductive stress, which would normally be 
overcome by having a phosphorylatable AlgR. Phenazines are redox-active 
heterocyclic compound (389-391). In P. aeruginosa (strain PA14), increase in the 
cellular NADH/NAD+ ratio (reductive stress) was closely associated with 
pyocyanin production by the organism. Exogenous pyocyanin decreased NADH 
levels to relieve this reductive stress (392). There was increased phenazine 
(pyocyanin) production in the ∆algR or algRD54N strain (Fig. 5.10), as well as 
the increased expression of the phzA2-G2 genes by ∆algR in a 6-day biofilm 
(273). These observations suggest that AlgR phosphorylation is modulating 
pyocyanin production, or that the ∆algR or algRD54N alleles are causing a 
reducing environment in P. aerginosa. Because C4-HSL production and rhlI 
expression were up-regulated in both of these backgrounds, the over-production 
of pyocyanin could be a direct effect through the Rhl quorum sensing system.  
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Pyocyanin production is also regulated by the PQS quorum sensing 
system. Production of PQS is funneled from chorismic acid, producing the 
intermediate metabolites anthranilate (catalyzed by the proteins encoded by 
phnAB) and anthraniloyl-CoA (pqsA). The PqsBCD enzymes produce HHQ from 
antrhaniloyl-CoA, which is further modified by PqsH to create PQS. Several of 
the genes (pqsBCD) required for PQS biosynthesis were also de-repressed by 
∆algR (273). The pqsABCD genes were up-regulated (between 2 and 3 fold) by 
algRD54N vs PAO1 or algRD54E (Appendix B), suggesting that either PQS or 
HHQ production is upregulated by algRD54N. PQS production was measured in 
the algR mutants (LB medium, 21 hrs growth). However, no differences in PQS 
production were observed (data not shown), suggesting that AlgR regulation of 
pyocyanin may be through the Rhl quorum sensing system. 
In addition, the algRD54N allele activated the catA (PA2507) (-17.5-fold) 
and catC (PA2508) (-11.8-fold) genes encoding catechol 1,2 dioxygenase and 
muconolactone delta isomerase proteins, respectively. Genes within the choline-
glycine betaine pathway were also up-regulated by algRD54N vs algRD54E 
(PA5378 to PA5421) (Table 6.2). These genes included gbcA (PA5411) and 
gbcB (PA5411), encoding the enzyme for conversion of betaine to 
dimethylglycine (DMG), dgcA (PA5398) and dgcB (PA5399), encoding the 
enzyme for conversion of DMG to sarcosine, and soxBDAG (PA5416-PA5419), 
encoding sarcosine oxidase for the conversion of sarcosine to glycine. Genes 
encoding a proposed choline and betaine ABC transporter (PA5378) and a 
glycine betaine transporter (PA5376-PA5378) were up-regulated as well (393).  
 131 
Microarrays comparing algRD54E with wild type showed only 9 genes 
were upregulated by algRD54E as compared to wild type algR allele (Table 6). 
These included the phoRB two component system (2 and 5-fold), and the 
pstSCA genes (5.8, 2.7, and 2.8-fold). Four genes encoding hypothetical proteins 
were also upregulated, including: PA1116, encoding a possible RNA-binding 
protein (2.6-fold), PA1606, encoding a protein with an immunoglobulin-like fold 
(2.3-fold), PA2428, encoding a protein with polyphosphate:nucleotide 
phosphotransferase activity (2.7-fold), and PA4844, encoding a methyl-accepting 
chemotaxis protein (3.3-fold).  The small number of genes regulated by 
algRD54E is an indication that the algRD54E allele closely resembles PAO1 with 
the wild type algR allele. Further studies are required to elucidate if regulation of 
these genes is direct by phosphorylated AlgR. 
 
Table 6.  All genes regulated in PAO1 algRD54E vs PAO1.  
Gene Function Gene Symbol Fold Change p-value 
PA1116 --- --- 2.7 0.04 
PA1606 --- --- 2.3 0.05 
PA2428 --- --- 3.7 0.02 
PA4844 --- --- 3.3 0.02 
PA5360 
two-component response regulator 
PhoB phoB 5.0 0.01 
PA5361 two-component sensor PhoR phoR 2.1 0.02 
PA5367 
membrane protein component of ABC 
phosphate transporter pstA 2.8 0.04 
PA5368 
membrane protein component of ABC 
phosphate transporter pstC 2.7 4.E-03 
PA5369 --- --- 5.8 0.01 
 
The microarrays were performed to gain insight into the cause of the 
virulence defect by algRD54N. In summary, we identified a multitude of novel 
genes that have not been identified in prior microarray studies. (231, 273, 282). 
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The transcription of these genes will need to be validated to demonstrate AlgR 
phosphorylation dependence, and whether they are important in our 




CHAPTER VII   
 
 





In this study, we explored the role of AlgR phosphorylation in P. 
aeruginosa by first, constructing a phospho-mimetic isoform of AlgR (AlgR D54E) 
and verifying its activity on the fimUpilVWXY1Y2E promoter (Chapter IV); 
second, ascertaining AlgR’s role on the Rhl quorum sensing system using strains 
expressing the genes encoding the phospho-mimetic (algRD54E) or phospho-
defective (algRD54N) isoforms (Chapter V); third, determining their virulence 
capacity (Chapter VI); and fourth, exploring possible reasons for the reduced 
virulence of algRD54N (Chapter VI). 
 
 
                                                
5 Republished with permission from American Society for Microbiology Journal of 
Bacteriology. Sections were taken from: Okkotsu, Y, Tieku, P, Fitzsimmons, LF, 
Churchill, ME, Schurr, MJ. 2013. Pseudomonas aeruginosa AlgR 
phosphorylation modulates rhamnolipid production and motility. J. Bacteriol. 
JB.00726-13.   
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AlgR D54E is the phosphomimetic form of AlgR response regulator 
 
FimU, PilV, PilW, PilX, and PilE are required for surface piliation, and most 
likely interact with PilA to stabilize the pilus fiber, resulting in normal twitching 
behaviour (224). Our results supported previous observations that 
phosphorylated AlgR is required for the expression of the fimUpilVWXY1Y2E 
operon and normal twitching behavior (157, 180). We utilized the fimU promoter 
and the corresponding twitching motility phenotype as functional readouts for 
AlgR to look at the AlgR D54E (phospho-mimetic) or AlgR D54N (phospho-
defective) activity. The expression of the algRD54E allele from a plasmid (Fig. 
4.2) or in single-copy from the chromosome (Fig. 4.3 B) activated fimU promoter 
transcription and displayed wild type twitching motility (Fig. 4.7 A, B). Conversely, 
the PAO1 ∆algZ or PAO1 algRD54N strains had decreased fimU transcriptional 
activity (Fig. 4.3 B) and abrogated twitching motility (Fig. 4.7 A, B).  
In other organisms an aspartate to glutamate mutation resulted in 
activation of OmpR D55E (307), NtrC D54E (308, 309), and RcsB D56E (306) to 
its target promoters in a kinase-independent manner. We showed that AlgR 
D54E activity was independent of the histidine kinase, AlgZ. The ∆algZ 
algRD54E background activated fimU promoter activity (Fig. 4.3 B) and twitching 
motility in vivo (Fig. 4.7 A, B). This idea was supported in vitro, where AlgR D54E 
(or AlgR D54N) could not be phosphorylated with radio-labeled acetyl phosphate 
(Fig. 4.5 A). There was a 12-fold increase in AlgR D54E protein expression in the 
∆algZ algRD54E background (Fig. 4.3 D), which potentially explains the elevated 
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fimU reporter activity (Fig. 4.3 B). We do now to know the reason for this 
elevated AlgR expression in this background. The rationale for deleting the algZ 
region, as noted in Figure 4.3 A, was to avoid affecting the previously identified 
transcriptional start sites/promoters for algR. It is possible that this mutation, in 
combination with the algRD54E allele increased AlgR expression. A proper 
stoichiometric expression of the minor pilins is essential for the formation of pilus 
strands and for functional twitching motility to occur (224). The increased 
amounts of AlgR D54E resulting in the 36-fold elevated fimU expression would 
likely disrupt the function of the type IVa pili complex, and result in the aberrant 
twitching motility phenotype observed for ∆algZ algRD54E (Fig. 4.7 A, B). It was 
previously noted that overexpression of individual pilins in their respective pilin 
deletion backgrounds abrogated twitching motility, but overexpression of 
individual pilins in a wild type strain expressing the fimUpilVWXY1Y2E genes 
showed only a modest decrease in twitching (224). Our results with PAZ 
algRD54E are in agreement with this observation, since this strain retains the 
fimU operon genes.  
Because LytR-like response regulators, as well as OmpR, PhoB, NarL, 
and FixJ type RRs contain only a single DNA-binding domain, dimerization is 
thought to be an important characteristic for gene regulation. AlgR is grouped 
into the LytTR subfamily of response regulators that bind to imperfect direct 
repeats with 12-13 bp spacers (131). S. aureus AgrA dimer was modeled to bind 
two direct repeats, and introduce a 38° bend in the DNA (133). Yet, another 
obvious consensus sequence 12-13 bp from the reported AlgR binding sites is 
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lacking on all of the AlgR-regulated promoters to date. Interestingly, we observed 
slight differences in the binding characteristics between AlgR-P and AlgR D54E 
to fimU DNA (Fig. 4.6 C). Since the 82-bp fragment used in the DNA binding 
studies included both of the characterized AlgR binding sites (ABS) for fimU, one 
possibility is that the steady state equilibrium of AlgR-P and AlgR resulted in 
interaction with both sites simultaneously. 
The current paradigm for the role of phosphorylation in RRs is that it shifts 
the equilibrium towards one of two predominant states of the protein 
conformation (394), likely inducing homodimerization (395).  We did not 
extensively study whether AlgR forms a homodimer, but the results from our 
native-PAGE (Fig. 4.5 C) suggest a conformational change after phosphorylation. 
The change in mobility in the native-PAGE also does not eliminate the possibility 
of a charge difference between AlgR and acetyl-phosphate treated AlgR. More 
work will be required to dissect this other binding site and how and if 
homodimerization may change binding.  
Several experiments could be conducted to determine AlgR dimerization. 
Analytical ultracentrifugation (AUC) would give an indication of the size and 
shape of the native AlgR protein in a buffered system. Briefly, sedimentation 
equilibrium (SE)-AUC is used to monitor the concentration distribution of 
macromolecules in a solution after low-speed centrifugation (396). SE-AUC has 
been utilized to study OmpR protein dimerization (397). The addition of the 
phosphate mimic, beryllium fluoride (BeF3-), to the OmpR protein resulted in an 
altered weight distribution as compared to OmpR protein without BeF3- indicating 
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dimerization of OmpR by phosphorylation. By performing SE-AUC experiments 
on AlgR with or without BeF3- we could determine whether phosphorylation 
induces dimerization in AlgR.  
Additionally, analysis of AlgR dimerization in the presence of DNA would 
be informative, as it would discern the relationship between dimerization and 
DNA binding. We hypothesize that performing DNase I footprinting experiments 
comparing AlgR or in vitro phosphorylated AlgR (with acetyl phosphate) on the 
rhlA and rhlI promoters will reveal novel, lower affinity half-sites. Comparisons of 
footprints among wild type AlgR, AlgR-P, AlgR D54N and AlgR D54E proteins on 
the fimU, rhlA or rhlI promoters will also reveal binding location, and may provide 
a mechanistic model of how AlgR phosphorylation could activate or repress 
these promoters. 
We further studied the AlgRD54N and AlgRD54E isoforms in comparison 
with purified AlgR protein for its stability (Fig. 4.4) and capacity to be 
phosphorylated (Fig. 4.5 and 4.6). The melting temperature of the AlgR D54E or 
AlgR D54N isoforms displayed a 10°C decrease in melting temperature 
compared to the wild type AlgR (Fig. 4.4 B). Yet, the PAO1 algRD54E strain 
transcriptionally activated the fimU promoter while the algRD54N strain did not 
(Fig. 4.3) and AlgR D54E bound the fimU promoter by EMSA. Additionally, AlgR 
D54N did not bind as well to fimU (Fig. 4.6 D) (180) but did bind to rhlA (data not 
shown) and rhlI (Fig. 5.8 C). These results indicate that despite their lowered 
melting temperatures, AlgR D54N and AlgR D54E isoforms were phospho-
defective and phosphor-mimetic, respectively. 
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As shown in other response regulators the phospho-mimetic isoform can 
have increased affinity towards its cognate DNA. For instance, in the 
Agrobacterium tumefaciens VirG response regulator, the VirG I77V/D54E mutant 
(a phospho-mimetic, active-form locked isoform), displayed increased binding 
towards the virB promoter compared to its wild type form (398). In this work, we 
also observed phosphorylation-dependent binding of the AlgR protein to the fimU 
DNA. Specifically, the phosphorylated form of AlgR (or AlgR D54E) had higher 
affinity for the fimU DNA as compared to the unphosphorylated form (or AlgR 
D54N) (Fig 4.6 B, C, D). Therefore, our results support the idea that AlgR D54E 
is in the active conformation. Additionally, fimU expression is dependent on AlgR 
phosphorylation (Fig 4.3 B). Pre-phosphorylating AlgR with acetyl phosphate 
resulted in increased AlgR binding to fimU (Fig. 4.6) (and rhlA (Fig. 5.5 B, C, E)) 
DNA. The results indicate that AlgR-P has increased affinity toward the two non-
consensus binding sites (fimU ABS1, 5‘- CCGTTTGGC and fimU ABS2, 5’-
CCCTCGGGC), suggesting that phosphorylation has a biological role. 
We also explored several of the conserved residues in the REC domain of 
AlgR. Previous work on the RcsB response regulator (306) and CheY from E. coli 
(161) showed that the mutation comparable to algRD8N activated the 
transcriptional regulators. In CheY D13N, the phosphorylation at D59 was 
stabilized, resulting in decreased rate of de-phosphorylation (161). Our results 
with algRD8N on fimU activity are in agreement with previous results (Fig. 4.1 B). 
In the sporulation-regulating Spo0F response regulator from Bacillus subtilis, a 
T82A substitution decreases its interaction with its kinase KinA, mimicking the 
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inactive form, and rendering it unable to form spores (399), We also observed 
abrogated twitching motility and decreased transcriptional activity of the fimU 
promoter by the algRT82A mutant (Fig. 4.1 A B).  Interestingly, the role of the 
comparable conserved threonine (algRT82A) appears to be response regulator 
specific. For instance, the T87 residue in CheY is required for optimal auto-
desphosphorylation of the protein by stabilizing the active conformation of CheY-
P, and the comparable CheY T87A mutation interacts with CheA but has 
decreased auto-desphosphorylation, rendering it more active (400). In the future, 
it would be interesting to further explore these algR mutants, as they may provide 
some insight into more subtle aspects of protein structure and AlgR 
phosphorylation.  
In summary, we created a phospho-mimetic isoform of AlgR and using the 
fimU promoter, showed that this protein (AlgR D54E) and allele (algRD54E) 
recapitulate the phosphorylation of AlgR. Phospho-mimics have not yet been 
tested in response regulators containing the AlgR/AgrA/LytR family of DNA 
binding domains, and this is the first report utilizing a phospho-mimetic response 
regulator in P. aeruginosa. We also validated the use of the fimU::lacZ reporter 
as a reporter for AlgZ or AlgR phosphorylation activity in vivo. These results 
helped to further dissect the role of AlgR phosphorylation, as discussed in the 




AlgR phosphorylation modulates rhamnolipid production 
 
We explored the role of AlgR phosphorylation on the Rhl quorum sensing 
system. Previous data indicated that the Rhl quorum sensing system was de-
repressed in a ∆algR strain in a 6-day biofilm, as the PAO1 ∆algR strain showed 
increased rhlA expression and rhamnolipid production (273). It was necessary to 
perform multiple assays to confirm the rhamnolipid phenotype, as the differences 
in production were subtle. We initially predicted to observe AlgR repression of 
rhlA transcription, and in fact, expression of algR from a plasmid recapitulated 
this observation (Fig. 5.4). We demonstrated that rhlA expression (Fig. 5.2) and 
rhamnolipid production (Fig. 5.3) were decreased in the algRD54N or ∆algZ 
strains, but unaffected in the algRD54E background. This result may be 
explained by both the location and affinities of the AlgR binding sites in the rhlA 
promoter (Fig 7.1). 
When the appropriate environmental signal is sensed by the cognate 
histidine kinase, there is increased phosphorylation of the response regulator, 
which tips the balance towards activation (or inactivation). For instance, the well-
studied E. coli osmoregulator OmpR controls the expression of ompF or ompC, 
depending on its predominant phosphorylation state. The cognate histidine 
kinase, EnvZ, responds to osmotic stress of the environment and phosphorylates 
OmpR, increasing the percentage of OmpR-P in the cells at high osmolarity. Both 
ompF and ompC have four and three OmpR binding sites within their promoters, 
respectively. The level of OmpR phosphorylation directly regulates the 
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expression of the two genes in a mutually exclusive manner, where cooperative 
binding of both proximal and distal binding sites in the ompF and ompC 
promoters influence how OmpR-P regulates transcription of both promoters (307, 
401).  
On a related note with the algD and algC promoters, AlgR binding sites 
(ABS) were found hundreds of bases apart from each other (115, 135, 136, 138). 
In the algD promoter, two identical ABSs are located -471 bp and -396 bp 
upstream, and one ABS is located -45 bp upstream of the transcriptional start 
site (135, 136). DNA looping has been proposed as a mechanism for algD 
regulation (Fig. 1.4 A) (138). Additionally, an ABS in the algC promoter has been 
reported to function as an enhancer element for algC transcription (146). We 
suggest AlgR phosphorylation as a mechanism for AlgR to coordinate the 
transcription of various genes, including the fimU promoter (Fig. 4.3 B) the rhlAB 
promoter (Fig 5.2), and rhlI promoter (Fig. 5.7).  
The AlgR phosphorylation state may modulate rhlAB expression as a 
function of the AlgR binding affinities, which could explain the differences in fimU 
and rhlA transcription by algRD54N and algRD54E (Fig. 1.4 B, Fig. 7.1). As 
compared to the highest affinity binding site (from the algD promoter (5‘- 
CCGTTCGTC)), fimU ABS1 (5‘- CCGTTTGGC) has two, and fimU ABS2 (5’-
CCCTCGGGC) has four mismatches (180) (underlined bases are different from 
canonical AlgR binding site). Previous work on algC ABS2 (5‘- CCGTTGTTC), 
algC ABS3 (5‘- CCGTGCGTC), and algD ABS3 (5‘- CCGTTTGTC), showed that 
mismatches in the binding site resulted in lowered AlgR affinity (138, 402),  
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Figure 7.1. Model of AlgR phosphorylation-dependent regulation of fimU 
and rhlA. AlgZ/FimS phosphorylates AlgR, and AlgR-P status increases affinity 
to lower affinity binding sites. Core 9 bp consensus sequence is shown in blue. 
Boxed sequences indicate rhlA and fimU AlgR binding sequences. Increased 
number of mismatches (red letters) is proposed to be lower affinity sites. AlgR-P, 
as compared to AlgR, has increased affinity to these lower affinity fimU and rhlA 
binding sites, resulting in phosphorylation dependent promoter activation.  
 
indicating that the sequence is essential for protein binding. In support of this 
idea, AlgR or AlgR-P qualitatively displayed higher affinity to the rhlA frag 1 DNA 
(containing the conserved rhlA ABS1 (5‘- CCGTTCGTC)) (Fig. 5.5 C), as 
compared to the fimU promoter DNA (containing the less conserved binding 
sites) (Fig. 4.3 C and Fig. 7.1). 
AgrA-type response regulators bind imperfect, direct 9 bp repeats 
separated by 12 bp (133). In our study, we observed multiple protein-DNA 
complexes with rhlA frag 1, which suggests that AlgR may be binding to multiple 
sites in rhlA frag 1 (Fig. 5.5 C). However, even though the sequence for rhlA 
AlgR binding site 2 (5’-CCGTGCTCC) has a similar sequence to the known AlgR 
binding site 1 (5’-CCGTTCGTC), and is located at the appropriate distance for 
AgrA-type regulators (10 bp), our data also confirms previous results that rhlA 
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When EMSAs were performed with AlgR-P, the deletion of rhlA ABS1 (highly 
conserved site) in rhlA frag 1 (Fig. 5.5 D, ∆1) resulted in a higher shift (top black 
triangle), compared to WT rhlA frag 1. These large shifts were also present when 
AlgR-P (Fig. 5.5 C, lanes 17 and 18), but not AlgR (Fig. 5.5 C, lanes 8 and 9), 
was added at high amounts. Additional experiments are needed to elucidate how 
this occurs, and how it is biologically relevant.   
AlgR phosphorylation state may also modulate the rhlAB expression as a 
function of the location of the AlgR binding site locations. In this study, a second 
region within rhlA frag 5 was found to bind phosphorylated AlgR (Fig. 5.5 E). In 
attempts to determine this third binding site, a probable AlgR binding sequence in 
rhlA frag 5 (5’CCGCCCGTC, underlined bases are different from canonical AlgR 
binding site) was mutated and investigated for binding and transcriptional activity 
(data not shown). We surmised that this binding site, located adjacent to the 
RhlR-binding lux box, is reminiscent of those found in class I activation of 
promoters, where an activator binds to a target located upstream of the -35 
element (403). A mutation of this proposed site was introduced (5’CCGCCCGTC 
to 5’ttaCCCGTC, lower case is mutagenized nucleotides), as we had previously 
observed that a  CCG to TTA mutation in the rhlI-ABS was effective at reducing 
AlgR binding (273). However, these mutations did not affect AlgR binding by 
EMSA (data not shown), indicating that it is not a real AlgR binding site. Using a 
transcriptional fusion, mutation of this site did decrease rhlA transcription, but this 
effect is most likely due to disruption of RhlR binding (data not shown) (352).  
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Considering that there may be a third AlgR binding site located within rhlA 
frag 5, and the fact that at least one AlgR binding site may be located on rhlA 
frag 1, it would be reasonable to suggest that a similar type of AlgR regulation, 
such as that found on the algD promoter, may occur with the rhlA promoter (Fig. 
7.1). We also propose that the binding affinities for the ABSs may affect whether 
the promoter is AlgR phosphorylation-dependent, or not (Fig. 7.1). This is 
supported by the fact that the algD promoter, containing two consensus AlgR 
binding sites (algD RB1 and algD RB2 (5‘- CCGTTCGTC)) (138), does not 
require AlgR phosphorylation for its transcription (181, 185), while fimU requires 
AlgR phosphorylation for activation (180). Therefore, further investigation of this 
downstream binding site is imperative to fully characterize the role that multiple 
AlgR bindings sites plays on rhlA transcription. 
In order to investigate the above statement, the following experiments 
could be performed. First, the nucleotide sequence of the unknown AlgR binding 
site, possibly located in rhlA frag 5, will be identified by DNase I footprinting. 
Footprinting will be performed with both AlgR or AlgR-P protein to ensure that a 
phosphorylation-dependent AlgR binding site will be identified. Second, site-
directed mutagenesis and EMSA will help to confirm the footprinting results. The 
identified binding site will be altered by site-directed mutagenesis (∆ABS), and 
EMSAs will be performed to assess AlgR or AlgR-P binding to rhlA frag 5 or rhlA 
frag 5 ∆ABS. Third, a mutation in this AlgR binding site will be introduced into the 
rhlA promoter, and rhlA transcriptional activity will be measured by either qPCR 
or transcriptional reporter assays. Mutations in this AlgR binding site should 
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abrogate AlgR-phosphorylation dependent regulation of rhlA transcription. 
Fourth, the effect of mutating multiple AlgR binding sites on the rhlA promoter will 
be determined. The previously identified AlgR binding site (located within rhlA 
frag 1) is a high affinity consensus sequence that is also found in the algD far-
upstream site (FUS). Deletion of the FUS algD-ABS1 or algD-ABS2 reduces 
algD promoter activity by up to 99%. If the AlgR binding sites found on the rhlA 
promoter are required for AlgR-dependent regulation, mutations in one or both of 
the AlgR binding sequences on the rhlA promoter should reduce rhlA 
transcriptional activity. Fifth, in order to determine the role of DNA looping in AlgR 
regulation of rhlA, electrophoretic mobility assays could be performed. As 
described by studies in the lac and ara promoters (404, 405), circularized 
radiolabeled fragments of the rhlA promoter will be created. The extent of 
migration of the circularized rhlA DNA by electrophoresis would depend on DNA 
looping caused by the occupancy of the AlgR protein to its binding sites. Utilizing 
AlgR or AlgR-P in combination with circularized rhlA DNA (introducing mutations 
in the AlgR binding sites) may indicate whether looping occurs during AlgR 
interaction with the rhlA promoter. Finally, utilizing fluorescently labeled rhlA DNA 
fragments for fluorescent resonance energy transfer (FRET) would be an 
additional method to observe DNA looping, as previously demonstrated for the 
lac promoter (406, 407). For this experiment, two fluorophores having 
overlapping emission and excitation wavelengths would be covalently attached 
adjacently to two AlgR binding sites within rhlA promoter fragments. Binding 
reactions of the fluorophore-containing DNA would be performed with AlgR or 
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AlgR-P. Excitation of the first fluorophore and the subsequent energy transfer 
and emission from the second fluorophore would be measured, either in the 
presence of AlgR or AlgR-P. Together, these experiments may provide a better 
understanding of how AlgR phosphorylation regulates the rhlA promoter.  
Additionally, we observed that rhlA expression and rhamnolipid production 
were unchanged or decreased in the PAO1 ∆algR background as compared to 
wild type (Fig. 5.2, 5.3). This result is in direct contradiction to previous results in 
a biofilm (273). However, this discrepancy could be due to differences in 
experimental conditions. In fact, our lab previously demonstrated stationary-
phase cultures did not display differences in rhlA expression (273). In agreement 
with this contention, we observed AlgR-phosphorylation dependent differences in 
rhlA transcription at 10 hrs of growth (Fig. 5.2), but this was lost by 16 hrs (data 
not shown), indicating that AlgR phosphorylation on rhlA transcription may play a 
role early on during growth. Regulation of the rhlAB genes is very complex, and 
is affected by a number of factors and conditions, including the Rhl quorum 
sensing system (241, 274), nitrogen metabolism (275), the sigma factors RpoN 
(350), RpoD (326), and RpoS (365), DksA (408), iron (409), phosphate levels 
(356), and RsmA (410). We speculate that in the absence of AlgR (as in the 
∆algR background), a modulatory component upon the rhlA promoter is absent, 
and rhlA expression is reliant on the other regulators to activate this promoter. 
Therefore, the restoration of rhlA expression in the absence of AlgR (i.e. ∆algR) 
could be explained by these other factors.  
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Rhamnolipid production and swarming motility are also preferentially 
induced by certain amino acids (198). Using glutamate as the sole carbon source 
induces swarming motility in the absence of the las and rhl systems, and 
rhamnolipid production (411). While our current experiments were performed in 
rich medium, our previous biofilm growth conditions were performed in minimal 
medium with glutamate (273). These results indicate the importance of nutrient 
source for these phenotypes. While AlgR (∆algR) was not required for repression 
of rhlA under our experimental conditions, it is possible that AlgR repression of 
rhlAB occurs either with certain amino acids or at later stages of biofilm 
development.  
While the single polar flagellum helps to propel the organisms, the 
products of the RhlA, RhlB, and RhlC enzymes (HAA, mono-rhamnolipids (m-
RL), and di-rhamnolipids (d-RL)) coordinate the formation of the dendrite 
phenotype in swarming cells (345). We observed AlgR-dependent effects on 
swarming motility (Fig. 5.1 A). WT or algRD54E backgrounds exhibited 
discernible dendrites, but the ∆algR, algRD54N, or ∆algZ backgrounds displayed 
a noticeable swarming motility defect (Fig. 5.1 A). The most likely explanation for 
the different swarming phenotypes observed between the ∆algR and algRD54N 
backgrounds is that the strain carrying the algRD54N allele produced less 
rhamnolipids than that with the ∆algR allele (Fig. 5.3). This decrease, in 
combination with abrogated twitching motility (Fig. 4.7), likely decreased overall 
swarming motility in algRD54N. Following this logic, we expected to see a similar 
swarming phenotype between PAO1 algRD54N and PAO1 ∆algZ. However, 
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PAO1 ∆algZ displayed a swarming phenotype similar to PAO1 ∆algR. PAO1 
algRD54N expresses AlgR D54N protein, which is unable to be phosphorylated, 
while the AlgR protein expressed in PAZ may be phosphorylated by other 
intracellular phospho-donors. We currently do not know if and when AlgR may be 
phosphorylated in the absence of AlgZ. If this is the case, under certain 
conditions, AlgR could potentially increase rhamnolipid production and partially 
restore the swarming defect. As for the PAO1 ∆algZalgRD54E mutant, we 
expected to observe a phenotype resembling that of wild type or PAO1 
algRD54E. However, instead, we observed a decrease in overall swarming. 
Rhamnolipid production appears to be finely regulated by AlgR levels- algR 
expressed from a plasmid repressed rhamnolipid production (Fig. 5.4). Since 
AlgRD54E expression is increased (Fig. 4.2), it is possible that this reduced 
swarming in PAO1 ∆algZalgRD54E is due to repression of rhamnolipids. In fact, 
when rhlAB was expressed from a plasmid in the algRD54N background, 
dendrite formation was partially restored (Fig. 5.6 C). Since the algR mutants 
showed no swimming defects (Fig. 5.1 B), we opine that the swarming defect is 
due to a dysregulation in rhamnolipid production. These results indicate an AlgR 
phosphorylation-dependent regulation of swarming motility through rhamnolipid 
expression.  
We have not eliminated the possibility that AlgR phosphorylation also 
regulates swarming motility indirectly. Swarming motility is a highly complex 
phenotype that is regulated by a number of factors (412-415). Recently, type IVa 
pili have been shown to control swarming motility through c-di-GMP levels (197). 
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Low intracellular c-di-GMP levels are required for swarming and swimming 
motility (416). Deletion of bifA, encoding a phosphodiesterase, results in a 
swarming defect due to a buildup of intracellular c-di-GMP (228). Deletion of 
PilY1, PilX, or PilW in a bifA deletion alleviates the swarming defect found in a 
bifA deletion (197, 228) without changing intracellular c-di-GMP levels (228), 
indicating that PilY1 suppresses swarming specifically through BifA (197). 
Overexpression of PilY1 represses swarming, but not in a sadC deletion 
(encoding a diguanylate cyclase that increases c-di-GMP levels) suggesting a 
role of PilY1 for directly or indirectly regulating c-di-GMP levels through SadC 
(197). While we did not observe any transcriptional effects on sadC or bifA in our 
microarrays (Appendix A), or a change in swarming motility in the algRD54E 
background (Fig. 5.1 A), it would be interesting to explore if and how AlgZR might 
affect c-di-GMP levels.  
AlgR repression of rhamnolipids in a 6-day biofilm was attributed to AlgR 
repression on the rhlI promoter (273). We showed here that AlgR also represses 
rhlI expression and C4-HSL production in our experimental conditions (Fig. 5.7). 
We observed up-regulation of rhlI and an increase in C4-HSL levels in the PAO1 
∆algR and PAO1 algRD54N backgrounds, supporting previous work that AlgR 
represses rhlI transcription. The location of the AlgR binding site(s) in the rhlI 
promoter could explain AlgR’s repressive role. As depicted in Figure 7.2 A, the 
known AlgR binding site is located within the sigma-factor binding region, 
downstream of the LasR binding site (lux box). We also discovered that a region 
downstream of the transcriptional start site had affinity for AlgR-P but not AlgR 
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(Fig 5.9 B, frag 1.2). We propose that AlgR phosphorylation represses rhlI 
transcription by binding to two of the binding regions (Fig. 7.2 B) as seen with 
wild type or the algRD54E strain (Fig. 5.7). On the other hand, ∆algR or 
algRD54N alleles would de-repress rhlI transcription due to reduced binding to 
the rhlI promoter (Fig 7.2 B, Fig 5.7). The RhlI acyl-homoserine lactone synthase 
encoded by rhlI catalyzes the formation of C4-HSL, and increased C4-HSL 
activates the RhlR transcriptional activator to increase rhlA expression. The 
repression of rhlI expression by ∆algR or algRD54N seems contradictory to 
results from the rhlA expression or rhamnolipid production, and suggests AlgR 
regulates rhlA transcription independently of rhlI. 
We demonstrated that AlgR phosphorylation is required for the 
rhamnolipid production at earlier points in growth, as a phosho-defectve isoform 
(algRD54N) was unable to express rhamnolipids, while a phospho-mimetic 
isoform (algRD54E) was able to express rhamnolipids (Fig. 5.3). Our results 
indicate that AlgR phosphorylation also activates twitching motility by regulating 
the pre-pillins, indicating concurrent modulation of both type IVa pili and 
rhamnolipid production. In agreement with our previous studies with the ∆algR 
mutant (273), biofilm formation in the ∆algR mutant was abrogated (Fig 5.11). 
Biofilm formation in the ∆algR mutant is most likely defective due to this strain’s 
inability to adhere to a surface, through the combinatory effects of the lack of 
surface pili (Fig. 4.7) (224), and the strain’s capacity to still produce rhamnolipids 
(Fig. 5.3). While the 96-well plate assay is suggestive of biofilm formation, it also 
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Figure 7.2. Model of AlgR regulation of rhlI. Transcription of rhlI is activated by 
LasR (262, 417), and modulated by RpoN (350, 351) and possibly RpoS (365, 
366). Other effectors of rhlI transcription include DksA (408) and PprB (418). (A), 
promoter region of rhlI showing 248 nucleotides upstream of the translational 
start site (ATG, double underline). Boxes: AlgR binding site (green), Possible 
RpoS ( s) binding site (black), RpoN binding site (blue), and LasR binding site 
(orange). Transcriptional start site is indicated by +1. (B), possible mechanism of 
AlgR repression of rhlI. In wild type cells, rhlI expression may be modulated by 
AlgR phosphorylation. An algR or algRD54N mutant may de-repress rhlI 
transcription by not binding to the yet-to-be-identified AlgR binding site (indicated 
as a question mark), found in Figure 5.9 B. AlgR D54E restores rhlI inhibition (red 
arrow) by interacting with this second binding site.  
 
measures cell attachment and adherence. On the other hand, the algRD54N 
strain were highly adherent to the 96-well microtiter plates at 72 hrs, which could 
be explained by the decreased rhamnolipid production in this background (Fig 
5.11 B). Together, these results indicate that AlgR-P regulated phenotypes are 






























AlgR-phosphorylation control of type IV pili and rhamnolipid production 
may contribute to the organism’s pathogenesis 
 
Motility serves as a major virulence factor for acute virulence. There is 
substantial evidence indicating that type IVa pili are virulence determinants 
associated with acute pneumonia in a mouse model of infection (419), murine 
burn wound model (17), and early CF infection and colonization in humans (106). 
Type IVa pili are required for a rabbit corneal infection model (420, 421), where it 
is utilized for translocation through the epithelium and exit from the site of 
infection. In an acute pneumonia model, mutants with defective type IVa pili are 
able to cause an infection, but have decreased dissemination into nearby organs 
(419).  
Invasiveness is a hallmark of P. aeruginosa ability to disseminate from the 
initial site of infection. The organism is able to utilize type IV pili to bind N-glycans 
on the apical surface of polarized human epithelial cells (calu-3) and invade the 
host cell by modulating phosphoinositide-3-kinase (PI3K) or protein kinase B 
(Akt1) phosphorylation (190, 422). PI3K’s main relevance to bacterial invasion is 
mediated through its kinase activity upon phosphotidylinositols that modulate the 
actin skeleton. E. coli, Listeria monocytogenes, and Helicobacter pylori also 
utilize PI3K phosphorylation for invasion into epithelial cells (423-425). Akt1 
phosphorylation has been shown to be required for Human Simplex Virus 1 entry 
(426), and may present a novel mechanism for bacterial invasion (422).  
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Type IVa pili have also been implicated with bacterial adherence to 
surfaces (187-190). In regards to the fimUpilVWXY1Y2E genes, pilY1 is required 
for bacterial adherence, cytotoxicity of A549 cells, virulence against C. elegans, 
and disease manifestation in mice (226, 229). PilY1, containing an RGD binding 
motif and possibly found at the tip of the type IVa pili, allows binding to integrin 
(188, 226). Additionally, FimU prepellin is also a virulence determinant, as a 
deletion in fimU reduces P. syringae pv. tabaci 6605 dissemination in an 
Arabidopsis plant model (427). 
Surface expression of type IVa pili requires a proper stoichiometric 
expression of the prepillins, as the interaction/compatibility of the FimU, PilV, 
PilW, PilX, PilY1, and PilE with other pilus assembly components dictates the 
efficiency of pilus assembly and disassembly (224, 230). Expression of the 
fimUpilVWXY1Y2E genes is required for surface type IVa pili expression and 
function (224).  As suggested by Giltner et. al., AlgR represents another level of 
control of regulation of twitching motility by regulating the fimUpilVWXY1Y2E 
genes. Therefore, our results add to this current body of work, and supports the 
idea that AlgR-phosphorylation is another level of regulation of the type IVa pili 
apparatus.  
Rhamnolipid production is another virulence determinant and required for 
P. aeruginosa pathogenicity. For instance, P. aeruginosa infection in patients 
under mechanical ventilation poses a significant problem. The mortality rate for 
ventillator-associated pneumonia (VAP) ranges from 24 to 50%, of which, 
between 50 to 80% is directly linked to P. aeruginosa infection (428). In a recent 
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study, quorum sensing, and particularly rhamnolipid production, was correlated 
with acquiring VAP in a clinical setting. Initially infecting P. aeruginosa strains 
display variable levels (high, medium, low) of rhamnolipid production. Yet, those 
strains that produce rhamnolipids, on average, retain their capacity to produce 
rhamnolipids over the course of infection. Additionally, patients that developed 
VAP were colonized by rhamnolipid-producing strains (429). An in vivo urinary 
tract infection model in mice showed rhamnolipid production increases over the 
course of five days. Virulence of wild type PAO1 was attributed to quorum-
sensing regulated virulence factors such as proteases, elastase, and 
rhamnolipids, as a ∆lasI∆rhlI mutant was cleared from the bladder by three days 
(430). 
There are multiple mechanisms in which rhamnolipid production can 
increase P. aeruginosa pathogenicity. Rhamnolipid-producing strains or 
exogenous rhamnolipids disrupt and alter the lung epithelical cell barrier by 
increasing the permeability of tight junctions (431). As a result, it increases 
paracellular invasion of P. aeruginosa. Rhamnolipids aid the organism in 
protection against polymorphonuclear leukocytes by preventing phagocytosis 
(279, 432). As a heat-stable hemolytic biosurfactant, rhamnolipids also aid in 
necrosis of polymorphonuclear leukocytes in vivo and in vitro, suggesting its role 
in clearing immune cells is physiologically relevant during P. aeruginosa infection 
(278, 433). Additionally, rhamnolipids repress the production of human beta-
defensins (hBD-2) from keratinocytes and decreasing an IL-8 mediated 
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inflammatory response, providing an additional role in subverting the host 
immune response (434). 
The fact that AlgR phosphorylation activates rhamnolipid production 
presents another mechanism of regulating this virulence factor. In the final results 
section, we utilized the algR mutants to determine if and how AlgR 
phosphorylation affects P. aeruginosa virulence. As both type IV pili and 
rhamnolipids aid in P. aeruginosa dissemination, the attenuation of the 
algRD54N in an acute pneumonia model of infection (Fig. 6.1) could be 
explained by abrogated twitching motility and rhamnolipid production (Fig. 7.3 A). 
Therefore, by regulating both of these virulence factors, the phosphorylation state 
of AlgR may modulate the pathogenicity of the organism. If rhlA and fimU are the 
only two important genes that AlgR is controlling in the infection model, then 
deletion of rhlA and fimU in PAO1 should phenocopy algRD54N.  
Prior to performing virulence studies using the algR mutants, we expected 
to observe the ∆algR and algRD54N mutants to phenocopy. Instead, there was a 
discrepancy between the ∆algR and algRD54N strains with regards to the murine 
acute pneumonia model, where the ∆algR mutant only displayed delayed 
virulence as compared to wild type PAO1 (Fig. 6.1 A). One explanation for this 
outcome is that in the presence of phospho-defective AlgR (AlgR D54N), the 
protein may have a broad impact on the transcriptome of the organism. Results 
from our microarrays comparing algRD54N and algRD54E support this notion. 
On the other hand, deletion of algR could relieve the transcriptional modulation of 
its regulon, thereby resulting in the regulation of a different set of genes. 
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Microarray analyses with the ∆algR strain under our same conditions would be 
required to confirm this contention. It would also be interesting to determine how 
other acute virulence factors, such as those under the control of PvdS 
(decreased in the algRD54N vs algRD54E) could be differentially regulated by 
∆algR and algRD54N and could explain the discrepancy in virulence.  
The reason for AlgR phosphorylation dependent regulation of both 
twitching motility and rhamnolipid production is unclear at this time. Rhamnolipids 
have been implicated in lowering the surface tension of surfaces to provide better 
motility (409), and our work supports this idea. We also speculate that it could 
play a role in biofilm formation, as both of these factors are required for initial 
colony formation and biofilm maturation. Biofilm formation is especially relevant 
in medical device (e.g. endotracheal tubes, catheters) associated infections (435, 
436).  
 In in vitro biofilms, it has been demonstrated that rhamnolipid production 
facilitates twitching motility, and the coordination of twitching motility and 
rhamnolipids was required for initial colony formation (280). Type IVa pili are 
utilized during early colonization of a biofilm by providing initial surface 
attachment (192). A ∆rhlA mutant showed a higher attachment to the plastic 
surface in a 96-well microtiter assay by 24 hrs (276), and form a flat mat rather 
than mushroom structures (280). Swarming motility requires the coordination of 
the Rhl quorum sensing system, rhamnolipid production, and twitching motility. 
Our work shows that AlgR is one of the critical regulators for these processes. 
Swarming motility is also utilized during early stages of biofilm development, as a 
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hyper-swarming ∆pilA mutant (Fig. 5.1 A) displayed increased cell spread (flat 
biofilm) in a flow-through biofilm model (411).  
The presence of rhamnolipids also aids in detachment of cells from a 
surface, by providing a means of disrupting cell-to-cell or cell-to-surface 
interactions (276, 437, 438). Rhamnolipids are required for bacterial dispersion 
from a mature biofilm structure (281, 439), and over-production of rhamnolipids 
(273, 281) or the exogenous addition of rhamnolipids accelerates dispersion 
(281). In addition, type IVa pili provide structural elements to a biofilm, as a ∆pilA 
was unable to form mushroom head structures (199, 200). 
More recently, it was demonstrated that over the course of an 11 day 
biofilm in a non-mucoid (PAO1) and mucoid strain (PA7), algR expression was 
negatively correlated with rhlA and rhlB expression. Specifically, a decrease in 
algR transcription in PAO1 at later time points (day 7 and beyond) was correlated 
with increased rhlA and rhlB transcription where biofilm rearrangement would 
occur (440). Our data is consistent with this observation, as an algR deletion 
increased rhlA expression and rhamnolipid production in a 6-day biofilm (273). 
Together, these results suggest a preliminary model where AlgR phoshorylation 
levels may act to coordinate rhamnolipid production and twitching motility, 
possibly to aid in either early colonization or biofilm maturation near the caps in 
vitro (Fig. 7.3 A). More investigation measuring algR or algZ transcription, or AlgZ 
kinase activity in an active biofilm would be required to positively associate AlgR 




Figure 7.3. Possible role of AlgR phosphorylation in P. aeruginosa. (A), 
though the signal for AlgZ activation is not yet identified, preliminary evidence 
suggests oxygen concentrations can affect the AlgR phosphorylation-dependent 
fimU promoter activity. Under such conditions, AlgR-P activates twitching motility 
and rhamnolipids, and represses the Rhl quorum sensing system. Anaerobic 
metabolism may also be affected either directly by AlgR (through regulation of 
dnr or other Anr-dependent genes (231)), or through the Rhl quorum sensing 
system by repression of denitrification genes, though these hypotheses require 
experimental verification. Together, AlgR-phosphorylation could help the 
organism establish an acute infection. AlgR is also required for alginate 
production. In situations where the AlgU regulon is activated, AlgR may be critical 
for chronic infections. (B), because twitching motility and rhamnolipid production 
are required for initial surface colonization and mushroom cap formation, AlgR 
phosphorylation may be involved in those two areas in a biofilm.  
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In addition to the above virulence factors, we also measured increased 
pyocyanin production for the algRD54N and ∆algR mutants. Pyocyanin has been 
shown to decrease the bacterial load in a murine acute pneumonia model, as 
phzM, phzS, or pqsR/mvfR mutants in PAO1 or PA14 displayed a 3-fold 
reduction in bacteria 16 hrs post inoculation compared to wild type (441). While  
we observed up to 5-fold induction of pyocyanin production in vitro in algRD54N, 
this strain was attenuated over the course of the infection model (Fig. 6.1). It is 
possible that the decrease in the other virulence factors (type IVa pili and 
rhamnolipids) may have compensated for the increased pyocyanin levels in 
algRD54N. Additionally, we did observe that several mice succumbed to infection 
by the end of the experiments, and perhaps pyocyanin played a role for virulence 
in these mice. 
 
 
AlgR-phosphorylation control of anaerobic metabolism as an alternative 
model for pathogenesis 
 
There is substantial evidence to suggest that P. aeruginosa prefers to 
respire under microaerobic conditions (382, 442). Infecting organisms in the CF 
lung are under a low oxygen or anaerobic environment (443). Macrocolonies of 
P. aeruginosa found in the intraluminal space contain very low oxygen (2.5 
mmHg, compared with 180 mmHg in the bronchial lumen) (444). Additionally, in 
vivo, the organism also grows a more robust biofilm under anaerobic conditions 
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vs aerobic conditions (445). While the role of denitrification and anaerobic 
metabolism is not well-studied in an acute infection in the clinical setting, there 
are indications that these genes are important in P. aeruginosa pathogenesis as 
it transitions into a chronic infection.  
Once the organism establishes a chronic infection, genes required for 
anaerobic metabolism are conserved. This idea is supported by a survey of P. 
aeruginosa isolates from CF patients over time, where the expression of 
anaerobic metabolism genes increased during chronic infection (304). Some of 
these genes and/or proteins that were up-regulated by chronic isolates vs early 
isolates included anr, arcDABC, oprG, and hemN (304). According to our 
previous microarray, there was also overlap between Anr-regulated genes and 
AlgR-repressed genes. Some of the overlapping genes included: arcA (PA5171), 
hemN (PA1546), ccoP2 (PA1555), ccoO2 (PA1556), and ccoN2 (PA1557), oprG 
(PA4067), and hcnB (PA2194) (231), that are expressed during hypoxic or 
microaerobic growth (284, 302). AlgR binding sequences are also found in the 
promoters of ccoN2 (PA1557) and hcnA (PA2193), suggesting direct AlgR 
repression of some of these genes (186, 231, 303). One of the AlgR-regulated 
genes from our previous microarray (231), hemN, has also been shown to be 
required for anaerobic growth (298). The hemN gene encodes a 
coproporphyrinogen III oxidase that is required for the last step of heme 
biosynthesis under anaerobic conditions, and is regulated by both Anr and Dnr 
(297). The hemN and anr genes are also required for virulence in a lettuce-leaf 
model of infection (298). Recently, it was demonstrated that Anr is required for 
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virulence in a murine acute pneumonia model of infection, as there was a 3-log 
reduction in recovery of a ∆anr mutant from the lungs at 24 hrs as compared to 
wild type cells (446).  
The observation that the algRD54N mutant was unable to grow well 
anaerobically on nitrate or nitrite (Fig. 6.2 A B) suggests that denitrification is 
affected in this background. While it appears that AlgR binds to the dnr promoter 
directly, binding is only suggestive of regulation (Fig. 6.2 C). Transcriptional 
analyses would be required to confirm whether AlgR phosphorylation regulates 
dnr or downstream genes under anaerobic conditions, and if it could explain the 
virulence defect caused by algRD54N.  
An alternative reason for the anaerobic growth defect in the algRD54N 
mutant could be through AlgR regulation of the Rhl quorum sensing system. 
Over the course of a chronic infection, such as in CF, mutations in the Las 
system (lasR) (103, 104, 447) or the PQS system (pqsR) (448) are isolated at a 
higher frequency compared to mutations in the Rhl system (rhlR). One of the 
prevailing theories for the expendability of the lasR gene is that mutations in lasR 
provide a growth advantage compared to their isogenic wild type strain (social 
cheating) (447, 449, 450). Another theory is that the quorum sensing systems 
could play an important role in controlling anaerobic metabolism. 
From a microarray determining genes under the control of the quorum 
sensing systems, forty-four genes involved with denitrification were repressed 
(451). Both a ∆lasR and ∆rhlR mutant displayed increased nitrate and nitrite 
reduction under anaerobic conditions (445, 452). The rate of nitrate reductase 
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activity was substantially increased in a ∆rhlI (or ∆lasI) mutant, which was 
suppressed by exogenous addition of C4-HSL (or 3-oxo-C12-HSL) (453). 
Because the Las system is above the Rhl system in its hierarchy, additional 
evidence shows C4-HSL, but not 3-oxo-C12-HSL, represses the anaerobic 
denitrification genes, narK1, nirS, norC, and nosR (453). These results are 
indicative that the Las and Rhl quorum sensing system, specifically through C4-
HSL and RhlR, may be required for repressing denitrification. Incidentally, due to 
the increased rate of denitrification by the ∆lasR or ∆rhlR mutants, nitric oxide 
(NO) production was also increased  (445, 452). When grown in a biofilm under 
anaerobic conditions, the ∆rhlR strain was killed, presumably through over-
production of nitric oxide leading to nitrosative stress (termed “metabolic suicide” 
by the authors) (445). Additionally, C4-HSL production and Rhl quorum sensing 
system gene expression were reduced when P. aeruginosa was grown 
anaerobically (454). These data suggest that it is advantageous for the organism 
to utilize the Rhl quorum sensing system during microaerobic growth, and to shut 
the system down during anaerobiosis.  
We observed increased rhlI transcription and C4-HSL production by the 
algRD54N and ∆algR mutants, indicating that the phosphorylation of AlgR 
represses rhlI expression. We observed reduced growth of the algRD54N mutant 
anaerobically on nitrate and nitrite (Fig. 6.2), which could be explained by the 
increased C4-HSL production (Fig. 5.7), and subsequent repression of the 
denitrification genes by RhlR (Fig. 7.3 B) (453). If this model is correct, we would 
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expect that the overexpression of rhlI should mimic the algRD54N strain when 
grown under anaerobic conditions.  
This hypothesis also elicits the question, why does AlgR phosphorylation 
activate rhamnolipid production, while repressing C4-HSL production? Recently, 
it was observed that increased rhamnolipid production was correlated with 
increased head space of culture flasks (455). It has been proposed that 
rhamnolipids partake in resistance against oxidative stress by forming a foamy 
barrier that reduces oxygen transfer to the cells (78, 455). AlgR phosphorylation, 
therefore, could differentially regulate rhlI and rhlA expression, as a mechanism 





The data shown here strongly indicate that the phosphorylation state of 
AlgR modulates virulence factor production and acute virulence. This work 
provides important preliminary data to establish whether novel antibiotics could 
be developed for the AlgZ/AlgR TCS. Nosocomial P. aeruginosa infections are 
problematic, and the increased incidence of multi-drug resistant strains in the 
clinical setting has called for novel drug targets. New antibiotics for P. aeruginosa 
have not been developed since 2007, with the latest anti-pseudomonal drug 
being doripenem, a carbapenem (456). 
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Novel strategies for combating P. aeruginosa include targeting the quorum 
sensing system (457, 458), boron-based protein synthesis inhibitors, fluorine-
containing tetracyclines, and novel protein synthesis inhibitors (459). Targeting 
two-component systems have also been proposed (460, 461). The advantages of 
developing drugs against two component systems include the fact that these 
bacterial signaling systems are both common and unique to bacteria. Recently, 
compounds that are effective against Streptococcus epidermidis (462), S. aureus 
(463) and Agrobacterium tumefacians (a plant pathogen) (464) have been 
characterized.  
Utilization of the fimU promoter could be a key tool in identifying a novel 
antimicrobial for the AlgZ/AlgR two component system. The fimU promoter is the 
only promoter under the AlgR regulon that is (to our knowledge) exclusively 
activated by the phosphorylated form of AlgR. Strains carrying a fluorescent 
reporter system, such as a fimU::gfp (gfp, encoding green fluorescent protein) 
transcriptional reporter, may be utilized for a high-throughput assay to screen a 
compound library to identify compounds that may inhibit AlgZ or AlgR activity. 
Characterizing the crystal structure of AlgZ may also aid in designing and testing 
compounds that could target the sensor domain and possibiy inhibit the AlgZ 
phosphor-transfer reaction. Additional work to determine the physiological signal 
for AlgZ kinase activity, particularly under infection conditions would also be 
necessary to establish when and how these antimicrobials could be delivered.  
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MICROARRAY DATA  
 
 
Table A.1. Total list of genes regulated in algRD54E vs algRD54N. 
Gene Function Gene Symbol Fold Change p-value 
PA0153 protocatechuate 3,4-dioxygenase, beta subunit pcaH -2.2 0.02 
PA0267 --- --- 2.0 0.03 
PA0307 --- --- 2.1 4.E-03 
PA0308  --- --- 2.1 0.01 
PA0342  thymidylate synthase thyA 2.0 0.01 
PA0449  --- --- -2.3 0.04 
PA0534  --- --- 5.8 0.03 
PA0535  --- --- 3.8 0.02 
PA0595  organic solvent tolerance protein OstA precursor ostA 2.7 0.01 
PA0614  --- --- -6.5 0.04 
PA0617  --- --- -4.5 0.05 
PA0619  --- --- -5.2 0.03 
PA0621  --- --- -3.4 0.04 
PA0622  --- --- -5.1 0.05 
PA0623  --- --- -5.4 0.03 
PA0624  --- --- -4.5 0.03 
PA0625  --- --- -4.6 0.04 
PA0626  --- --- -4.0 0.05 
PA0627  --- --- -7.9 0.03 
PA0628  --- --- -6.8 0.03 
PA0629  --- --- -4.4 0.04 
PA0630  --- --- -4.3 0.04 
PA0631  --- --- -6.0 0.04 
PA0632  --- --- -5.1 0.03 
PA0633  --- --- -6.6 0.03 
PA0635  --- --- -5.8 0.04 
PA0636  --- --- -6.6 0.03 
PA0637  --- --- -5.7 0.04 
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PA0638  --- --- -4.8 0.04 
PA0639  --- --- -6.3 0.03 
PA0643  --- --- -2.6 0.04 
PA0646  --- --- -2.2 0.03 
PA0674  --- --- 2.1 0.05 
PA0706  chloramphenicol acetyltransferase cat 2.5 0.02 
PA0730  --- --- 4.7 2.E-03 
PA0734  --- --- 11.3 0.04 
PA0757  --- --- 2.2 0.04 
PA0758  --- --- 22.2 0.02 
PA0789  --- --- 2.0 1.E-03 
PA0794  --- --- -2.1 0.03 
PA0802  --- --- 2.3 0.03 
PA0807  --- --- -3.0 0.04 
PA0907  --- --- -2.5 0.04 
PA0911  --- --- -3.9 0.04 
PA0918  --- --- -2.4 0.01 
PA0921  --- --- 3.7 0.01 
PA0929  --- pirR 2.2 0.03 
PA0941  --- --- -2.1 0.01 
PA0968  --- --- 2.3 0.01 
PA0983  --- --- -2.1 0.01 
PA0997  Homologous to beta-keto-acyl-acyl-carrier protein synthase pqsB -2.8 2.E-03 
PA0998  Homologous to beta-keto-acyl-acyl-carrier protein synthase pqsC -2.6 2.E-03 
PA0999  3-oxoacyl-[acyl-carrier-protein] synthase III pqsD -2.4 5.E-03 
PA1055  --- --- -2.3 0.01 
PA1077  flagellar basal-body rod protein FlgB flgB 3.1 0.02 
PA1078  flagellar basal-body rod protein FlgC flgC 2.3 0.02 
PA1081  flagellar basal-body rod protein FlgF flgF 3.0 0.01 
PA1116  --- --- 4.8 0.01 
PA1118  --- --- -2.3 0.02 
PA1135  --- --- -2.6 0.02 
PA1172  cytochrome c-type protein NapC napC -3.1 0.03 
PA1173  cytochrome c-type protein NapB precursor napB -4.4 0.02 
PA1174  periplasmic nitrate reductase protein NapA napA -3.7 0.02 
PA1192  --- --- 2.4 0.02 
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PA1193  --- --- 2.1 0.01 
PA1202  --- --- -2.3 0.01 
PA1216  --- --- -3.4 0.03 
PA1217  --- --- -2.5 0.04 
PA1218  --- --- -2.2 0.01 
PA1300  --- --- 2.8 3.E-04 





phnW -2.5 1.E-03 
PA1333 --- --- -3.6 1.E-03 
PA1363  --- --- 3.3 0.04 
PA1562  aconitate hydratase 1 acnA -2.0 0.01 
PA1606  --- --- 2.6 0.03 
PA1688  --- --- 2.0 0.03 
PA1737  --- --- -2.1 0.04 
PA1744  --- --- -3.7 3.E-06 
PA1860  --- --- -2.4 0.03 
PA1970  --- --- -17.3 7.E-06 
PA2023  UTP--glucose-1-phosphate uridylyltransferase galU 2.1 0.01 
PA2024  --- --- -2.7 0.02 
PA2053  carbonate dehydratase cynT -2.4 0.03 
PA2274  --- --- -3.8 2.E-03 
PA2378  --- --- -2.1 3.E-03 
PA2422  --- --- -2.1 0.03 
PA2426  sigma factor PvdS pvdS 3.2 0.03 
PA2428  --- --- 5.3 5.E-03 
PA2486  --- --- -20.5 2.E-05 
PA2491  --- --- -9.0 8.E-07 
PA2493  
Resistance-Nodulation-Cell 
Division (RND) multidrug efflux 
membrane fusion protein MexE 
mexE -14.2 2.E-03 
PA2494  
Resistance-Nodulation-Cell 
Division (RND) multidrug efflux 
transporter MexF 
mexF -13.1 3.E-03 
PA2495  
Multidrug efflux outer 
membrane protein OprN 
precursor 
oprN -13.0 1.E-03 
PA2507  catechol 1,2-dioxygenase catA -17.5 0.04 
PA2508  muconolactone delta-isomerase catC -11.8 0.03 
PA2519  transcriptional regulator XylS xylS -4.1 0.01 
PA2532  thiol peroxidase tpx -3.3 4.E-05 
PA2638  NADH dehydrogenase I chain B nuoB -2.0 0.02 
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PA2759  --- --- -36.8 1.E-06 
PA2762  --- --- -3.8 0.05 
PA2805  --- --- -2.3 0.04 
PA2811  --- --- -3.8 9.E-04 
PA2812  --- --- -3.2 4.E-04 
PA2813  --- --- -4.3 5.E-05 
PA2827  --- --- -2.1 0.01 
PA2906  --- --- 2.1 0.03 
PA2937  --- --- -2.7 0.04 
PA2946  --- --- 2.3 0.01 
PA2983  --- --- 2.3 0.01 
PA3104  secretion protein XcpP xcpP 2.5 0.01 
PA3120  3-isopropylmalate dehydratase small subunit leuD -2.1 2.E-03 
PA3121 3-isopropylmalate dehydratase large subunit leuC -2.2 4.E-03 
PA3129  --- --- 2.1 0.04 
PA3141  nucleotide sugar epimerase/dehydratase WbpM wbpM 2.2 0.05 
PA3229  --- --- -24.0 4.E-04 
PA3235  --- --- -2.5 0.04 
PA3236  --- --- -4.4 0.02 
PA3308  RNA helicase HepA hepA 2.0 0.03 
PA3397  ferredoxin--NADP+ reductase fpr 6.2 5.E-03 
PA3409  --- --- 2.4 0.02 
PA3410  --- --- 6.0 0.01 
PA3430  --- --- -2.4 0.02 
PA3525  argininosuccinate synthase argG 2.2 3.E-03 
PA3537  ornithine carbamoyltransferase, anabolic argF 3.2 4.E-03 
PA3620  DNA mismatch repair protein MutS mutS 2.4 1.E-04 
PA3628  --- --- -3.1 0.02 
PA3629  alcohol dehydrogenase class III adhC -3.0 0.02 
PA3635  enolase eno 2.0 0.03 
PA3645  (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase fabZ 2.1 0.01 
PA3648  --- --- 2.4 3.E-04 
PA3686  adenylate kinase adk 2.4 4.E-03 
PA3717  --- --- 2.1 0.03 
PA3722  --- --- 3.0 0.02 
PA3742  50S ribosomal protein L19 rplS 2.4 0.01 
PA3743  tRNA (guanine-N1)-methyltransferase trmD 3.7 0.01 
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PA3744  16S rRNA processing protein rimM 3.2 0.01 
PA3745  30S ribosomal protein S16 rpsP 3.2 0.01 
PA3746  signal recognition particle protein Ffh ffh 2.1 1.E-03 
PA3763  phosphoribosylformylglycinamidine synthase purL 2.0 7.E-04 
PA3779  --- --- 2.3 0.03 
PA3818  --- --- 2.5 0.01 
PA3828  --- --- 2.0 0.01 
PA3904 --- --- 3.1 0.02 
PA3905  --- --- 2.2 0.04 
PA3906  --- --- 2.4 0.03 
PA3919  --- --- -2.1 0.01 
PA4004  --- --- 2.0 1.E-03 
PA4042 exodeoxyribonuclease VII small subunit xseB 2.0 0.01 
PA4043 geranyltranstransferase ispA 2.3 0.01 
PA4069  --- --- 2.5 0.02 
PA4070  --- --- -2.8 2.E-03 
PA4139  --- --- -6.4 0.02 
PA4181  --- --- 2.2 0.02 
PA4205  hypothetical protein mexG -2.4 2.E-03 
PA4207  
probable Resistance-
Nodulation-Cell Division (RND) 
efflux transporter 
mexI -2.0 1.E-03 
PA4208  probable outer membrane protein precursor opmD -2.3 7.E-05 
PA4236  catalase katA -2.3 0.01 
PA4262  50S ribosomal protein L4 rplD 2.1 0.04 
PA4263  50S ribosomal protein L3 rplC 2.0 0.03 
PA4269  DNA-directed RNA polymerase beta* chain rpoC 2.1 0.01 
PA4276  secretion protein SecE secE 2.6 0.01 
PA4317  --- --- 2.1 0.02 
PA4354  --- --- -2.8 2.E-03 
PA4356  xenobiotic reductase xenB -2.3 0.01 
PA4433  50S ribosomal protein L13 rplM 2.4 0.04 
PA4451  --- --- 2.1 0.01 
PA4456  --- --- 2.3 0.03 
PA4471  --- --- 2.1 0.01 
PA4481  rod shape-determining protein MreB mreB 2.4 0.01 
PA4550  type 4 fimbrial biogenesis protein FimU fimU 23.7 0.02 
PA4551  type 4 fimbrial biogenesis protein PilV pilV 21.0 0.02 
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PA4552  type 4 fimbrial biogenesis protein PilW pilW 22.9 0.02 
PA4553  type 4 fimbrial biogenesis protein PilX pilX 12.0 0.03 
PA4554  type 4 fimbrial biogenesis protein PilY1 pilY1 13.8 0.03 
PA4555  type 4 fimbrial biogenesis protein PilY2 pilY2 11.1 0.03 
PA4556  type 4 fimbrial biogenesis protein PilE pilE 6.8 0.04 
PA4563  30S ribosomal protein S20 rpsT 3.0 0.03 
PA4602  serine hydroxymethyltransferase glyA3 2.9 0.03 
PA4611  --- --- -2.2 0.05 
PA4623 --- --- -18.4 2.E-06 
PA4627  --- --- 2.3 0.03 
PA4674  --- --- -2.1 0.04 
PA4675  --- --- 2.2 0.01 
PA4702  --- --- -2.3 0.05 
PA4743  ribosome-binding factor A rbfA 2.8 0.01 
PA4746  --- --- 2.6 0.01 
PA4748  triosephosphate isomerase tpiA 2.8 0.03 
PA4765  Outer membrane lipoprotein OmlA precursor omlA 2.3 4.E-03 
PA4811  nitrate-inducible formate dehydrogenase, beta subunit fdnH -3.0 0.02 
PA4844  --- --- 4.4 0.01 
PA4852  --- --- 2.6 0.03 
PA4853  DNA-binding protein Fis fis 3.0 0.01 
PA4881  --- --- -38.5 9.E-07 
PA4896  --- --- 5.3 0.01 
PA4899  --- --- -3.0 0.03 
PA4954 chemotaxis protein MotA motA 2.1 0.02 
PA4963  --- --- 2.0 0.01 
PA5129  glutaredoxin grx 2.0 0.03 
PA5130  --- --- 2.6 0.01 
PA5192  phosphoenolpyruvate carboxykinase pckA 2.5 0.03 
PA5274  nucleoside diphosphate kinase regulator rnk 2.5 5.E-04 
PA5298  --- --- 2.4 0.01 
PA5305  --- --- -2.2 3.E-03 
PA5360  two-component response regulator PhoB phoB 7.6 3.E-03 
PA5361  two-component sensor PhoR phoR 2.4 0.01 
PA5367 membrane protein component of ABC phosphate transporter pstA 2.8 0.04 
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PA5368 membrane protein component of ABC phosphate transporter pstC 3.1 2.E-03 
PA5369  --- --- 8.3 0.01 
PA5378  --- --- -3.3 0.01 
PA5379 L-serine dehydratase sdaB -3.4 0.01 
PA5380  --- --- -2.2 0.02 
PA5396  --- --- -5.8 0.01 
PA5397  --- --- -6.6 0.01 
PA5398  --- --- -5.0 0.01 
PA5399  --- --- -3.1 0.01 
PA5400  --- --- -2.0 0.01 
PA5401  --- --- -3.2 0.01 
PA5409  --- --- -2.1 1.E-03 
PA5410  --- --- -6.0 0.02 







glyA2 -4.2 0.01 
PA5416  sarcosine oxidase beta subunit soxB -4.8 0.02 
PA5417  sarcosine oxidase delta subunit soxD -5.4 0.02 
PA5418  sarcosine oxidase alpha subunit soxA -4.0 0.02 
PA5419  sarcosine oxidase gamma subunit soxG -4.2 0.01 
PA5420  formyltetrahydrofolate deformylase purU2 -3.4 0.01 
PA5421  glutathione-independent formaldehyde dehydrogenase fdhA -5.6 0.01 
PA5426 phosphoribosylaminoimidazole carboxylase, catalytic subunit purE 2.5 2.E-03 
PA5494  --- --- -2.2 0.04 
PA5554 ATP synthase beta chain atpD 2.1 0.01 
PA5555  ATP synthase gamma chain atpG 2.2 0.02 
PA5560  ATP synthase A chain atpB 3.0 1.E-03 
PA5569  ribonuclease P protein component rnpA 2.6 0.01 




Table A.2. Total list of genes regulated in algRD54N vs PAO1. 
 
Gene Function Gene Symbol Fold Change p-value 
PA0228  beta-ketoadipyl CoA thiolase PcaF pcaF 4.2 0.05 
PA0232  gamma-carboxymuconolactone decarboxylase pcaC 3.2 0.05 
PA0433  --- --- -2.3 0.01 
PA0449  --- --- 2.3 0.04 
PA0595  organic solvent tolerance protein OstA precursor ostA -2.1 0.05 
PA0614  --- --- 6.5 0.04 
PA0619  --- --- 4.9 0.04 
PA0622  --- --- 5.2 0.05 
PA0623  --- --- 4.4 0.04 
PA0625  --- --- 4.5 0.04 
PA0626  --- --- 4.3 0.04 
PA0627  --- --- 7.8 0.03 
PA0628  --- --- 6.1 0.03 
PA0629  --- --- 4.1 0.05 
PA0631  --- --- 5.5 0.04 
PA0633  --- --- 6.6 0.03 
PA0634  --- --- 4.5 0.04 
PA0635  --- --- 5.9 0.04 
PA0636  --- --- 6.5 0.03 
PA0637  --- --- 6.1 0.03 
PA0638  --- --- 4.9 0.03 
PA0639  --- --- 7.2 0.03 
PA0706  chloramphenicol acetyltransferase cat -2.1 0.04 
PA0826  tmRNA ssrA 2.1 0.03 
PA0911  --- --- 4.2 0.03 
PA0997  Homologous to beta-keto-acyl-acyl-carrier protein synthase pqsB 2.8 2.E-03 
PA0998  Homologous to beta-keto-acyl-acyl-carrier protein synthase pqsC 2.3 4.E-03 
PA0999  3-oxoacyl-[acyl-carrier-protein] synthase III pqsD 2.1 0.01 
PA1077  flagellar basal-body rod protein FlgB flgB -2.7 0.03 
PA1078  flagellar basal-body rod protein FlgC flgC -2.2 0.03 
PA1081  flagellar basal-body rod protein FlgF flgF -2.2 0.03 
PA1123  --- --- -5.1 0.04 
PA1135  --- --- 2.4 0.03 
PA1151  pyocin S2 immunity protein imm2 2.9 0.04 
PA1156  ribonucleoside reductase, large chain nrdA -2.2 0.01 
PA1173  cytochrome c-type protein NapB precursor napB 3.8 0.02 
PA1174  periplasmic nitrate reductase protein NapA napA 2.9 0.05 
PA1202  --- --- 2.3 0.01 
PA1216  --- --- 3.3 0.04 
PA1218  --- --- 2.1 0.02 
PA1300  --- --- -2.8 3.E-04 
PA1301  --- --- -2.4 4.E-03 
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PA1310  2-aminoethylphosphonate:pyruvate aminotransferase phnW 2.2 3.E-03 
PA1333  --- --- 2.8 5.E-03 
PA1562  aconitate hydratase 1 acnA 2.1 0.02 
PA1744  --- --- 2.7 3.E-05 
PA1942  --- --- 2.1 4.E-05 
PA1970  --- --- 19.6 5.E-06 
PA2023  UTP--glucose-1-phosphate uridylyltransferase galU -2.1 0.01 
PA2034  --- --- -2.4 0.02 
PA2274  --- --- 5.0 7.E-04 
PA2299  --- --- -2.1 0.05 
PA2300  chitinase chiC -3.2 0.04 
PA2378  --- --- 2.1 3.E-03 
PA2384  --- --- -4.6 0.02 
PA2402  --- --- -3.5 0.04 
PA2406  --- --- -2.8 0.04 
PA2411  --- --- -3.6 0.05 
PA2427  --- --- -3.9 0.05 
PA2486  --- --- 21.6 2.E-05 
PA2491  --- --- 6.1 3.E-06 
PA2493  
Resistance-Nodulation-Cell Division 
(RND) multidrug efflux membrane 
fusion protein MexE 
mexE 17.6 1.E-03 
PA2494  
Resistance-Nodulation-Cell Division 
(RND) multidrug efflux transporter 
MexF 
mexF 15.4 2.E-03 
PA2495  Multidrug efflux outer membrane protein OprN precursor oprN 12.8 1.E-03 
PA2507  catechol 1,2-dioxygenase catA 24.9 0.03 
PA2508  muconolactone delta-isomerase catC 19.1 0.01 
PA2519  transcriptional regulator XylS xylS 4.9 0.01 
PA2532  thiol peroxidase tpx 2.8 9.E-05 
PA2759  --- --- 24.9 3.E-06 
PA2762  --- --- 5.4 0.02 
PA2811  --- --- 3.6 1.E-03 
PA2812  --- --- 2.7 1.E-03 
PA2813  --- --- 4.0 8.E-05 
PA2946  --- --- -2.0 0.01 
PA3229  --- --- 21.7 5.E-04 
PA3236  --- --- 6.4 0.01 
PA3478  rhamnosyltransferase chain B rhlB -2.3 0.03 
PA3620  DNA mismatch repair protein MutS mutS -2.4 1.E-04 
PA3628  --- --- 3.0 0.02 
PA3629  alcohol dehydrogenase class III adhC 3.1 0.01 
PA3648  --- --- -2.2 7.E-04 
PA3686  adenylate kinase adk -2.3 5.E-03 
PA4070  --- --- 2.0 0.01 
PA4142  --- --- -2.5 3.E-03 
PA4205  hypothetical protein mexG 2.9 4.E-04 
PA4206  
probable Resistance-Nodulation-Cell 
Division (RND) efflux membrane 
fusion protein precu 
mexH 2.4 8.E-04 
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PA4207  probable Resistance-Nodulation-Cell Division (RND) efflux transporter mexI 2.3 3.E-04 
PA4208  probable outer membrane protein precursor opmD 2.2 1.E-04 
PA4354  --- --- 4.0 3.E-04 
PA4467  --- --- -3.1 0.01 
PA4468  superoxide dismutase sodM -2.1 0.03 
PA4470  fumarate hydratase fumC1 -2.4 0.03 
PA4471  --- --- -2.4 5.E-03 
PA4623  --- --- 13.6 4.E-06 
PA4674  --- --- 2.1 0.05 
PA4765  Outer membrane lipoprotein OmlA precursor omlA -2.1 0.01 
PA4811  nitrate-inducible formate dehydrogenase, beta subunit fdnH 2.4 0.05 
PA4853  DNA-binding protein Fis fis -2.2 0.05 
PA4881  --- --- 36.9 1.E-06 
PA4896  --- --- -3.2 0.04 
PA5129  glutaredoxin grx -2.0 0.03 
PA5298  --- --- -2.0 0.02 
PA5378  --- --- 2.5 0.02 
PA5379  L-serine dehydratase sdaB 3.1 0.02 
PA5380  --- --- 2.1 0.03 
PA5396  --- --- 7.3 0.01 
PA5397  --- --- 9.1 0.01 
PA5398  --- --- 6.2 4.E-03 
PA5399  --- --- 2.8 0.01 
PA5401  --- --- 3.1 0.01 
PA5410  --- --- 7.4 0.01 
PA5411  --- --- 3.7 0.02 
PA5415  serine hydroxymethyltransferase /// serine hydroxymethyltransferase 
glyA1 /// 
glyA2 3.7 0.01 
PA5416  sarcosine oxidase beta subunit soxB 5.9 0.01 
PA5417  sarcosine oxidase delta subunit soxD 6.1 0.02 
PA5418  sarcosine oxidase alpha subunit soxA 4.4 0.02 
PA5419  sarcosine oxidase gamma subunit soxG 4.4 0.01 
PA5420  formyltetrahydrofolate deformylase purU2 3.5 0.01 
PA5421  glutathione-independent formaldehyde dehydrogenase fdhA 6.5 3.E-03 
PA5426  phosphoribosylaminoimidazole carboxylase, catalytic subunit purE -2.1 0.01 
PA5497  --- --- -2.6 0.03 
PA5554  ATP synthase beta chain atpD -2.2 0.01 
PA5555  ATP synthase gamma chain atpG -2.4 0.01 
PA5556  ATP synthase alpha chain atpA -2.2 0.01 
PA5557  ATP synthase delta chain atpH -2.0 0.01 
PA5560  ATP synthase A chain atpB -2.7 2.E-03 
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